Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3006184	cb-hb	g/l (g/l)	5367	14812	0.00%
3006184	cb-hb	— (—)	2788	3769	100.00%	Distribution not available
3006184	b-hb-vt	g/l (g/l)	1243	2727	0.00%
3006184	cb-hb-hy	g/l (g/l)	938	1576	0.00%
3006184	b-hb-vt	— (g/l)	722	1021	0.00%
3006184	cb-hb	g/l_______ (g/l)	224	361	0.00%
3006184	cb-chb	g/L (g/l)	108	262	0.00%
3006184	b-hb-vt	g/L (g/l)	104	184	0.00%
3006184	cb-thb	g/l (g/l)	19	22	0.00%
3006184	b-hb-vt	G/L (g/l)	9	11	0.00%	Distribution not available
3006184	cb-chb	— (—)	8	16	100.00%	Distribution not available
3006184	cb-hb-hy	— (—)	5	5	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Care involving dialysis

470

663

8.06

322.83

5.7

2.0

118.98

132.93

g/l

22.18

427

500

Secondary hypertension

372

387

10.39

318.33

4.7

1.8

125.65

134.05

g/l

6.34

353

281

Abnormalities of breathing

2247

5172

2.54

308.54

2.5

2.1

131.68

130.87

g/l

0.70

1732

4100

Other interstitial pulmonary diseases

846

1724

5.45

307.65

2.6

2.3

128.48

127.53

g/l

0.34

410

1374

2721

5113

3.21

307.65

2.8

1.9

126.69

132.57

g/l

21.69

2106

3931

Asthma

1834

3158

3.07

307.65

2.4

1.8

132.14

133.25

g/l

0.93

1376

2637

Dialysis, with operation codes

620

1122

6.09

307.65

5.4

2.0

118.81

133.21

g/l

32.65

552

829

Chronic kidney disease

1661

3526

4.92

307.65

3.9

2.0

121.90

130.13

g/l

29.09

1450

2649

Other respiratory diseases principally affecting the interstitium

920

2039

4.94

307.65

2.7

2.3

126.62

127.45

g/l

0.31

477

1631

All chronic kidney diseases

2231

4636

4.05

307.65

3.5

1.9

123.47

132.53

g/l

44.20

1897

3400

Implicit bacterial Sepsis

1577

4035

3.52

307.65

3.5

1.9

123.15

130.57

g/l

21.72

1287

2995

Interstitial lung disease endpoints

846

1731

5.43

307.65

2.6

2.3

128.48

127.38

g/l

0.41

410

1381

Interstitial lung disease

846

1731

5.43

307.65

2.6

2.3

128.48

127.38

g/l

0.41

410

1381

ILD, hospital admissions 1, main diag only

746

1520

5.47

307.65

2.6

2.3

128.73

127.24

g/l

0.56

350

1219

Respiratory insufficiency

476

535

9.96

307.65

4.6

1.8

135.91

128.54

g/l

5.17

367

446

Renal failure

2218

4819

4.19

307.65

3.7

2.0

121.87

130.69

g/l

42.74

1900

3586

Condition for Implicit Sepsis (Organ dysfunction codes)

2511

6276

2.86

307.65

3.1

1.8

127.99

132.71

g/l

14.26

2032

4704

Bacterial Sepsis

1755

4393

3.46

307.65

3.4

1.9

123.21

130.93

g/l

26.07

1431

3259

All-cause Heart Failure

1954

4673

3.04

307.65

3.2

2.1

125.54

130.11

g/l

10.07

1559

3491

Heart failure and antihypertensive medication

895

1062

5.80

307.65

3.5

1.7

126.54

132.14

g/l

5.56

714

757

ILD, hospital admission 2, with pulmonary infections

610

817

8.48

307.65

2.9

1.9

127.25

128.26

g/l

0.29

332

620

Renal tubulo-interstitial diseases

2988

6800

3.35

307.65

3.2

1.9

124.46

133.02

g/l

55.52

2502

5053

COPD (mode)

1095

1827

4.93

307.65

3.0

1.9

131.03

131.28

g/l

0.10

804

1492

Heart failure, not strict

2502

4932

3.56

307.65

3.2

1.9

125.94

133.12

g/l

28.97

2002

3630

Implicit Sepsis, including avohilmo

2548

6273

3.00

307.65

3.1

1.8

127.98

132.60

g/l

13.86

2052

4708

Explicit Sepsis, including avohilmo

1587

4490

3.35

307.65

3.4

1.9

121.26

131.11

g/l

39.28

1339

3343

Asthma, unspecified (mode), excluding more controls

1410

2635

3.95

307.65

2.5

1.8

131.20

133.60

g/l

2.62

1064

2203

Anaemias

639

604

7.05

307.65

3.2

1.9

119.49

135.63

g/l

40.85

536

488

All kidney diseases

3011

6893

3.02

307.65

3.0

1.9

125.63

133.70

g/l

49.38

2510

5140

Other disorders of fluid, electrolyte and acid-base balance

1169

3193

3.63

307.65

3.3

2.1

123.75

129.10

g/l

9.65

1010

2376

All pneumoniae

3115

6816

3.07

307.65

2.9

1.9

126.95

133.56

g/l

32.26

2418

5273

Influenza and pneumonia

3112

6706

2.95

307.65

2.8

1.9

127.28

133.53

g/l

29.31

2419

5191

Other bacterial diseases, including avohilmo

2736

6910

2.53

307.65

2.9

1.9

125.60

134.00

g/l

47.43

2196

5271

Viral Sepsis

880

2085

4.51

307.65

3.6

1.9

126.47

130.02

g/l

3.42

730

1592

Other bacterial diseases

2727

6947

2.68

307.65

3.0

2.0

124.61

133.63

g/l

54.45

2205

5275

Implicit viral Sepsis, including avohilmo

1138

3188

3.75

307.65

3.4

1.9

126.89

130.03

g/l

3.40

916

2406

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3017

6920

3.00

307.65

2.8

1.9

126.53

133.48

g/l

35.13

2354

5342

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

655

393

13.07

307.65

2.7

1.8

128.35

129.69

g/l

0.34

309

307

Implicit Sepsis

2495

6031

3.16

307.65

3.2

1.9

127.51

132.25

g/l

14.19

2025

4509

Pneumonia, organism unspecified

2909

6373

3.24

307.65

2.9

1.9

126.44

133.50

g/l

34.95

2287

4917

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2862

7454

2.66

307.65

2.8

2.0

121.34

134.23

g/l

103.21

2207

5757

ILD, hospital admissions 3, with pneumonia sepsis

530

743

8.13

307.65

3.1

2.0

126.28

128.51

g/l

0.84

312

573

ILD, hospital admissions

842

1699

5.52

307.65

2.6

2.3

128.39

127.50

g/l

0.31

406

1361

Implicit bacterial Sepsis, including avohilmo

1720

4298

3.49

307.65

3.4

1.9

123.59

130.82

g/l

22.22

1393

3184

Dyspnoea

2597

7560

2.55

307.65

2.6

2.1

130.34

130.09

g/l

0.17

1955

5884

Heart failure,strict

1837

3728

3.61

307.65

3.3

1.9

125.98

132.18

g/l

16.12

1477

2742

Covid-19 confirmed case

1648

4309

4.07

307.65

3.3

2.1

126.65

129.26

g/l

3.59

1370

3299

Implicit viral Sepsis

880

2085

4.51

307.65

3.6

1.9

126.47

130.02

g/l

3.42

730

1592

Pneumonias (Asthma/COPD co-morbidities)

3112

6800

3.09

307.65

2.8

1.9

126.81

133.64

g/l

34.16

2416

5255

Septicaemia

1512

4471

3.22

307.65

3.5

2.1

120.92

131.46

g/l

43.60

1271

3371

Explicit Sepsis

1560

4414

3.36

307.65

3.4

1.9

121.39

131.00

g/l

37.16

1316

3296

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2533

6283

2.80

307.65

3.1

1.8

128.47

133.09

g/l

13.81

2072

4718

Asthma, unspecified (mode)

1463

3012

3.62

307.65

2.5

1.8

130.89

132.79

g/l

1.89

1110

2509

Bacterial infection, other or unspecified, including avohilmo

1797

5443

2.80

307.65

3.1

2.0

122.66

132.33

g/l

44.15

1453

4086

Other septicaemia

1363

4131

3.26

307.65

3.5

2.1

120.52

131.01

g/l

39.06

1151

3115

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2721

5113

3.21

307.65

2.8

1.9

126.69

132.57

g/l

21.69

2106

3931

Other septicaemia, including avohilmo

1389

4199

3.25

307.65

3.5

2.1

120.40

131.26

g/l

41.96

1174

3164

Heart failure, strict

1986

4743

3.04

307.65

3.2

2.1

125.53

130.27

g/l

10.91

1586

3542

Asthma, excluding more controls

1740

2769

3.31

307.65

2.4

1.8

132.29

134.05

g/l

1.78

1304

2320

Acute renal failure

950

2343

4.34

307.65

4.2

2.0

119.22

130.65

g/l

32.36

810

1752

Asthma (only as main-diagnosis), excluding more controls

1574

2769

3.22

307.65

2.3

1.8

133.00

134.05

g/l

0.78

1175

2320

Provisional assignment of new diseases of uncertain etiology

1869

6049

3.20

307.65

3.1

2.1

127.49

130.21

g/l

4.49

1528

4669

Codes for special purposes

1871

6054

3.20

307.65

3.1

2.1

127.48

130.22

g/l

4.56

1530

4672

Nephropathy related operations

616

1190

5.73

307.59

5.6

2.1

118.59

131.61

g/l

28.41

553

915

Fever of other and unknown origin

1614

5049

2.85

307.09

3.0

2.1

125.14

131.76

g/l

19.71

1326

3838

Other diseases of pleura

1566

4861

2.92

306.99

3.4

2.1

128.29

128.44

g/l

0.07

1166

3746

Other heart diseases

1083

1885

3.84

304.16

2.8

1.7

130.64

135.92

g/l

7.46

847

1416

Early onset COPD, excluding more controls

651

1321

5.19

302.26

2.9

1.9

134.12

132.99

g/l

0.42

453

1081

Malaise and fatigue

1561

4347

2.92

301.63

2.5

2.1

128.32

130.87

g/l

3.44

1291

3263

Persons encountering health services for specific procedures and health care

2684

7029

2.30

300.96

2.9

2.0

126.87

133.51

g/l

30.51

2167

5357

Non-invasive ventilation

708

1280

4.97

300.51

3.2

1.7

128.70

132.72

g/l

3.48

624

953

Transplanted organ and tissue status

494

790

6.94

300.22

4.8

2.2

121.86

132.75

g/l

13.80

400

593

Asthma (only as main-diagnosis)

1633

3158

2.96

294.59

2.3

1.8

132.61

133.25

g/l

0.42

1216

2637

ILD medications: prednisolone, methylprednisolone, prednisone

2718

6759

2.28

294.16

2.8

2.0

128.63

131.86

g/l

7.56

2017

5454

Metabolic disorders

2383

6126

2.39

290.70

2.7

2.0

128.44

132.08

g/l

8.37

1898

4627

Oral corticosteroids

2714

7211

2.25

289.42

2.6

2.1

129.55

131.17

g/l

2.27

1989

5745

Type 2 diabetes, wide definition

2091

5372

2.52

288.87

2.8

2.0

128.42

130.72

g/l

3.26

1696

3953

L04AD Calcineurin inhibitors

518

902

6.33

288.63

4.7

2.2

121.70

132.68

g/l

14.76

417

704

Acute tubulo-interstitial nephritis

1741

5685

2.66

288.21

2.9

1.9

124.12

131.85

g/l

29.55

1437

4233

COPD

1478

4283

2.92

285.21

2.9

2.2

130.41

127.97

g/l

2.52

1058

3323

Bacterial infection, other or unspecified

1627

5181

2.74

283.70

3.1

2.0

122.17

132.06

g/l

41.78

1310

3898

Hypertensive diseases (excluding secondary)

1111

1805

3.67

282.56

2.8

1.6

131.61

135.90

g/l

5.63

928

1340

Other medical care

1493

4613

2.81

272.97

3.1

2.0

120.72

131.48

g/l

45.27

1224

3432

ILD medications: immunosuppressive drugs

1679

6007

2.60

270.26

3.2

2.0

125.66

132.62

g/l

22.03

1203

4828

Asthma (mode)

1662

3188

2.80

266.96

2.3

1.8

131.98

133.32

g/l

1.19

1266

2657

ILD medications

2729

6874

2.18

263.69

2.8

2.0

128.63

131.97

g/l

8.16

2009

5553

Diseases of arteries, arterioles and capillaries (FINNGEN)

657

928

5.09

262.89

3.3

1.7

125.19

134.33

g/l

11.34

515

647

Other chronic obstructive pulmonary disease

1393

4151

2.86

259.40

2.9

2.2

130.14

127.92

g/l

2.10

1012

3222

Glomerular diseases

729

1858

4.20

255.98

4.4

2.2

122.97

130.02

g/l

10.80

652

1423

Heart failure and coronary heart disease

1398

3525

2.90

255.38

3.3

2.1

124.89

128.78

g/l

5.51

1148

2619

Insulin medication

1683

5728

2.51

246.06

3.1

2.1

126.82

130.94

g/l

8.44

1455

4295

First line medication for Crohn's disease

2601

6605

2.16

245.04

2.7

2.0

128.00

132.44

g/l

13.08

1943

5300

Inflammatory bowel disease treatment related agents

2738

7418

2.09

238.49

2.7

2.1

129.38

131.30

g/l

3.13

2028

5923

COPD/asthma/ILD related infections

2271

5113

2.27

235.64

2.6

1.9

128.77

132.57

g/l

9.06

1765

3931

COPD/asthma related infections

2271

5113

2.27

235.64

2.6

1.9

128.77

132.57

g/l

9.06

1765

3931

Heart failure and bmi 25plus

1209

2788

3.03

234.71

3.3

2.1

127.34

131.05

g/l

4.31

970

2110

Idiopathic pulmonary fibrosis

453

852

6.02

234.56

2.6

2.3

130.71

126.96

g/l

1.40

198

686

Infections, IBD-co-morbidities

475

560

6.23

234.52

3.2

1.9

122.96

131.22

g/l

7.42

379

446

Hypertension, essential

1675

3776

2.56

233.36

2.5

1.8

130.72

133.61

g/l

4.07

1350

2715

Other diseases of the respiratory system

812

2371

3.64

233.34

4.0

2.2

131.90

126.80

g/l

5.34

631

1830

Other respiratory disorders and diseases

812

2371

3.64

233.34

4.0

2.2

131.90

126.80

g/l

5.34

631

1830

Kidney transplant status

317

417

8.77

232.22

5.6

2.2

121.13

133.25

g/l

11.26

296

326

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1856

7137

2.33

231.99

2.5

2.2

128.04

129.53

g/l

1.42

1179

5687

Viral pneumonia

517

1089

5.08

231.46

3.7

2.0

127.73

131.03

g/l

1.91

417

845

Other pulmonary diagnosis

1628

3185

2.61

227.14

2.4

1.8

129.79

133.24

g/l

5.51

1227

2663

Glomerular disorders in diseases classified elsewhere

527

1153

4.98

226.83

4.6

2.1

122.16

130.35

g/l

10.68

468

885

Other heart diseases, wide

2017

5435

2.29

225.78

2.6

1.9

130.16

133.55

g/l

6.52

1579

4179

Cardiovascular diseases (excluding rheumatic etc)

1247

2482

2.93

224.28

2.6

1.8

133.18

135.66

g/l

2.71

1023

1929

L04AA Selective immunosuppressants

748

2126

3.71

223.12

4.1

2.1

124.31

131.06

g/l

9.78

568

1638

Later onset COPD, excluding more controls

685

1316

4.17

223.08

3.1

1.9

127.37

129.53

g/l

1.16

511

1070

Chronic lower respiratory diseases

2835

7535

2.02

223.03

2.5

2.2

131.75

130.53

g/l

1.51

2126

5977

Erysipelas, including avohilmo

1846

6052

2.31

221.39

2.8

2.0

126.73

133.58

g/l

22.75

1456

4550

Asthma-related infections

1630

6856

2.38

220.16

2.6

2.2

130.58

129.76

g/l

0.65

1228

5392

Asthma, hospital admission 2, infections

1630

6856

2.38

220.16

2.6

2.2

130.58

129.76

g/l

0.65

1228

5392

Atrial fibrillation and flutter

713

1146

4.14

220.14

2.7

1.7

129.89

135.39

g/l

4.86

544

807

COPD, hospital admissions

1403

4722

2.60

219.12

2.9

2.2

129.88

128.05

g/l

1.60

1019

3626

Hypertensive diseases

1671

3877

2.48

218.35

2.6

1.8

130.89

133.63

g/l

3.86

1365

2800

Hypertension

1670

3876

2.48

217.98

2.6

1.8

130.88

133.63

g/l

3.88

1364

2800

ILD differential diagnosis

1605

3188

2.57

217.42

2.4

1.8

129.69

133.32

g/l

5.89

1204

2657

Cardiac arrhythmias

1238

2859

2.83

217.29

2.4

1.7

132.41

133.95

g/l

1.17

957

2157

COPD differential diagnosis

1605

3191

2.57

217.05

2.4

1.8

129.69

133.32

g/l

5.89

1204

2657

Diabetes mellitus

2339

6469

2.13

216.71

2.6

2.0

130.41

131.50

g/l

1.14

1917

4858

Asthma-related pneumonia or sepsis

1161

4311

2.79

216.32

2.8

2.2

128.08

127.96

g/l

0.06

873

3346

Asthma, hospital admissions 3, pneumonia

1161

4311

2.79

216.32

2.8

2.2

128.08

127.96

g/l

0.06

873

3346

Excluding asthma or asthma-COPD overlap

1601

3185

2.56

216.20

2.4

1.8

129.70

133.24

g/l

5.64

1203

2663

COPD, early/later onset

1404

4747

2.58

215.30

2.9

2.2

130.04

128.05

g/l

1.82

1020

3646

Other chronic obstructive pulmonary disease, including avohilmo

1580

5505

2.43

215.00

2.8

2.2

130.60

128.59

g/l

2.05

1157

4217

Asthma-related pneumonia

1156

4299

2.78

214.76

2.8

2.2

128.09

127.95

g/l

0.06

871

3337

Persons encountering health services in other circumstances

1184

4426

2.73

213.53

2.9

2.1

131.13

130.92

g/l

0.10

1059

3409

Non-ischemic cardiomyopathy

970

2540

3.16

213.46

3.0

2.0

126.08

129.41

g/l

3.11

730

1859

Diabetes, varying definitions

2323

6483

2.12

212.68

2.5

2.0

130.44

131.47

g/l

1.04

1900

4871

General symptoms and signs

2362

5663

2.13

210.57

2.4

2.1

130.02

132.61

g/l

4.59

1891

4317

Aplastic and other anaemias

1427

5431

2.49

207.83

3.3

2.2

113.14

130.79

g/l

122.70

1174

4112

Type 2 diabetes

2233

6197

2.12

206.57

2.5

2.0

130.43

131.22

g/l

0.69

1824

4620

Atrial fibrillation and flutter with reimbursement

626

927

4.41

206.19

2.6

1.7

129.60

133.49

g/l

2.37

469

641

Insulin, intermediate and long-acting

1543

6468

2.37

205.27

3.0

2.2

126.98

130.90

g/l

7.39

1331

4862

Sleep apnoea

2261

6977

2.08

202.77

2.4

2.2

134.95

129.19

g/l

20.20

1774

5315

Insulin, combination of fast acting with intermediate-acting or long-acting

1685

6895

2.28

202.14

3.1

2.1

126.79

130.73

g/l

8.06

1457

5183

Extracorporeal dialysis

337

552

6.93

201.44

6.0

2.1

117.39

130.82

g/l

16.28

311

433

Insulin, fast-acting

1068

3959

2.80

200.87

3.3

2.2

126.39

131.21

g/l

7.81

945

3018

Cerebrovascular diseases (FINNGEN)

679

1264

3.87

198.45

2.6

1.7

130.67

134.65

g/l

2.89

529

901

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2142

6113

2.12

197.72

2.6

2.0

129.74

131.43

g/l

2.08

1773

4554

Ischemic heart diseases

1923

5300

2.21

196.09

2.7

2.0

130.07

131.37

g/l

1.26

1510

3942

COPD related to multimorbidity

1237

4155

2.61

195.70

3.0

2.2

129.26

127.67

g/l

1.20

923

3197

COPD, hospital admission 2, with asthma infections

1059

3372

2.82

194.36

3.2

2.2

129.00

127.55

g/l

0.94

790

2598

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2261

7113

2.04

193.49

2.8

2.1

127.63

132.05

g/l

12.63

1811

5433

Percutaneous Coronary Intervention

1847

5161

2.22

193.02

2.7

2.1

129.32

131.12

g/l

2.05

1447

3834

Bleeding

2078

7115

2.09

192.64

2.7

2.2

126.75

130.93

g/l

9.77

1629

5432

Intracranial trauma

1298

3530

2.53

186.71

2.4

2.1

130.60

130.08

g/l

0.28

1074

2702

Coronary revascularization (ANGIO or CABG)

1829

5162

2.20

185.92

2.7

2.1

129.41

131.13

g/l

1.88

1436

3835

Sleep apnoea, including avohilmo

2310

7088

2.01

185.82

2.3

2.2

135.10

128.98

g/l

23.74

1820

5402

Obesity related asthma

971

3569

2.82

185.78

2.6

2.2

133.42

130.16

g/l

3.50

737

2744

Abnormal findings on diagnostic imaging of lung

1393

5725

2.38

185.65

2.4

2.3

128.36

128.75

g/l

0.18

800

4532

Insulin, fast-acting or short human

1072

4143

2.68

185.56

3.3

2.2

126.42

130.88

g/l

6.86

949

3167

COPD, hospital admissions 3, with asthma pneumonia sepsis

925

2805

2.96

184.46

3.3

2.2

127.71

126.91

g/l

0.39

695

2175

Viral pneumonia (unknown virus, not influenza)

326

561

6.39

184.05

4.1

2.3

127.05

130.87

g/l

1.53

262

463

Hard cardiovascular diseases

1870

5191

2.17

183.45

2.7

2.0

130.08

131.66

g/l

1.66

1463

3871

Dialysis

239

304

9.08

180.23

6.2

2.1

120.07

133.48

g/l

9.97

219

235

Presence of other functional implants

1591

4913

2.28

179.77

2.7

2.1

127.19

129.66

g/l

3.29

1357

3642

Cardiovascular diseases

1129

2210

2.76

178.64

2.6

1.8

133.44

135.25

g/l

1.54

930

1761

Tramadol

1773

4971

2.18

177.72

2.6

2.1

129.13

132.69

g/l

6.10

1285

3907

Other anaemias

1297

5206

2.41

177.27

3.1

2.2

112.79

130.62

g/l

110.67

1056

3950

Other and unspecified anaemias

1288

5173

2.41

177.10

3.1

2.2

112.76

130.59

g/l

109.84

1047

3928

Erysipelas

1430

5475

2.31

176.20

2.9

2.0

125.91

132.89

g/l

18.82

1134

4109

Diabetes, insulin treatment (Kela reimbursement)

2295

7046

1.97

175.41

2.6

2.1

129.69

131.31

g/l

2.08

1890

5265

Pain in throat and chest

1814

5071

2.15

175.24

2.3

2.1

132.35

130.86

g/l

1.49

1395

4012

Hyperlipidaemia, other/unspecified

1096

3934

2.59

173.41

2.6

2.1

127.11

129.59

g/l

2.25

912

2922

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

820

1670

3.16

172.50

2.4

1.7

130.07

134.89

g/l

5.72

664

1230

Emergency coronary revascularization (for ACS)

1995

5957

2.06

172.48

2.7

2.1

128.69

130.48

g/l

2.17

1569

4461

Major coronary heart disease event

1932

5647

2.09

172.13

2.7

2.1

129.35

130.96

g/l

1.76

1513

4213

Oxycodone

1087

3710

2.58

169.93

2.8

2.1

120.07

131.31

g/l

34.78

827

2876

Asthma (diagnoses ohter than nonallergic)

2092

8761

1.96

168.57

2.4

2.2

130.89

130.31

g/l

0.47

1557

6883

Complications of surgical and medical care, not elsewhere classified

2317

8242

1.91

165.04

2.7

2.1

126.02

131.56

g/l

19.27

1786

6382

Paroxysmal tachycardia

512

1098

4.00

164.85

2.7

1.7

132.01

133.82

g/l

0.73

380

806

Intestinal infectious diseases

2217

8756

1.91

163.33

2.7

2.1

128.89

131.13

g/l

3.69

1801

6741

Other CVD (FINNGEN)

353

503

5.63

163.03

2.7

1.7

125.82

131.24

g/l

3.03

299

359

Type 2 diabetes, definitions combined

2044

6034

2.00

162.80

2.4

2.0

131.27

131.04

g/l

0.14

1643

4487

Disorders of lipoprotein metabolism and other lipidaemias

1845

5514

2.07

162.20

2.4

2.1

129.18

131.51

g/l

3.10

1424

4123

Type 2 diabetes, strict (exclude DM1)

2051

6078

2.00

161.64

2.4

2.0

131.22

130.99

g/l

0.14

1648

4523

Obesity due to excess calories

1163

4971

2.40

161.58

2.7

2.2

131.07

131.21

g/l

0.07

942

3828

Hypertensive heart and/or renal disease

736

1766

3.16

159.25

3.1

2.0

124.04

129.40

g/l

5.91

605

1244

Hypo-osmolality and hyponatraemia

589

1770

3.47

158.92

3.1

2.2

124.34

128.08

g/l

3.08

506

1329

Type 2 diabetes, definitions combined, including avohilmo

2022

5960

1.99

158.62

2.4

2.0

131.21

130.94

g/l

0.17

1627

4432

Codeine

1966

5352

2.02

156.61

2.3

2.1

129.87

132.84

g/l

5.12

1492

4244

1129

4797

2.39

155.82

2.6

2.2

132.14

130.51

g/l

1.41

856

3776

COPD, hospital admissions 1, only main diagnosis

1044

3675

2.53

155.70

3.1

2.3

131.50

127.18

g/l

5.26

754

2839

Diabetes medication

2267

7076

1.90

155.37

2.6

2.1

129.94

131.37

g/l

1.71

1853

5341

GASTRO-related operations

1577

3639

2.21

154.97

2.4

1.8

129.52

134.63

g/l

11.23

1244

2887

Any gastric operation

1577

3639

2.21

154.97

2.4

1.8

129.52

134.63

g/l

11.23

1244

2887

Nutritional anaemias

1347

5941

2.22

153.66

2.8

2.2

116.54

130.13

g/l

64.61

1086

4534

All influenza

695

2365

3.04

153.26

2.9

2.0

128.82

131.62

g/l

2.04

552

1830

Other nutritional deficiencies

1557

6928

2.09

153.26

2.7

2.2

130.95

130.90

g/l

0.02

1231

5326

Bacterial pneumoniae

1005

3580

2.53

152.44

2.8

1.9

125.96

131.68

g/l

9.38

769

2730

Iron deficiency anaemia

1187

5152

2.33

152.00

2.9

2.2

115.64

129.99

g/l

63.85

963

3924

Concussion

1086

3498

2.45

151.45

2.3

2.1

130.55

130.11

g/l

0.21

910

2677

Diarrhoea and gastroenteritis of presumed infectious origin

1680

7531

2.03

151.43

2.8

2.1

129.56

131.00

g/l

1.48

1379

5814

Asthma/COPD (KELA code 203)

2109

7527

1.90

149.35

2.4

2.2

131.15

130.51

g/l

0.52

1569

5969

Symptoms and signs involving the circulatory and respiratory systems

2015

5187

1.97

148.79

2.3

2.1

132.20

130.93

g/l

1.35

1561

4114

Any reimbursement code in KELA

1008

1917

2.68

148.51

2.4

1.7

131.94

136.86

g/l

7.65

825

1497

Polyarthropathies

1581

4903

2.11

147.88

2.9

2.2

126.84

131.84

g/l

11.47

1246

3822

Endocrine, nutritional and metabolic diseases

1502

3510

2.19

145.66

2.4

1.9

132.11

133.66

g/l

1.44

1224

2655

Valvular heart disease excluding rheumatic fever

1088

3266

2.44

145.65

2.7

2.0

125.27

131.83

g/l

12.20

867

2418

Non-rheumatic valve diseases

1084

3250

2.44

145.25

2.7

2.0

125.30

131.77

g/l

11.86

863

2406

Ischaemic heart disease, wide definition

1751

5434

2.02

144.59

2.6

2.1

129.34

130.72

g/l

1.30

1391

4007

Other acute lower respiratory infections

1365

6192

2.15

144.10

3.0

2.2

130.56

129.84

g/l

0.50

1085

4817

Obesity

1450

6647

2.10

143.78

2.8

2.2

131.20

131.00

g/l

0.11

1132

5113

Obesity and other hyperalimentation

1455

6669

2.09

143.72

2.8

2.2

131.15

130.97

g/l

0.10

1137

5126

Early onset COPD

651

2229

3.05

142.92

2.9

2.2

134.12

129.72

g/l

3.39

453

1711

STROKE

1135

3310

2.36

139.65

2.5

2.0

130.01

132.04

g/l

1.68

896

2417

Parasetamol

1426

3332

2.20

138.92

2.4

2.1

131.14

133.87

g/l

3.44

1150

2562

Syncope and collapse

1105

4057

2.33

138.42

2.3

2.1

129.41

130.73

g/l

0.97

896

3036

Coronary atherosclerosis

1467

4457

2.12

137.83

2.7

2.1

127.56

130.42

g/l

3.56

1167

3280

Disorders resulting from impaired renal tubular function

214

326

7.55

137.70

5.5

2.2

120.63

129.94

g/l

5.40

188

259

Bronchitis

2422

8255

1.78

137.28

2.7

2.1

130.78

130.44

g/l

0.26

1920

6367

Benzodiazepine use

2246

8517

1.81

135.73

2.4

2.2

130.65

130.52

g/l

0.08

1755

6593

Haemorrhage from respiratory passages

891

3215

2.52

134.27

2.7

2.2

127.09

128.65

g/l

0.93

667

2495

Certain infectious and parasitic diseases

1957

5189

1.92

132.63

2.6

1.9

128.02

133.70

g/l

17.14

1529

4017

Hyperkalaemia

271

533

5.55

132.48

4.3

2.0

116.09

127.66

g/l

9.33

241

412

Acute bronchitis

1071

4729

2.28

131.40

3.1

2.2

130.97

128.76

g/l

2.17

847

3660

Other dialysis

190

271

8.19

130.30

6.2

2.5

118.91

130.75

g/l

7.05

170

217

Invasive ventilation

306

677

4.90

130.04

4.2

2.2

124.12

128.39

g/l

1.79

248

547

COPD-related respiratory insufficiency

433

1233

3.74

129.74

4.1

2.2

134.06

127.48

g/l

4.71

319

956

Angina pectoris

1314

4153

2.15

128.81

2.4

2.1

128.12

129.91

g/l

1.56

1101

3046

2420

7023

1.77

128.44

2.6

2.1

130.26

g/l

0.00

1894

5434

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1362

5241

2.09

128.33

2.8

2.2

127.79

129.22

g/l

1.22

1122

3908

Lung cancer and mesothelioma

487

1233

3.47

128.32

2.4

1.9

122.71

130.64

g/l

6.30

296

1012

Bacterial pneumonia, not elsewhere classified

920

3410

2.43

128.11

2.8

1.9

125.90

131.65

g/l

8.57

690

2611

Diagnoses used for exclusion with ILD

740

2868

2.68

128.03

2.5

2.3

129.51

128.62

g/l

0.37

504

2233

Symptoms and signs involving the urinary system

1774

7175

1.90

127.79

2.5

2.2

129.32

130.03

g/l

0.54

1415

5463

Gout

829

2869

2.57

127.73

3.3

2.2

125.59

130.01

g/l

4.77

675

2196

Volume depletion

360

913

4.19

127.24

4.0

2.1

123.94

128.23

g/l

2.34

325

700

Diseases of arteries, arterioles and capillaries

1633

6254

1.96

127.15

2.9

2.2

124.76

130.02

g/l

12.00

1260

4757

Opioids

1960

5452

1.88

127.10

2.4

2.1

129.33

132.89

g/l

7.15

1500

4333

Diseases of the respiratory system

1213

2723

2.27

127.04

2.5

1.8

129.21

132.26

g/l

3.60

923

2227

Episodal and paroxysmal disorders

2255

6465

1.79

124.93

2.3

2.2

132.71

129.24

g/l

8.17

1784

4998

Non-allergic asthma (mode), excluding more controls

418

1168

3.65

124.91

2.3

1.8

132.48

131.99

g/l

0.13

307

968

Other arrhythmias

1281

4606

2.11

124.72

2.3

1.9

132.94

132.54

g/l

0.21

1011

3480

Constipation

2015

7623

1.82

124.64

2.6

2.2

127.53

130.44

g/l

5.52

1578

5851

Extreme obesity with alveolar hypoventilation

209

346

6.78

123.49

4.6

2.1

133.34

130.13

g/l

0.82

180

274

Other antidepressants

2205

6347

1.80

123.48

2.4

2.2

131.15

130.76

g/l

0.27

1734

4881

Unspecified kidney failure

387

1056

3.90

123.47

3.5

2.0

120.13

129.80

g/l

9.67

315

790

Asthma, including avohilmo

2547

8288

1.71

123.41

2.3

2.2

132.13

130.40

g/l

2.66

1921

6527

Diabetic nephropathy, excluding more controls

539

1433

3.25

123.23

3.9

2.2

122.80

132.64

g/l

15.31

468

1096

Pulmonary heart disease, diseases of pulmonary circulation

889

3817

2.40

123.06

2.9

2.2

127.64

127.82

g/l

0.07

696

2913

Nausea and vomiting

746

2898

2.59

120.78

2.8

2.2

127.99

128.85

g/l

0.41

619

2229

Complications of medical and surgical care

1681

8219

1.87

119.48

2.7

2.2

124.98

130.67

g/l

16.35

1299

6333

Codeine or tramadol medication

2377

7565

1.73

118.43

2.3

2.2

129.43

130.96

g/l

1.96

1815

5922

Other and unspecified iron deficiency

911

4014

2.33

117.93

2.8

2.2

115.73

129.90

g/l

50.60

734

3079

Persons encountering health services in other circumstances, wide

2429

7350

1.72

117.44

2.7

2.1

129.82

131.02

g/l

1.38

1933

5623

Adjustment and management of implanted device

559

1965

2.97

117.17

2.8

2.0

127.68

129.62

g/l

0.97

431

1472

Other disorders of kidney and ureter

446

1381

3.42

117.07

4.1

2.3

125.28

128.30

g/l

1.88

375

1066

Diabetic maculopathy, excluding more controls

349

918

4.01

116.99

3.4

2.3

125.65

130.73

g/l

3.00

311

699

Antihypertensive medication - note that there are other indications

1062

2445

2.30

116.87

2.5

1.8

132.76

134.35

g/l

1.26

876

1913

Care involving use of rehabilitation procedures

1355

6220

1.99

116.74

2.4

1.9

129.04

132.99

g/l

6.89

1134

4679

Diseases of oesophagus, stomach and duodenum

2247

7730

1.74

116.42

2.4

2.2

128.62

131.42

g/l

5.07

1706

6045

Exposure to unspecified factor

2214

8842

1.73

115.02

2.6

2.2

129.59

131.06

g/l

1.83

1731

6873

Certain disorders involving the immune mechanism

536

1863

3.00

114.60

2.7

2.3

130.06

130.12

g/l

0.02

327

1448

Intestinal infectious diseases, including avohilmo, including avohilmo

2453

8161

1.70

114.55

2.5

2.2

129.00

130.94

g/l

3.08

1929

6309

Substance abuse, excluding more controls

1244

5165

2.05

114.28

2.6

2.2

131.85

131.78

g/l

0.03

990

3946

Headache

1322

5170

2.01

113.13

2.3

2.1

132.69

132.33

g/l

0.21

1056

3924

Complications of procedures, not elsewhere classified

1770

7981

1.81

112.35

2.7

2.1

125.89

131.28

g/l

14.96

1363

6168

Pure hypercholesterolaemia

1569

5296

1.91

111.80

2.3

2.1

129.94

131.17

g/l

1.03

1191

3951

Emphysema

283

662

4.58

111.78

2.9

2.1

134.45

128.21

g/l

2.65

173

524

Other (not insulin) diabetes medications

2000

6694

1.78

111.57

2.5

2.0

130.51

130.97

g/l

0.31

1613

5014

Other disorders of urethra and urinary system

1553

5774

1.90

111.17

2.8

2.2

127.82

129.58

g/l

2.05

1251

4454

Venous thromboembolism

1303

6469

1.98

111.00

2.7

2.2

128.08

128.78

g/l

0.44

1044

4905

Oedema, not elsewhere classified

799

3334

2.40

110.88

2.8

2.1

126.85

130.15

g/l

3.13

627

2478

Neurological diseases

1648

4400

1.91

110.39

2.3

2.1

132.67

129.66

g/l

4.83

1327

3367

Non-allergic asthma (mode)

418

1267

3.36

110.10

2.3

1.8

132.48

131.28

g/l

0.39

307

1048

Type 1 diabetes, wide definition, subgroup 1

502

1715

3.02

109.86

3.2

2.1

127.34

133.30

g/l

6.08

444

1320

Hypertensive Heart Disease

606

1680

2.82

109.82

2.9

2.0

125.14

128.99

g/l

2.90

493

1185

Pain in limb

1810

6466

1.80

107.99

2.3

2.2

129.64

130.92

g/l

1.26

1424

5049

Autoimmune diseases excluding thyroid diseases

2173

6936

1.72

106.30

2.6

2.1

128.42

131.96

g/l

8.26

1712

5394

Gout, FINNGEN

829

3657

2.33

106.20

3.3

2.2

125.59

129.20

g/l

3.50

675

2804

Type 1 diabetes

583

2198

2.72

105.75

3.2

2.1

126.78

132.43

g/l

6.58

518

1677

Sleep disorders (combined)

2283

7125

1.69

105.06

2.3

2.2

132.98

128.80

g/l

11.55

1776

5531

Bacterial pneumonia (organism specified)

1106

4953

2.07

104.96

2.9

2.2

125.54

129.61

g/l

5.63

854

3832

Diseases of the digestive system

1151

5766

2.03

104.95

2.8

2.2

123.24

129.45

g/l

12.59

933

4420

Disorders of other endocrine glands

1026

4900

2.11

103.99

3.0

2.2

128.80

129.68

g/l

0.54

884

3753

Asthma, hospital admissions , main diagnosis only

1768

8839

1.77

103.85

2.3

2.2

131.85

130.22

g/l

1.93

1323

6930

Myocardial infarction

1113

3798

2.09

103.71

3.0

2.1

125.96

129.87

g/l

5.07

906

2802

Major coronary heart disease event excluding revascularizations

1335

4573

1.96

103.43

2.8

2.1

127.02

130.04

g/l

3.64

1073

3370

Conduction disorders

705

2311

2.51

103.26

2.7

1.9

126.63

130.72

g/l

3.53

564

1722

ILD-related respiratory insufficiency

186

331

6.40

102.60

3.6

2.2

132.15

128.45

g/l

0.73

273

Hernia of abdominal wall, postoperative

452

1503

3.08

102.51

3.0

1.9

129.45

134.21

g/l

3.37

370

1132

Other diseases of urinary system

2056

6789

1.72

101.94

2.5

2.2

129.70

130.82

g/l

1.18

1624

5237

Gout, unspecified

616

2450

2.62

101.55

3.2

2.3

125.39

129.00

g/l

2.62

502

1868

Gout, idiopatic and unspecified

726

3118

2.41

101.01

3.3

2.3

125.96

128.78

g/l

2.03

591

2380

Autoimmune diseases excluding thyroid diseases, strict definition

2091

6727

1.71

100.83

2.6

2.1

128.51

131.96

g/l

7.56

1652

5248

Hypothyroidism (congenital or acquired)

409

649

3.59

100.61

2.5

2.0

133.51

136.20

g/l

1.52

339

528

Pulmonary embolism

777

3445

2.32

99.86

2.9

2.2

127.79

127.95

g/l

0.05

623

2633

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2128

8228

1.68

99.08

2.5

2.2

129.83

130.95

g/l

1.21

1674

6364

Gout, strict definition

559

2151

2.71

98.77

3.5

2.3

125.86

128.69

g/l

1.65

463

1650

Biguanides

1952

6927

1.72

98.67

2.4

2.1

130.47

130.48

g/l

0.01

1558

5228

Type 1 diabetes, wide definition

511

1877

2.80

97.71

3.3

2.1

127.41

132.48

g/l

4.74

452

1446

Pulmonary heart disease

777

3480

2.30

97.49

2.9

2.2

127.79

127.93

g/l

0.05

623

2656

Pain, not elsewhere classified

629

2562

2.51

97.45

2.4

2.1

130.68

130.98

g/l

0.11

481

1910

Other functional intestinal disorders

1086

4979

2.02

97.32

2.6

2.2

127.54

129.94

g/l

2.53

890

3874

Retention of urine

897

3394

2.19

96.72

2.7

2.3

126.82

128.74

g/l

1.45

766

2585

Dental caries

615

2346

2.54

95.84

3.0

2.2

125.31

130.77

g/l

4.98

442

1863

Hypokalaemia

361

1108

3.41

95.72

2.9

2.1

126.45

128.82

g/l

1.00

311

833

Fall on same level

2300

7532

1.65

95.62

2.5

2.2

129.61

132.22

g/l

4.89

1819

5842

Poisoning by drugs, medicaments and biological substances

546

2104

2.67

95.23

2.4

2.2

132.41

131.99

g/l

0.16

469

1639

Other soft tissue disorders, not elsewhere classified

1953

6572

1.71

95.16

2.3

2.2

129.94

131.05

g/l

1.07

1553

5143

Hypothyroidism, levothyroxine purchases

397

645

3.51

94.67

2.5

2.0

133.48

136.19

g/l

1.51

329

524

Hypothyroidism and >3 levothyroxin purchases

397

645

3.51

94.67

2.5

2.0

133.48

136.19

g/l

1.51

329

524

Implicit fungal Sepsis, including avohilmo

249

600

4.42

94.53

3.9

1.9

122.97

130.01

g/l

3.66

193

451

Morphin

142

209

7.79

94.38

4.0

2.0

129.98

128.81

g/l

0.19

132

170

Disorders of gallbladder, biliary tract and pancreas

2051

7722

1.67

93.79

2.5

2.2

128.55

130.60

g/l

3.00

1647

5870

Pacemaker

978

4498

2.08

93.71

2.8

2.3

127.00

127.38

g/l

0.18

793

3427

Vocal cord dysfunction

277

618

4.05

93.24

2.2

1.8

132.98

132.68

g/l

0.06

194

449

Peripheral artery disease

1110

4498

2.00

92.98

2.9

2.2

122.86

128.49

g/l

9.45

869

3434

DVT of lower extremities and pulmonary embolism

1025

5166

2.02

92.95

2.8

2.2

127.91

128.16

g/l

0.11

825

3909

Depression medications

444

688

3.29

92.85

2.1

1.9

135.81

137.26

g/l

0.63

368

560

Symptoms and signs involving cognition, perception, emotional state and behaviour

2009

8130

1.67

92.79

2.2

2.3

130.86

130.51

g/l

0.25

1573

6267

Poisoning by medicine

501

1884

2.74

91.84

2.4

2.2

132.81

132.22

g/l

0.22

432

1474

Any death

1442

5610

1.83

91.69

3.0

2.1

119.69

132.44

g/l

57.15

1090

4286

Mental and behavioural disorders due to psychoactive substance use

1291

6470

1.86

90.60

2.6

2.3

131.81

131.88

g/l

0.03

1031

5011

Caries of dentine

552

2107

2.60

90.43

3.0

2.2

125.27

130.80

g/l

4.62

399

1672

Injuries to the head

2291

8534

1.61

89.37

2.4

2.2

129.92

130.97

g/l

1.13

1831

6581

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

567

2260

2.53

89.24

2.3

2.2

131.81

131.88

g/l

0.03

473

1749

Anaemia in chronic diseases classified elsewhere

141

220

7.35

88.80

5.8

2.2

112.35

131.43

g/l

15.16

134

168

Neurological diseases, wide definition

507

880

2.94

88.56

2.2

1.9

134.17

133.03

g/l

0.44

423

741

Intracranial injury

1313

6791

1.83

88.21

2.4

2.3

129.50

130.39

g/l

0.63

1092

5243

Other diseases of the digestive system

836

4010

2.14

88.20

2.9

2.3

122.39

129.03

g/l

10.04

684

3101

Abnormalities of heart beat

759

3404

2.20

86.86

2.2

2.1

130.58

128.77

g/l

1.17

616

2663

GI-bleeding

835

4030

2.13

86.62

2.9

2.3

122.26

129.04

g/l

10.40

684

3114

Substance abuse

1244

6364

1.85

85.76

2.6

2.3

131.85

131.94

g/l

0.04

990

4932

Other cataract

986

3689

2.03

85.75

2.9

2.1

127.39

130.43

g/l

3.15

791

2746

Disorders of lens

1362

4687

1.83

84.73

2.7

2.1

127.30

131.49

g/l

7.03

1060

3503

Cardiodefibrillation

906

4537

2.05

84.51

2.4

2.3

130.75

128.42

g/l

1.69

661

3483

Osteopathies and chondropathies

1239

6256

1.84

84.40

2.7

2.2

124.02

129.99

g/l

13.39

987

4771

Lung transplant status

17.05

83.88

2.8

2.6

121.60

135.24

g/l

2.05

Lung transplantation

17.01

83.85

2.8

2.6

121.60

135.24

g/l

2.05

Autoimmune diseases

2191

6969

1.61

83.23

2.5

2.1

129.32

132.00

g/l

5.08

1734

5421

Atherosclerosis, excluding cerebral and coronary sclerosis

1036

4237

1.97

83.13

3.0

2.2

122.69

128.27

g/l

8.75

805

3233

Cough

838

3814

2.09

82.88

2.2

2.1

132.29

129.47

g/l

2.58

584

2980

Pleural effusion

447

1680

2.77

82.71

3.2

2.1

122.62

127.55

g/l

3.65

350

1308

Convulsions, not elsewhere classified

518

2057

2.55

82.39

2.6

2.1

130.46

132.71

g/l

1.36

435

1570

Glomerulonephritis

301

910

3.48

82.14

4.5

2.3

124.43

129.62

g/l

2.80

273

706

Mood disorders, excluding more controls

1834

6542

1.67

81.84

2.3

2.2

132.12

130.68

g/l

1.55

1420

4998

Schizophrenia or delusion, excluding more controls

619

2677

2.33

81.27

2.6

2.2

130.98

131.85

g/l

0.41

556

2031

Undetermined asthma, excluding more controls

270

761

3.65

81.07

2.7

1.8

132.24

132.00

g/l

0.05

202

626

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1320

7397

1.78

81.05

2.7

2.2

124.79

130.38

g/l

12.70

1021

5673

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

591

1171

2.57

81.01

2.2

2.0

132.25

134.48

g/l

1.20

476

960

Use of hypnotics and sedatives

2116

7618

1.61

80.92

2.4

2.2

129.86

131.23

g/l

1.51

1615

5896

Certain infectious and parasitic diseases, including avohilmo

1328

3660

1.84

80.31

2.5

1.9

128.79

133.54

g/l

8.60

1034

2895

Unspecified mental disorder

822

4065

2.06

79.37

2.5

2.2

131.52

131.83

g/l

0.14

730

3100

Persons with potential health hazards related to communicable diseases

737

3467

2.15

79.25

2.7

2.2

133.37

132.31

g/l

0.57

636

2746

Disorders of thyroid, IBD co-morbidities

314

632

3.47

78.97

1.9

131.07

130.49

g/l

0.13

212

514

Substance use, excluding alcohol

451

1747

2.66

78.01

2.7

2.2

134.08

132.84

g/l

0.46

346

1360

Cerebrovascular diseases

1586

6576

1.70

77.96

2.5

2.3

128.89

129.41

g/l

0.33

1211

5019

Explicit bacterial Sepsis

303

949

3.33

77.75

3.3

2.0

122.72

130.64

g/l

6.02

251

709

Explicit bacterial Sepsis, including avohilmo

306

968

3.29

77.22

3.3

2.0

122.62

130.77

g/l

6.37

253

722

Low back pain

1587

6411

1.69

77.03

2.3

2.2

131.64

131.05

g/l

0.40

1253

4968

Acute upper respiratory infections of multiple and unspecified sites

1546

6736

1.69

76.69

2.8

2.1

131.32

130.41

g/l

0.75

1238

5201

ILD medications: pirfenidone

11.56

76.57

2.0

2.4

143.35

124.86

g/l

3.19

Genitourinary diseases

1037

2687

1.96

75.79

2.6

1.8

132.19

136.60

g/l

5.86

856

2019

Diabetic nephropathy

543

2320

2.43

75.04

3.9

2.4

122.77

130.20

g/l

10.37

471

1852

Used for control exclusion in common control thyroid runs

2039

6496

1.60

74.84

2.4

2.1

130.23

132.07

g/l

2.49

1613

5072

Later onset COPD

766

3005

2.11

74.26

3.0

2.2

126.55

125.97

g/l

0.24

578

2333

Second line medication for Crohn's disease

1163

6589

1.79

73.60

2.7

2.2

127.33

130.96

g/l

4.97

791

5152

Viral and other specified intestinal infections, including avohilmo

593

2555

2.28

73.55

2.6

2.1

131.42

132.53

g/l

0.50

500

2048

Senile cataract

1257

4319

1.80

73.45

2.6

2.2

127.37

130.78

g/l

4.50

972

3215

L04AX Other immunosuppressants

1135

6395

1.80

73.35

2.7

2.2

126.98

130.83

g/l

5.35

770

4993

Hydronephrosis

309

1014

3.17

73.33

3.4

2.0

123.41

131.34

g/l

6.09

276

751

Hypothyroidism, drug reimbursement

217

363

4.26

72.60

2.6

1.8

128.52

135.22

g/l

3.81

174

281

Cardiomyopathy

406

1548

2.70

72.56

2.7

2.0

130.61

131.33

g/l

0.19

286

1158

Undetermined asthma

270

820

3.38

72.26

2.7

1.8

132.24

131.05

g/l

0.34

202

682

Viral and other specified intestinal infections

467

1858

2.51

72.04

2.7

2.1

130.23

132.66

g/l

1.26

401

1517

Cystitis

1662

6055

1.65

71.91

2.4

2.2

129.00

129.88

g/l

0.74

1286

4669

Any mental disorder

2088

6708

1.57

71.81

2.4

2.2

130.46

130.61

g/l

0.10

1638

5126

Amiodarone users

322

1101

3.09

71.73

2.0

2.3

132.22

128.24

g/l

1.21

157

863

Depression or dysthymia

1284

3988

1.78

71.41

2.4

2.2

132.12

130.59

g/l

1.19

961

3031

Disorders of mineral metabolism

247

720

3.60

71.29

3.6

2.1

123.20

130.13

g/l

3.44

213

537

Kela-code for severe mental illness

736

3642

2.06

71.13

2.6

2.2

131.25

131.55

g/l

0.13

657

2770

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2126

7318

1.56

70.95

2.6

2.1

129.84

131.09

g/l

1.35

1641

5597

Other retinal disorders

1421

6465

1.70

70.74

2.7

2.2

127.20

129.27

g/l

2.40

1139

4913

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

369

1360

2.80

70.56

2.4

2.2

133.03

132.99

g/l

0.01

321

1069

Symptoms and signs involving the digestive system and abdomen

1926

6105

1.60

70.33

2.4

2.2

129.96

131.05

g/l

1.03

1529

4678

Problems related to lifestyle

264

808

3.39

70.21

2.6

2.2

131.57

132.91

g/l

0.33

232

631

Other diseases of intestines

2008

7195

1.57

69.87

2.4

2.1

128.49

132.24

g/l

8.68

1545

5649

Myocardial infarction, strict

960

3630

1.91

69.62

2.9

2.1

126.63

129.75

g/l

3.11

782

2675

Personality disorders, excluding more controls

483

2030

2.42

69.52

2.5

2.1

133.43

132.45

g/l

0.39

410

1577

Iron deficiency anaemia secondary to blood loss (chronic)

436

1762

2.56

69.50

3.0

2.2

112.33

129.20

g/l

27.68

355

1364

1207

6253

1.75

69.33

2.6

2.3

129.94

132.16

g/l

2.15

975

4831

AV-block

443

1515

2.57

69.31

2.7

2.0

125.80

129.83

g/l

2.29

358

1142

Infections of the skin and subcutaneous tissue

1203

6893

1.74

69.16

2.9

2.2

129.29

131.98

g/l

3.01

960

5339

Streptococcal septicaemia

272

859

3.32

69.15

3.4

2.1

121.77

131.15

g/l

7.66

226

647

Abdominal and pelvic pain

1915

6105

1.59

68.90

2.4

2.2

131.23

131.05

g/l

0.11

1529

4678

1251

6390

1.73

68.44

2.6

2.3

129.88

132.12

g/l

2.23

1008

4948

Streptococcal septicaemia, including avohilmo

275

881

3.27

68.24

3.3

2.1

121.67

131.35

g/l

8.17

228

664

Hypertensive Renal Disease

149

311

5.17

68.04

4.1

2.1

120.14

127.17

g/l

2.24

134

214

Symptoms and signs involving the nervous and musculoskeletal systems

1231

7261

1.72

67.81

2.3

2.2

130.97

129.28

g/l

1.70

1031

5544

Mental and behavioural disorders due to alcohol

1061

5705

1.80

67.78

2.6

2.3

131.01

132.12

g/l

0.70

862

4399

Other/unspecified cytomegaloviral diseases

100

144

7.86

67.68

4.8

2.1

119.10

132.34

g/l

4.93

112

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

634

3028

2.14

67.57

2.6

2.2

134.95

131.49

g/l

2.63

515

2227

Glucagon-like peptide-1 (GLP-1) analogues

634

3028

2.14

67.57

2.6

2.2

134.95

131.49

g/l

2.63

515

2227

Falls/tendency to fall

1998

6451

1.57

67.31

2.4

2.2

130.11

132.27

g/l

3.30

1580

5003

Other bacterial intestinal infections

457

1917

2.46

67.01

3.0

2.2

121.77

128.90

g/l

7.11

366

1475

Implicit fungal Sepsis

145

301

5.19

66.63

4.3

1.8

118.69

130.39

g/l

5.82

114

232

Fungal Sepsis

152

329

4.96

66.39

4.3

1.8

118.40

129.93

g/l

5.88

120

252

Gastro-oesophageal reflux disease

1370

7003

1.67

66.17

2.4

2.2

130.12

130.85

g/l

0.47

1024

5438

Myocardial infarction, without ST-elevation

972

4856

1.84

66.16

2.9

2.3

124.83

128.27

g/l

3.81

799

3693

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

567

2622

2.21

65.55

2.3

2.2

131.81

131.75

g/l

0.02

473

2061

Suicide or other Intentional self-harm

504

2226

2.32

65.34

2.3

2.2

132.11

131.67

g/l

0.16

420

1723

Lung diseases due to external agents

395

1573

2.61

65.09

2.8

2.3

127.43

127.78

g/l

0.09

317

1218

Adrenocortical insufficiency

142

296

5.20

65.07

3.1

2.1

126.10

129.10

g/l

0.75

136

240

Unspecified haematuria

952

4271

1.85

64.48

2.6

2.3

128.55

129.64

g/l

0.64

777

3235

Finngen Rheumatological endpoints

1763

6377

1.58

64.17

2.4

2.1

129.82

132.29

g/l

3.83

1359

5001

Disorders of choroid and retina

1659

7385

1.59

63.82

2.7

2.2

127.80

130.00

g/l

3.01

1316

5623

Other disorders of adrenal gland

160

373

4.59

63.71

3.2

2.2

125.55

129.81

g/l

1.37

150

295

Mood disorders

1968

8285

1.53

63.52

2.3

2.2

132.32

130.68

g/l

2.10

1533

6432

Alcohol use disorder, Swedish definition

1129

5995

1.74

63.51

2.7

2.3

129.27

132.23

g/l

3.25

902

4615

Mood [affective] disorders

1963

8277

1.53

63.42

2.3

2.2

132.28

130.69

g/l

2.01

1528

6423

Other CVD

548

2545

2.22

63.30

2.6

2.3

125.67

126.98

g/l

0.62

457

1981

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1873

7719

1.55

63.12

2.6

2.2

128.09

130.91

g/l

4.74

1462

5906

Chronic nephritic syndrome

148

330

4.86

62.57

4.6

2.2

124.84

131.59

g/l

2.31

139

254

ILD medications: azathioprine

323

1183

2.81

62.57

3.5

2.0

127.77

132.47

g/l

2.33

232

957

Anxiety disorders, excluding more controls

1508

5989

1.63

62.47

2.3

2.2

133.03

130.90

g/l

2.56

1172

4580

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1194

7128

1.70

62.37

2.7

2.2

124.43

130.00

g/l

11.55

925

5475

Supplementary factors related to causes of morbidity and mortality classified elsewhere

688

3488

2.01

62.34

2.6

2.2

127.58

130.46

g/l

2.19

614

2685

Nerve, nerve root and plexus disorders

2070

8287

1.51

62.31

2.3

2.2

130.28

130.42

g/l

0.09

1640

6345

Dizziness and giddiness

1498

7325

1.61

61.54

2.2

2.3

130.14

129.72

g/l

0.27

1172

5611

Other diseases of blood and blood-forming organs, wide

517

2371

2.24

61.50

3.0

2.2

126.03

129.95

g/l

2.15

428

1814

Depression

1812

7912

1.55

61.25

2.3

2.2

132.45

130.95

g/l

1.72

1406

6132

Other reaction to severe stress, and adjustment disorders

678

3432

2.01

61.24

2.5

2.2

132.40

131.77

g/l

0.28

538

2686

Hypotension

492

2219

2.29

61.22

2.6

2.3

125.72

126.70

g/l

0.41

413

1736

Liquid cancers, including Hilmo

792

3714

1.92

60.88

2.7

2.2

119.84

131.50

g/l

25.95

618

2860

Autoimmune diseases related-to ILD

1594

8538

1.58

60.68

2.5

2.2

129.39

131.05

g/l

1.94

1233

6824

Alcohol use disorder, ICD-based

860

4733

1.85

60.55

2.6

2.3

130.40

132.27

g/l

1.29

691

3638

Mental and behavioural disorders due to alcohol, excluding acute intoxication

918

5103

1.81

60.55

2.6

2.3

130.65

132.33

g/l

1.15

740

3935

Selective serotonin reuptake inhibitors

1880

6382

1.55

60.41

2.3

2.2

132.01

130.78

g/l

1.22

1474

4908

Psychiatric diseases

1818

5891

1.56

60.40

2.4

2.2

130.33

130.77

g/l

0.29

1431

4495

Contact with and exposure to communicable diseases

555

2617

2.15

60.22

2.6

2.1

134.58

132.66

g/l

1.17

520

2108

Cholelithiasis, broad definition with cholecystitis

1686

7257

1.56

59.63

2.4

2.2

129.28

129.94

g/l

0.49

1348

5497

Cardiomyopathies, Primary/intrinsic

290

1032

2.91

59.54

2.7

2.1

131.50

131.32

g/l

0.04

207

781

Other bacterial intestinal infections, including avohilmo

535

2519

2.18

59.39

2.8

2.2

122.71

129.26

g/l

7.01

417

1939

Sub-endpoint used in defining T1D endpoints

620

3029

2.05

59.33

3.2

2.2

126.87

130.35

g/l

3.09

549

2373

Osteoporosis

642

2963

2.04

59.10

2.7

2.2

120.99

126.93

g/l

7.52

520

2241

Sequelae of external causes of morbidity and mortality

592

2908

2.09

58.82

2.8

2.3

125.06

129.13

g/l

3.58

484

2223

Other symptoms and signs involving the nervous and musculoskeletal systems

860

4774

1.83

58.81

2.4

2.3

131.25

129.57

g/l

1.34

754

3624

Continuous positive airway pressure

308

925

2.83

58.62

1.9

1.7

136.73

132.67

g/l

1.40

175

664

Diseases of liver

742

3953

1.92

58.08

2.7

2.3

124.69

130.51

g/l

7.43

582

3002

Other general symptoms and signs

146

335

4.52

58.03

2.5

2.1

134.62

132.33

g/l

0.62

127

269

Ulcer of lower limb, not elsewhere classified

407

1739

2.43

57.64

3.4

2.3

120.75

128.14

g/l

6.80

323

1353

Schizophrenia or delusion

619

3108

2.03

57.59

2.6

2.2

130.98

131.84

g/l

0.41

556

2388

Bacterial intestinal infections, IBD co-morbidities

455

2038

2.30

57.43

3.0

2.3

121.84

128.59

g/l

6.39

360

1577

Pneumonia due to other infectious organisms, not elsewhere classified

121

245

5.32

57.28

3.6

2.1

121.90

130.78

g/l

2.72

204

Cytomegalovirus infection, IBD co-morbidity

102

179

6.31

56.85

4.7

2.3

119.42

132.09

g/l

4.94

139

Stroke, including SAH

1329

5926

1.63

56.84

2.5

2.3

128.74

129.00

g/l

0.13

1043

4483

Schizophrenia, schizotypal and delusional disorders

619

3123

2.02

56.81

2.6

2.2

131.04

131.82

g/l

0.37

559

2398

Type of accident

635

3244

2.00

56.37

2.6

2.2

127.25

130.32

g/l

2.30

567

2498

Unstable angina pectoris

794

3383

1.88

56.34

2.5

2.1

127.76

128.76

g/l

0.48

640

2511

Azathioprine

323

1249

2.66

56.29

3.5

2.1

127.77

131.75

g/l

1.79

232

1002

Sequelae with surgical and medical care as external cause

488

2271

2.21

56.08

2.7

2.3

123.73

128.44

g/l

3.90

402

1741

Cardiomyopathy (excluding other)

293

1086

2.79

55.69

2.7

2.1

131.37

131.52

g/l

0.03

209

825

Cytomegaloviral disease

103

187

6.07

55.36

4.7

2.2

120.00

132.13

g/l

4.66

144

Other headache syndromes

750

4057

1.87

55.00

2.2

2.1

133.34

128.32

g/l

6.75

569

3101

Injuries to the thorax

992

5851

1.72

54.79

2.4

2.3

129.64

129.94

g/l

0.13

758

4493

Non-selective monoamine reuptake inhibitors

733

3797

1.88

54.51

2.4

2.2

128.82

128.73

g/l

0.03

571

2864

Disorders of calcium metabolism

183

524

3.67

54.45

3.7

2.1

119.44

129.24

g/l

5.10

162

397

Cytomegaloviral disease, including avohilmo

103

190

5.97

54.41

4.7

2.2

120.00

132.29

g/l

4.80

147

Exclusions for E4_PCOS_BROAD

388

1660

2.40

54.34

2.9

2.3

129.24

131.32

g/l

0.96

336

1304

Sarcoidosis

318

1251

2.63

53.78

2.1

2.2

134.51

129.51

g/l

2.23

169

982

Injuries to the abdomen, lower back, lumbar spine and pelvis

878

4962

1.77

53.73

2.4

2.3

127.55

128.98

g/l

0.95

696

3832

Cholelithiasis

1599

7156

1.54

53.46

2.4

2.2

129.36

129.86

g/l

0.33

1277

5420

Stroke, excluding SAH

1266

5704

1.63

53.26

2.5

2.3

128.76

128.70

g/l

0.03

1002

4307

299

1150

2.67

52.67

3.0

2.1

131.29

130.93

g/l

0.08

224

890

Dorsalgia

1840

6543

1.50

52.33

2.3

2.2

131.58

131.11

g/l

0.32

1450

5083

Systemic sclerosis (FG)

158

6.35

52.23

2.0

1.9

122.66

127.62

g/l

0.60

131

Diabetic retinopathy, excluding more controls

631

1777

2.04

52.12

3.2

2.2

126.22

133.28

g/l

9.59

545

1373

Urinary track infection

965

2760

1.77

51.98

2.4

1.9

127.90

129.75

g/l

1.67

753

2136

Presence of cardiac and vascular implants and grafts

931

3975

1.75

51.94

2.5

2.2

125.04

129.39

g/l

5.05

706

2961

Acute peritonitis

196

606

3.41

51.89

4.9

2.2

118.54

130.04

g/l

8.86

170

483

Congenital malformations of the urinary system

175

504

3.66

51.78

4.2

2.3

128.41

131.03

g/l

0.75

158

408

Reimbursement for rheumatic diseases

1088

6632

1.65

51.66

2.6

2.2

127.12

129.84

g/l

2.93

764

5129

Spondylopathies

1491

5710

1.56

51.31

2.3

2.2

129.02

130.50

g/l

1.35

1178

4348

Other external causes of accidental injury

1453

4646

1.58

51.30

2.3

2.2

129.40

131.85

g/l

3.04

1131

3623

Enterocolitis due to Clostridium difficile

293

1136

2.68

51.18

3.3

2.3

119.76

128.21

g/l

6.50

240

883

Spondylosis

1094

5220

1.66

50.94

2.3

129.28

130.20

g/l

0.56

885

3952

Paralytic ileus and intestinal obstruction

582

2989

1.99

50.85

2.7

2.2

125.28

128.89

g/l

2.82

487

2287

Peripheral arterial reconstruction

443

2068

2.21

50.72

3.3

2.3

119.59

127.10

g/l

7.93

344

1611

Traumatic subdural haemorrhage

317

1190

2.56

50.53

2.5

2.1

129.09

125.52

g/l

1.62

269

878

Congenital malformations of the urinary system, including avohilmo

179

536

3.51

49.82

4.1

2.3

128.54

130.49

g/l

0.50

160

432

Ischaemic Stroke, excluding all haemorrhages

1199

5533

1.62

49.80

2.5

2.3

128.54

128.56

g/l

0.01

963

4178

Other disorders of skin and subcutaneous tissue

1444

8020

1.54

49.36

2.8

2.2

126.11

130.01

g/l

7.07

1105

6174

Other viral diseases, including avohilmo

696

3782

1.85

49.34

3.0

2.1

130.46

132.49

g/l

1.39

581

2995

Lower back pain or/and sciatica

2036

8826

1.45

49.17

2.3

2.2

131.29

130.47

g/l

0.74

1594

6836

Diverticular disease of intestine

1373

5503

1.57

49.12

2.5

2.2

128.34

130.73

g/l

2.73

1002

4207

Insulin, fast-acting (human)

290

1143

2.60

48.64

3.4

2.1

125.34

132.27

g/l

4.88

262

886

Personality disorders

483

2361

2.08

48.46

2.5

2.2

133.43

132.72

g/l

0.26

410

1867

Accidents

1437

4646

1.56

48.41

2.3

2.2

129.44

131.85

g/l

2.93

1122

3623

Systemic connective tissue disorders

725

4064

1.82

48.26

2.4

2.2

127.56

127.78

g/l

0.08

514

3128

Other viral diseases

553

2836

1.98

47.96

3.3

2.1

129.95

132.31

g/l

1.44

469

2242

Other or unspecified ileus, impaction or obstruction

433

2044

2.17

47.90

2.7

2.3

124.04

128.64

g/l

3.37

367

1593

Persons encountering health services for specific procedures, not carried out

206

691

3.08

47.17

2.3

1.9

132.62

133.05

g/l

0.08

149

531

Enlarged lymph nodes

320

1339

2.45

47.16

2.3

2.1

125.51

131.86

g/l

4.01

243

996

Suppurative and necrotic conditions of lower respiratory tract

176

541

3.44

47.15

3.4

2.2

120.65

129.67

g/l

4.59

133

425

Disorders of adult personality and behaviour

504

2528

2.03

47.09

2.4

2.1

133.12

132.81

g/l

0.10

426

2002

Acute upper respiratory infections

1963

8207

1.45

47.06

2.6

2.1

130.84

129.96

g/l

0.86

1526

6343

Other neurological diseases

1434

7367

1.53

46.92

2.4

2.3

128.97

129.40

g/l

0.25

1148

5620

Other systemic involvement of connective tissue (FG)

518

2594

2.00

46.08

2.3

2.1

127.68

128.67

g/l

0.41

381

1986

Presbycusis

393

1797

2.23

45.88

2.6

2.3

127.34

125.10

g/l

1.14

344

1390

Liquid cancers

629

3241

1.87

45.71

2.8

2.2

120.17

131.20

g/l

17.93

480

2504

Anxiety disorders

1601

7448

1.49

45.61

2.3

2.2

133.35

130.90

g/l

3.56

1253

5771

Viral hepatitis, IBD co-morbidity

105

227

4.77

45.44

2.7

2.0

129.91

132.53

g/l

0.43

174

Cardiac arrest

139

306

3.98

45.28

3.1

1.8

126.35

132.97

g/l

2.14

111

213

Familial hypercholesterolemia

340

1492

2.34

45.20

2.2

125.78

128.74

g/l

1.32

278

1144

Delirium, not induced by alcohol and other psychoactive substances

337

1475

2.36

44.98

3.0

2.3

122.57

126.10

g/l

1.87

288

1125

Other disorders of bladder

296

1230

2.49

44.68

2.6

2.3

131.65

129.32

g/l

0.84

248

948

Neurotic, stress-related and somatoform disorders

1576

7376

1.48

44.52

2.3

2.2

133.33

130.96

g/l

3.31

1235

5718

Epilepsy

586

3144

1.89

44.41

2.3

131.20

128.08

g/l

2.57

488

2411

Failure and rejection of transplanted organs and tissues

7.84

44.23

5.4

2.4

118.24

131.31

g/l

2.92

Unspecified fall

1038

6420

1.61

44.17

2.4

2.3

128.89

129.68

g/l

0.45

835

4947

External causes of morbidity and mortality

1125

3516

1.62

43.85

2.4

2.1

129.46

132.70

g/l

4.29

895

2717

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

102

225

4.78

43.44

3.3

1.9

123.79

135.26

g/l

5.02

173

Gastrointestinal diseases

947

2839

1.69

43.34

2.3

1.9

130.58

133.72

g/l

3.45

757

2253

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

344

1493

2.29

43.28

3.3

2.3

131.43

131.99

g/l

0.16

289

1191

Injuries to the hip and thigh

1020

5753

1.61

43.20

2.5

2.3

125.18

129.02

g/l

4.79

813

4407

Gastroduodenal ulcer

570

3075

1.88

42.69

2.9

2.3

121.35

128.02

g/l

7.04

451

2387

Other sleep disorders

244

944

2.66

42.66

2.1

2.3

135.49

129.24

g/l

3.49

208

735

Anxiety (asthma-related co-morbidities)

1003

4753

1.62

42.65

2.2

2.1

134.53

132.45

g/l

1.92

785

3661

Chronic apical periodontitis

2046

8193

1.41

42.57

2.3

2.2

130.67

130.53

g/l

0.08

1601

6354

Schizophrenia

316

1378

2.35

42.53

2.7

2.3

129.78

132.67

g/l

1.37

294

1062

Other disorders involving the immune mechanism, not elsewhere classified

107

251

4.57

42.44

4.4

2.3

122.14

132.00

g/l

3.36

198

Noninfective enteritis and colitis

871

5312

1.66

42.29

2.6

2.2

128.81

130.75

g/l

1.47

684

4102

Candidiasis, including avohilmo

595

3271

1.85

42.28

2.6

2.2

127.18

129.34

g/l

1.21

437

2510

Intestinal stricture

659

3741

1.79

42.17

2.7

2.3

124.42

128.37

g/l

3.77

548

2843

Alcohol dependence

538

2876

1.91

41.87

2.6

2.3

130.22

131.75

g/l

0.72

427

2207

Open wound of head

1076

6492

1.57

41.83

2.4

2.3

128.68

131.03

g/l

2.25

872

4965

Other arthritis (FG)

585

3210

1.85

41.78

2.8

2.1

128.64

130.97

g/l

1.48

462

2459

Dysphagia

531

2831

1.91

41.68

2.6

2.2

127.79

128.59

g/l

0.29

395

2114

Cutaneous abscess, furuncle and carbuncle

512

2697

1.93

41.64

3.0

2.2

127.96

131.64

g/l

2.45

401

2094

Acute sinusitis

913

5128

1.64

41.56

2.4

2.1

132.84

131.16

g/l

1.26

699

3949

Obesity, other/unspecified

578

3164

1.85

41.52

2.3

2.1

132.39

130.81

g/l

0.77

399

2439

All influenza (not pneumonia)

283

1190

2.43

41.32

2.8

2.0

129.66

131.99

g/l

0.76

217

925

Other viral diseases, not elsewhere classified, including avohilmo

493

2553

1.95

41.28

2.7

2.1

131.53

131.92

g/l

0.13

416

2021

Other noninfective gastroenteritis and colitis

508

2679

1.93

41.12

2.7

2.3

127.35

129.49

g/l

1.05

397

2088

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

357

1610

2.20

41.05

3.2

2.3

131.10

131.76

g/l

0.20

298

1279

Systemic sclerosis

197

5.07

41.03

2.0

122.66

128.97

g/l

0.87

157

Fracture of rib(s), sternum and thoracic spine

661

3787

1.78

40.99

2.3

130.15

129.16

g/l

0.45

508

2936

Other anxiety disorders

788

3993

1.70

40.97

2.2

134.37

132.12

g/l

1.85

612

3131

Nephrotic syndrome

108

263

4.41

40.87

4.8

2.1

123.99

131.18

g/l

1.82

208

Cystic kidney disease

111

276

4.31

40.85

4.7

2.3

129.67

130.73

g/l

0.17

103

222

Allergic asthma (mode), excluding more controls

315

1359

2.29

40.49

1.8

133.77

133.57

g/l

0.05

215

1150

Abnormal results of function studies

211

781

2.80

40.45

2.7

2.2

130.90

130.77

g/l

0.02

170

634

Pneumocystosis, including avohilmo

185

5.30

40.43

4.1

2.3

119.23

128.76

g/l

2.52

144

Pneumocystosis

185

5.30

40.43

4.1

2.3

119.23

128.76

g/l

2.52

144

Abnormal spermatozoa

315

1412

2.31

40.16

2.6

2.4

131.15

130.04

g/l

0.31

294

1064

Diseases of peritoneum

248

1001

2.56

39.96

4.5

2.2

120.18

128.46

g/l

6.38

209

779

Cystic kidney disease, including avohilmo

115

298

4.12

39.96

4.6

2.3

129.85

131.18

g/l

0.23

105

241

Unspecified acute lower respiratory infection

331

1514

2.24

39.80

3.2

2.2

129.19

130.51

g/l

0.40

266

1188

Other gastritis (incl. Duodenitis)

464

2404

1.97

39.80

2.5

2.3

126.02

129.05

g/l

1.68

356

1858

Pneumonitis due to solids and liquids

231

904

2.66

39.79

3.0

2.3

124.62

127.52

g/l

1.00

191

707

Osteoporosis with pathological fracture (FG)

200

728

2.87

39.79

2.7

2.0

120.27

125.43

g/l

2.45

169

557

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

526

2326

1.90

39.02

2.5

2.2

122.21

131.17

g/l

9.17

322

1793

Cellulitis

463

2414

1.96

38.97

3.1

2.2

128.10

130.67

g/l

1.30

377

1875

Leisure time condition

390

1920

2.08

38.75

2.6

2.3

128.67

129.40

g/l

0.24

349

1502

Recurrent or chronic depression

641

2513

1.79

38.72

2.1

134.74

132.07

g/l

1.86

477

1896

Pyothorax

138

413

3.54

38.72

3.6

2.3

121.71

129.06

g/l

2.69

107

331

Hypothyroidism, strict autoimmune

1295

5716

1.50

38.29

2.6

2.1

129.33

130.25

g/l

0.65

1005

4443

Other and unspecified nonorganic psychotic disorders

349

1653

2.15

38.28

2.4

2.2

133.01

133.61

g/l

0.20

313

1307

Migraine

772

3610

1.68

38.19

2.3

2.2

134.10

129.47

g/l

7.37

606

2786

Non-small cell lung cancer, including Hilmo

361

1625

2.14

38.10

2.3

2.2

122.53

130.97

g/l

6.12

218

1281

Systemic sclerosis, icd10

207

4.77

37.74

2.0

2.1

122.66

128.09

g/l

0.71

164

Immunodeficiencies

134

400

3.53

37.64

3.0

2.4

127.46

130.08

g/l

0.43

326

Bronchiectasis

192

705

2.83

37.52

2.5

2.2

127.26

126.03

g/l

0.24

113

555

Artificial opening status

151

486

3.26

37.50

3.5

2.1

124.30

130.74

g/l

2.05

121

364

Disorders of parathyroid gland

443

2281

1.96

37.39

3.5

2.1

123.21

126.19

g/l

1.78

373

1717

Coagulation defects, purpura and other haemorrhagic conditions

408

2069

2.02

37.31

3.0

2.3

123.41

130.05

g/l

5.22

323

1601

Other viral diseases, not elsewhere classified

358

1725

2.11

37.26

3.1

2.2

131.14

131.62

g/l

0.13

309

1366

Neuromuscular dysfunction of bladder

215

838

2.65

37.26

2.5

2.2

129.16

129.00

g/l

0.03

174

648

Other specified/unspecified arthritis

515

2818

1.86

37.22

2.9

2.2

128.88

130.99

g/l

1.17

404

2175

Alcohol abuse, main dg, excluding more controls

293

1312

2.28

37.09

2.7

2.2

130.90

132.92

g/l

0.65

253

998

Pain (limb, back, neck, head abdominally)

1275

4263

1.51

37.08

2.3

2.2

130.95

131.17

g/l

0.11

1007

3298

Soft tissue disorders

1812

6634

1.41

36.88

2.3

2.2

130.05

131.05

g/l

0.90

1444

5194

Amputation

256

1088

2.43

36.87

3.5

2.3

117.36

128.65

g/l

9.21

202

843

Other/unspecified dorsalgia

697

4117

1.69

36.71

2.4

2.2

130.29

129.69

g/l

0.25

570

3150

Hernia

1668

7886

1.42

36.71

2.5

2.2

129.28

130.66

g/l

1.35

1267

6096

Dermatitis

1179

7783

1.50

36.61

2.5

2.2

128.80

130.20

g/l

1.16

916

6058

All anxiety disorders

1029

5202

1.55

36.43

2.2

134.36

132.09

g/l

2.32

806

4059

Polycystic kidney disease

230

4.45

36.34

4.7

2.4

129.09

131.02

g/l

0.33

183

Malignant neoplasm

1428

5771

1.46

36.33

2.3

2.2

126.60

133.30

g/l

16.00

1076

4482

Specific personality disorders

399

2024

2.00

36.28

2.4

2.2

131.44

132.68

g/l

0.51

337

1596

Malignant neoplasm of bronchus and lung, including Hilmo

473

2101

1.92

36.27

2.4

2.2

122.99

131.22

g/l

7.29

287

1632

Tubulo-interstitial nephritis, not specified as acute or chronic

160

542

3.06

36.18

2.9

1.9

124.42

130.57

g/l

2.33

134

402

Phlebitis and thrombophlebitis (not including DVT)

448

2372

1.93

36.04

2.8

2.2

130.24

129.35

g/l

0.31

360

1796

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

240

4.32

35.93

4.7

2.3

121.74

132.80

g/l

3.94

190

Malignant neoplasm, wide definition

1453

5871

1.45

35.77

2.3

2.2

126.69

133.38

g/l

16.35

1087

4564

Other diseases of liver

366

1814

2.06

35.73

2.7

2.2

127.01

130.31

g/l

1.49

288

1395

Rheumatoid arthritis

598

3055

1.76

35.40

2.7

2.2

124.62

129.80

g/l

5.86

436

2348

Acute alcohol intoxication

502

2770

1.84

35.39

2.8

2.3

131.67

131.26

g/l

0.13

417

2145

Abnormal findings on examination of blood, without diagnosis

952

5593

1.56

35.37

2.7

2.3

125.18

130.41

g/l

8.12

755

4284

Allergic asthma (mode)

315

1438

2.16

35.33

1.8

1.9

133.77

133.02

g/l

0.21

215

1218

Gastric ulcer

387

1965

2.01

35.33

2.7

2.3

121.19

127.86

g/l

4.80

290

1535

Mental and behavioural disorders due to opioids

242

4.19

35.27

3.2

2.1

129.95

134.86

g/l

1.01

193

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

152

508

3.09

35.16

2.6

2.1

134.17

136.36

g/l

0.54

137

410

Other dorsopathies, not elsewhere classified

1759

6557

1.40

35.13

2.2

131.54

131.13

g/l

0.27

1369

5097

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

204

798

2.64

35.09

2.6

2.2

127.83

130.03

g/l

0.64

175

633

Other pulmonary heart/vessel disease

137

434

3.33

35.06

3.0

2.2

127.05

127.10

g/l

0.01

340

Malignant neoplasm, including Hilmo

1446

5866

1.45

34.97

2.3

2.2

126.73

133.40

g/l

16.10

1080

4560

Diabetic maculopathy

343

1583

2.12

34.94

3.4

2.5

125.48

130.39

g/l

3.11

306

1280

Elevated blood glucose level

210

836

2.60

34.93

3.0

2.3

126.65

130.29

g/l

1.18

172

658

Viral infections characterized by skin and mucous membrane lesions

784

4897

1.62

34.78

2.8

2.2

127.30

130.43

g/l

2.78

604

3784

Malignant neoplasm

1416

5766

1.45

34.64

2.3

2.2

126.70

133.28

g/l

15.34

1067

4477

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

500

2692

1.84

34.43

2.4

2.2

120.66

131.50

g/l

17.24

407

2055

Factors influencing health status and contact with health services

493

1306

1.92

34.31

2.2

1.8

130.63

137.04

g/l

6.03

396

1026

Other infectious diseases, including avohilmo

219

897

2.52

34.27

2.9

2.2

125.90

128.62

g/l

0.79

184

702

Other pleural conditions

244

1050

2.40

34.20

3.7

2.1

119.67

127.84

g/l

5.35

195

819

Fracture of femur

603

3187

1.73

33.96

2.4

2.3

121.39

126.69

g/l

5.07

489

2464

Nonischemic cardiomyopathy

220

906

2.50

33.88

2.9

2.2

132.23

129.38

g/l

0.76

156

666

Speech therapy

517

2921

1.80

33.79

2.0

2.3

129.53

128.10

g/l

0.70

442

2219

Pneumothorax

170

620

2.84

33.69

2.8

2.0

126.86

129.38

g/l

0.51

486

Organic, including symptomatic, mental disorders

1063

4985

1.52

33.59

2.5

2.3

127.03

127.79

g/l

0.45

870

3753

Other hearing loss

618

3561

1.71

33.39

2.5

2.3

128.32

126.75

g/l

0.90

510

2687

Other degenerative diseases of the nervous system

497

1995

1.84

33.28

2.2

2.1

129.13

126.43

g/l

1.60

418

1458

Acute pancreatitis

392

2043

1.96

33.15

3.0

2.3

126.01

129.87

g/l

2.01

327

1552

Other complications of surgical and medical care, not elsewhere classified

206

834

2.54

32.95

2.6

2.2

127.61

130.10

g/l

0.70

168

659

Mental and behavioural disorders due to sedatives or hypnotics

155

545

2.94

32.84

3.1

2.2

132.23

132.88

g/l

0.11

121

432

Diabetic retinopathy, strict definition

437

2098

1.91

32.76

3.5

2.5

124.78

131.06

g/l

6.54

392

1685

Symptoms and signs concerning food and fluid intake

224

944

2.43

32.61

2.9

2.2

126.99

130.23

g/l

1.38

182

709

Misadventures to patients during surgical and medical care

304

1459

2.13

32.50

3.0

2.2

122.53

129.38

g/l

4.62

234

1132

Neoplasms

1223

4372

1.48

32.45

2.3

2.1

131.24

135.15

g/l

6.22

983

3516

Systemic sclerosis,strict definition

7.52

32.40

1.8

1.9

124.33

128.97

g/l

0.47

Protozoal diseases

269

3.93

32.30

3.9

2.2

121.49

128.65

g/l

1.84

211

Kela reimbursement Agammaglobulinemia (D80-84)

8.85

32.28

1.9

122.00

132.81

g/l

—

Preparatory care for dialysis

129

415

3.28

32.27

3.8

2.3

121.30

129.49

g/l

3.50

102

332

Secondary right heart disease

123

386

3.36

32.02

3.1

2.2

127.47

127.92

g/l

0.05

306

Acute alcohol intoxication, ICD10

391

2061

1.93

31.96

2.8

2.2

132.51

132.57

g/l

0.02

338

1594

Other disorders of glucose regulation and pancreatic internal secretion

191

759

2.60

31.86

3.2

2.2

124.51

130.26

g/l

2.67

160

604

Peripheral artery operations in Hilmo

289

1371

2.16

31.85

3.3

2.2

117.51

128.16

g/l

9.78

222

1053

Coxarthrosis [arthrosis of hip](FG)

996

4553

1.52

31.75

2.3

2.2

126.57

130.29

g/l

4.41

759

3473

Primary_lymphoid and hematopoietic malignant neoplasms

498

2840

1.79

31.62

2.9

2.3

118.62

128.82

g/l

13.65

375

2191

Malignant neoplasm of respiratory system and intrathoracic organs

459

2101

1.85

31.51

2.3

2.2

120.83

131.37

g/l

10.40

276

1626

Diseases of pulp and periapical tissues, including avohilmo

1838

7003

1.37

31.37

2.3

2.2

129.99

130.24

g/l

0.16

1436

5414

Other and unspecified drugs and medicaments

198

807

2.53

31.36

2.7

2.3

127.48

128.94

g/l

0.37

172

638

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

223

959

2.40

31.35

2.5

2.2

124.98

129.59

g/l

1.82

172

749

Other diseases of anus and rectum

595

3553

1.69

31.33

2.6

2.2

125.06

129.14

g/l

3.93

467

2738

Emotionally unstable personality disorder

220

941

2.39

31.08

2.5

2.2

130.85

133.75

g/l

1.14

189

763

Other disorders of ear

1633

7693

1.38

31.08

2.4

2.2

129.36

130.42

g/l

0.91

1297

5856

Statin medication

1024

3839

1.51

30.92

2.6

2.1

131.39

131.90

g/l

0.26

808

2976

Other diseases of pericardium

112

338

3.46

30.90

3.6

2.2

122.27

130.82

g/l

2.91

258

Diseases of the skin and subcutaneous tissue

1714

6277

1.38

30.83

2.4

2.1

129.56

131.79

g/l

2.90

1314

4947

IgA nephropathy (IgA glomerulonephritis)

189

4.48

30.68

5.1

2.2

123.57

131.72

g/l

2.05

145

Excessive earwax

1204

7640

1.44

30.67

2.3

130.89

129.52

g/l

1.23

1006

5804

Immunodeficiency with predominantly antibody defects

206

4.29

30.66

3.2

2.4

125.54

129.54

g/l

0.43

167

Protozoal diseases, including avohilmo

279

3.78

30.61

3.9

2.2

121.49

128.65

g/l

1.87

219

Other diseases of oesophagus

219

944

2.39

30.60

2.7

2.3

127.21

128.74

g/l

0.37

181

745

Disorders of the thyroid gland

1678

7998

1.37

30.40

2.4

2.2

130.00

130.08

g/l

0.04

1277

6218

Sicca syndrome [Sjögren]

187

754

2.56

30.32

2.0

2.2

128.31

127.45

g/l

0.17

128

589

Dorsopathies

1768

6587

1.37

30.31

2.2

130.92

131.17

g/l

0.15

1377

5123

Other and unspecified dermatitis

954

6422

1.50

30.30

2.6

2.2

128.58

129.91

g/l

0.91

736

4970

Thrombocytopenia, unspecified

180

714

2.62

30.28

3.2

2.3

115.90

129.26

g/l

8.87

155

563

Hypothyreosis and Thyroxine purchase for inclusion criteria

1625

7792

1.38

30.21

2.5

2.2

129.54

129.58

g/l

0.02

1252

6043

Solid cancers, including Hilmo

1392

5768

1.42

30.13

2.3

2.1

126.84

133.31

g/l

14.87

1041

4476

Other metabolic disorders

234

1043

2.29

30.04

2.5

2.1

130.79

130.14

g/l

0.15

184

790

Agranulocytosis

238

1072

2.28

29.99

3.1

2.3

117.21

128.88

g/l

10.25

207

829

Other special examinations and investigations of persons without complaint or reported diagnosis

1197

4178

1.46

29.94

2.2

2.3

131.75

131.26

g/l

0.27

950

3383

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1617

9267

1.37

29.83

2.4

2.2

129.45

131.02

g/l

1.64

1200

7257

Hernia of abdominal wall

852

5627

1.53

29.80

2.8

2.3

129.90

130.34

g/l

0.19

693

4282

Sensorineural hearing loss

1390

6643

1.41

29.54

2.5

2.3

128.59

129.46

g/l

0.62

1115

5010

Complications of internal orthopaedic prosthetic devices, implants and grafts

461

2623

1.79

29.53

2.4

2.3

124.41

127.93

g/l

2.11

346

2011

Bipolar affective disorders

306

1528

2.04

29.23

2.2

132.90

132.17

g/l

0.21

249

1205

Idiopathic gout

234

1062

2.28

29.11

3.3

2.3

128.05

129.16

g/l

0.26

187

812

Chronic pancreatitis

260

1228

2.17

29.09

2.6

2.2

121.46

131.33

g/l

7.73

200

932

Osteomyelitis

162

623

2.70

29.07

3.7

2.2

119.49

130.52

g/l

6.11

136

491

Other symptoms and signs involving cognitive functions and awareness

912

5424

1.51

29.03

2.2

2.3

128.81

128.43

g/l

0.17

706

4138

Any event in cancer register

1487

6287

1.39

29.00

2.3

2.2

127.20

132.97

g/l

12.97

1123

4914

Hypothyroidism, other/unspecified

1557

7496

1.38

28.95

2.5

2.2

129.62

129.70

g/l

0.04

1195

5826

Fracture of lumbar spine and pelvis

475

2738

1.76

28.81

2.5

2.3

124.15

127.38

g/l

2.06

368

2118

Diseases of the musculoskeletal system and connective tissue

864

2810

1.55

28.79

2.2

2.1

131.42

133.11

g/l

1.23

698

2278

Cholecystectomy

1262

7641

1.41

28.77

2.3

2.2

129.24

129.05

g/l

0.10

1010

5806

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

437

2431

1.80

28.76

2.7

2.1

132.78

131.79

g/l

0.40

370

1965

Other systemic involvement of connective tissue

525

3119

1.71

28.73

2.3

127.71

127.62

g/l

0.03

383

2393

Gout due to impairment of renal function

100

6.07

28.72

4.8

2.2

122.19

125.87

g/l

0.40

Calcific aortic valvular stenosis, diagnosis (helper)

649

3915

1.62

28.66

2.6

2.3

121.91

126.97

g/l

5.27

517

3029

Operations 2 for CAVS

649

3915

1.62

28.66

2.6

2.3

121.91

126.97

g/l

5.27

517

3029

Fitting and adjustment of external prosthetic device

14.29

28.65

7.0

1.6

117.79

130.11

g/l

1.64

Meniscus derangement

957

4272

1.50

28.59

2.2

130.39

131.74

g/l

0.88

756

3282

Other diseases of pancreas

191

800

2.47

28.57

2.7

2.3

125.14

129.13

g/l

1.31

154

601

Other symptoms and signs involving the circulatory and respiratory systems

143

519

2.84

28.56

2.6

2.2

130.92

128.67

g/l

0.48

110

406

Calcific aortic valvular stenosis

649

3923

1.62

28.43

2.6

2.3

121.91

126.98

g/l

5.30

517

3035

Calcific aortic valvular stenosis, operated

649

3923

1.62

28.43

2.6

2.3

121.91

126.98

g/l

5.30

517

3035

Solid cancers

1354

5678

1.41

28.42

2.3

2.2

126.47

133.19

g/l

15.44

1013

4402

Malignant neoplasm of bronchus and lung

408

1877

1.85

28.41

2.3

2.2

121.82

131.01

g/l

7.66

244

1473

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

316

1617

2.00

28.38

2.5

2.3

119.45

131.90

g/l

13.78

252

1264

Calcific aortic valvular stenosis, including rheumatic fever

650

3928

1.62

28.37

2.6

2.3

121.88

126.95

g/l

5.31

518

3036

Status epilepticus

278

3.61

28.32

3.5

2.2

128.54

129.12

g/l

0.08

232

Haemorrhage, not elsewhere classified

102

309

3.45

28.04

3.5

2.2

122.91

129.89

g/l

1.95

237

Seropositive rheumatoid arthritis

442

2506

1.78

28.00

2.9

2.1

123.84

128.59

g/l

3.78

315

1906

Spinal stenosis

953

4764

1.49

27.92

2.3

127.38

129.24

g/l

1.42

722

3596

Conductive and sensorineural hearing loss

1429

6898

1.39

27.91

2.5

2.3

128.70

129.71

g/l

0.78

1139

5210

Deforming dorsopathies

505

2990

1.71

27.88

2.5

2.2

128.16

129.91

g/l

0.86

389

2304

Other symptoms and signs involving the urinary system

234

1081

2.23

27.76

2.4

2.3

132.25

130.10

g/l

0.62

214

843

Myocarditis

220

3.88

27.63

3.6

1.8

132.83

137.53

g/l

0.77

154

Acidosis

170

4.47

27.58

4.2

2.1

127.30

130.62

g/l

0.43

136

Hyperparathyroidism

369

1983

1.88

27.53

3.7

2.1

123.29

126.08

g/l

1.40

312

1498

Charcot foot

114

5.35

27.50

4.4

2.1

121.72

133.60

g/l

2.53

Congenital malformations, deformations and chromosomal abnormalities

941

6094

1.48

27.48

2.7

2.2

132.43

132.03

g/l

0.20

744

4773

Mycoses

525

3159

1.69

27.39

3.0

2.3

125.56

129.60

g/l

3.07

388

2439

Non-small cell lung cancer

245

1144

2.17

27.38

2.5

2.2

122.04

130.38

g/l

4.68

148

908

Combinations of oral blood glucose lowering drugs

519

3115

1.69

27.37

2.3

129.53

130.15

g/l

0.20

412

2315

Polyneuropathies and other disorders of the peripheral nervous system

441

2535

1.77

27.33

2.9

2.4

127.52

128.49

g/l

0.33

332

1970

Fibromyalgia

177

731

2.48

27.17

2.1

2.0

131.61

129.46

g/l

0.60

142

567

Sulfasalazine

458

2662

1.74

27.08

2.6

2.1

126.79

130.63

g/l

2.51

340

2067

Chronic tubulo-interstitial nephritis

267

3.60

27.02

3.3

1.7

126.56

130.55

g/l

0.89

200

ILD medications: nintedanib

9.18

26.88

2.4

2.3

140.42

126.70

g/l

1.20

CR(E)ST syndrome

133

5.00

26.80

1.7

1.8

118.89

127.87

g/l

1.08

102

Coxarthrosis

907

3945

1.50

26.78

2.3

2.2

126.60

130.58

g/l

4.66

694

3020

Dilated cardiomyopathy

262

1285

2.10

26.67

2.5

2.3

131.42

129.45

g/l

0.53

186

993

Other and unspecified polyneuropathies, also in other diseases

395

2217

1.82

26.63

2.9

2.4

127.46

128.48

g/l

0.32

298

1718

Alcohol abuse, main dg

293

1493

2.00

26.60

2.7

2.4

130.90

132.56

g/l

0.51

253

1165

Pleural plaque

226

1050

2.22

26.56

2.4

2.1

130.25

127.36

g/l

0.84

158

818

Purpura and other haemorrhagic conditions

280

1411

2.03

26.32

2.9

2.3

118.80

129.48

g/l

9.13

227

1100

Diseases of the eye and adnexa

1242

4421

1.42

26.29

2.3

2.1

132.62

133.51

g/l

0.60

986

3477

Vitreous haemorrhage

224

1041

2.21

26.23

3.2

2.4

123.85

128.07

g/l

1.83

193

803

Candidiasis

274

1372

2.04

26.17

2.8

2.2

123.09

128.97

g/l

3.43

201

1072

Other infectious diseases

174

728

2.47

26.14

3.0

2.3

125.42

128.64

g/l

0.88

146

576

Noninfectious colitis NAS

272

1360

2.04

26.10

2.7

2.3

128.30

129.05

g/l

0.17

218

1069

Other and unspecified effects of external causes

460

2709

1.72

25.97

2.8

2.2

131.08

131.02

g/l

0.02

377

2127

Arthropathies

1482

5496

1.37

25.91

2.3

2.2

130.05

132.51

g/l

3.33

1189

4330

Acute pancreatitis (for exclusion)

392

2212

1.80

25.91

3.0

2.3

126.01

130.04

g/l

2.18

327

1695

Gonarthrosis [arthrosis of knee](FG)

1247

5144

1.41

25.84

2.2

2.1

129.55

131.40

g/l

1.61

957

3939

Vascular disorders of the intestines

177

752

2.43

25.74

2.9

2.3

118.16

127.92

g/l

5.02

140

602

Nonorganic sleeping disorders, excluding more controls

325

1732

1.90

25.68

2.4

2.1

135.52

131.53

g/l

2.28

252

1344

Hypercalcemia

119

418

2.98

25.57

3.4

2.3

118.28

128.94

g/l

4.39

108

330

Schizoaffective disorder

152

603

2.59

25.52

2.7

2.3

129.37

131.90

g/l

0.66

142

470

Pain in joint

963

4065

1.47

25.50

2.3

2.2

131.26

131.53

g/l

0.12

693

3132

Diabetic retinopathy

806

3333

1.53

25.42

3.0

2.5

126.52

129.99

g/l

3.61

682

2668

Zoster [herpes zoster], including avohilmo

951

6388

1.45

25.42

2.4

2.2

127.42

129.10

g/l

1.19

716

4897

Collagenous colitis

199

893

2.29

25.41

2.8

2.3

127.17

128.39

g/l

0.27

147

709

Aortic aneurysm

474

2779

1.70

25.37

2.6

2.2

128.80

129.53

g/l

0.23

359

2135

Functional dyspepsia

468

2789

1.70

25.33

2.2

130.75

129.69

g/l

0.44

373

2151

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

145

566

2.64

25.21

2.8

2.2

132.16

131.37

g/l

0.17

137

455

Zoster [herpes zoster]

378

2129

1.81

25.18

2.8

2.3

124.45

127.52

g/l

1.39

285

1640

Dermatitis and eczema

1963

8964

1.30

25.16

2.4

2.2

129.70

130.94

g/l

1.29

1482

7017

Fibrosis and cirrhosis of liver

175

749

2.41

25.03

3.0

2.3

116.61

129.51

g/l

7.48

142

576

Respiratory conditions due to other external agents

188

4.12

24.99

2.8

2.1

125.46

127.09

g/l

0.21

149

Viral pneumonia (known virus, not influenza)

243

3.65

24.98

3.8

2.2

127.47

129.98

g/l

0.41

197

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

897

5973

1.46

24.94

2.2

2.3

134.22

130.99

g/l

3.18

651

4685

Migraine with aura

358

1985

1.82

24.85

2.2

2.1

135.23

128.74

g/l

7.44

284

1555

Caries of dentine, including avohilmo

1357

5058

1.38

24.85

2.3

128.86

129.21

g/l

0.19

1042

3944

Periapical abscess

787

5313

1.50

24.81

2.4

2.3

133.06

131.18

g/l

1.32

632

4044

Other embolism and thrombosis

253

1260

2.05

24.61

2.7

2.2

128.63

129.03

g/l

0.08

206

962

Diseases of the myoneural junction and muscle

260

1310

2.03

24.54

2.6

2.3

130.65

128.47

g/l

0.73

220

1014

Ventral hernia

451

2687

1.71

24.54

2.9

2.3

129.30

128.45

g/l

0.30

366

2060

Arthropathies in other diseases classified elsewhere

280

3.40

24.47

3.6

2.4

123.06

129.96

g/l

1.76

219

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

366

2060

1.81

24.46

2.4

2.2

119.58

131.08

g/l

15.21

302

1587

Injuries to the shoulder and upper arm

1522

8839

1.34

24.34

2.3

2.2

130.36

130.77

g/l

0.24

1186

6847

Cardiomyopathy, other and unspecified

152

618

2.53

24.26

2.9

2.1

129.81

130.81

g/l

0.16

111

461

Cholecystitis

287

1501

1.95

24.23

2.5

2.4

129.47

128.07

g/l

0.40

230

1145

Arthrosis

1164

4565

1.41

24.16

2.2

2.1

129.98

131.77

g/l

1.49

907

3523

Hypothyroidism, strict autoimmune, 3 medication purchases required

1425

7129

1.35

24.03

2.5

2.2

129.06

129.36

g/l

0.17

1098

5527

severe traumatic brain injury, does not include concussion

452

2716

1.69

23.86

2.4

2.3

129.33

127.68

g/l

0.70

369

2115

Abnormal findings on diagnostic imaging of other body structures

270

1391

1.98

23.84

3.0

2.2

125.54

128.11

g/l

0.98

224

1104

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

183

817

2.31

23.76

3.5

2.2

120.17

127.34

g/l

4.23

155

641

Traumatic subarachnoid haemorrhage

271

3.37

23.58

1.9

2.2

131.28

124.93

g/l

1.03

203

Fentanyl

216

1029

2.14

23.56

3.1

2.1

120.67

129.29

g/l

5.41

171

819

Migraine without aura

273

1416

1.95

23.41

2.2

2.1

134.72

129.79

g/l

3.69

206

1139

Transport accidents

751

4209

1.50

23.27

2.1

2.2

131.71

132.04

g/l

0.14

595

3282

Polyarthrosis

384

1992

1.76

23.23

2.3

2.1

124.10

128.09

g/l

2.30

316

1514

Superficial injury of abdomen, lower back and pelvis

295

1578

1.90

23.23

2.4

2.3

129.87

130.03

g/l

0.04

244

1244

Other joint disorders

1416

5484

1.35

23.17

2.2

130.70

132.48

g/l

1.90

1128

4321

Mycoses, including avohilmo

1594

9261

1.32

23.09

2.4

2.2

129.63

131.08

g/l

1.35

1153

7280

Non-small cell lung cancer, adenocarcinoma

153

642

2.47

22.96

2.6

2.2

123.27

131.49

g/l

2.56

509

471

2692

1.66

22.91

2.3

126.01

125.33

g/l

0.25

366

2052

Sequelae of cerebrovascular disease

711

4072

1.51

22.81

2.3

128.91

127.25

g/l

0.90

567

3118

Drug-induced osteoporosis with pathological fracture

147

4.41

22.77

3.2

2.4

120.02

125.91

g/l

0.96

117

Need for other prophylactic measures

130

507

2.65

22.76

2.5

2.3

132.90

130.32

g/l

0.42

404

Diseases of pulp and periapical tissues and dental caries

1139

4202

1.40

22.72

2.3

127.77

128.87

g/l

0.72

862

3295

Gonarthrosis

1066

4298

1.41

22.71

2.2

129.93

131.26

g/l

0.89

828

3301

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

297

1607

1.89

22.69

2.9

2.3

119.03

130.50

g/l

10.60

244

1229

Hypoglycaemia, other or unspecified

145

596

2.51

22.68

2.9

2.3

124.14

130.42

g/l

2.43

121

477

Malignant neoplasm of urinary organs, including Hilmo

240

1210

2.03

22.66

3.2

2.2

126.47

130.81

g/l

1.96

199

949

Familial hypercholesterolemia, with ischemic heart disease

202

957

2.17

22.63

2.3

126.19

127.70

g/l

0.36

169

714

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1018

6658

1.40

22.60

2.6

2.2

132.31

131.72

g/l

0.33

796

5202

Transient ischemic attack

963

5447

1.42

22.52

2.4

2.3

127.14

128.35

g/l

0.75

765

4106

Disorders of eyelid, lacrimal system and orbit

1517

8458

1.32

22.38

2.1

2.3

129.27

129.88

g/l

0.41

1123

6569

Shoulder lesions

1286

5697

1.36

22.34

2.2

130.64

130.45

g/l

0.09

968

4373

Coronary artery bypass grafting

482

2193

1.65

22.33

2.6

2.2

123.93

129.06

g/l

3.77

392

1641

Irritable bowel syndrome

443

2695

1.66

22.19

2.0

2.2

131.76

130.31

g/l

0.63

327

2096

Attention to artificial openings

104

367

2.95

22.16

3.4

1.8

129.28

131.67

g/l

0.40

274

Parkinson's disease, excluding more controls

236

1090

2.03

22.08

2.1

2.2

127.33

125.92

g/l

0.40

201

790

Other intervertebral disc disorders

1359

6052

1.35

22.03

2.2

132.15

130.82

g/l

1.08

1020

4645

Other specified and unspecified personality disorders

161

703

2.34

21.92

3.0

2.3

132.85

132.94

g/l

0.02

136

551

Internal derangement of knee

613

3994

1.53

21.86

2.5

2.2

130.26

132.09

g/l

1.04

480

3076

Amputation of toe

168

754

2.30

21.62

3.6

2.3

117.62

127.96

g/l

5.74

138

589

Dental operations

1036

3809

1.41

21.49

2.3

2.2

128.51

129.46

g/l

0.56

795

2907

Superficial injury of head

432

2632

1.66

21.48

2.5

2.3

130.10

129.58

g/l

0.16

343

2039

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

566

3680

1.56

21.48

2.2

131.47

129.17

g/l

1.35

416

2809

DVT of lower extremities

351

2030

1.76

21.40

2.5

2.2

128.53

128.81

g/l

0.07

282

1546

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

209

1026

2.09

21.30

3.2

2.2

126.71

130.97

g/l

1.63

174

808

Hyperplasia of prostate

665

2476

1.53

21.21

2.5

2.3

132.20

132.12

g/l

0.03

514

1843

Cirrhosis of liver, NAS

133

544

2.54

21.19

3.2

2.3

114.66

129.73

g/l

8.17

113

423

Other and unspecified immunodeficiencies with predominantly antibody defects

5.47

21.14

3.3

1.9

123.94

130.11

g/l

0.39

Open wound of lower leg

295

1629

1.84

21.08

2.7

2.3

126.27

129.25

g/l

1.27

230

1280

Other disorders of veins

680

4536

1.49

21.05

2.5

2.2

128.09

129.51

g/l

0.72

469

3427

Nonhereditary hypogammaglobulinemia

5.59

20.99

2.8

2.3

132.94

130.34

g/l

0.14

Post-traumatic stress disorder

145

616

2.40

20.98

1.9

2.2

132.34

131.80

g/l

0.12

122

517

Malignant neoplasm of urinary organs

207

1020

2.08

20.90

3.3

2.2

126.47

130.65

g/l

1.55

171

801

Diseases of the ear and mastoid process

1894

7440

1.28

20.89

2.4

2.2

131.17

131.05

g/l

0.07

1495

5728

Dental caries, including avohilmo

1245

4718

1.36

20.88

2.3

127.95

129.10

g/l

0.81

942

3702

Alzheimer disease, excluding more controls

316

1127

1.84

20.87

2.1

2.2

128.08

125.34

g/l

1.15

264

829

Mixed hyperlipidaemia

319

3.03

20.85

2.3

2.0

124.70

129.99

g/l

0.92

244

Intestinal malabsorption

107

396

2.80

20.84

2.8

2.2

125.64

130.65

g/l

1.30

315

Diaphragmatic hernia

651

4392

1.50

20.78

2.2

2.3

128.45

128.04

g/l

0.15

439

3350

Postprocedural endocrine and metabolic disorders, not elsewhere classified

197

953

2.10

20.74

2.5

2.1

130.07

129.73

g/l

0.07

156

730

Diseases of oral cavity, salivary glands and jaws

989

3640

1.41

20.65

2.4

2.2

128.17

128.58

g/l

0.18

746

2920

Malignant neoplasm of bladder, including Hilmo

253

1323

1.93

20.64

2.4

2.2

126.20

131.33

g/l

2.34

197

1057

Drug-induced neutropenia

151

664

2.34

20.39

2.8

2.3

117.78

129.03

g/l

6.90

134

520

Other specific joint derangements/joint disorders

1153

5304

1.36

20.39

2.3

2.2

131.26

132.72

g/l

1.13

850

4171

Injury, poisoning and certain other consequences of external causes

837

2915

1.45

20.22

2.4

2.1

129.21

132.37

g/l

3.19

655

2264

Abnormal findings on antenatal screening of mother

124

499

2.53

20.20

2.9

1.9

129.74

131.85

g/l

0.64

119

424

Hypopituitarism

139

592

2.41

20.11

2.7

2.2

132.82

134.05

g/l

0.23

122

459

Psoriatic and enteropathic arthropathies

198

972

2.08

20.09

2.2

2.1

132.30

131.54

g/l

0.17

152

742

Symptoms and signs involving speech and voice

580

3850

1.52

20.06

2.4

2.2

129.10

128.36

g/l

0.30

406

2957

Other condition

260

1403

1.89

20.03

2.7

2.3

126.59

131.02

g/l

1.89

229

1094

Arterial embolism and thrombosis

132

553

2.46

19.88

3.9

2.1

120.94

128.19

g/l

2.34

106

428

Chronic gastritis

494

3175

1.58

19.84

2.2

126.26

127.42

g/l

0.39

315

2446

Intestinal adhesions without obstruction

182

872

2.14

19.83

2.4

2.3

125.62

128.41

g/l

0.65

138

693

Dental pulpitis, including avohilmo

1456

7163

1.31

19.67

2.3

134.60

131.54

g/l

5.12

1184

5506

616

3558

1.51

19.67

2.3

125.48

125.89

g/l

0.16

478

2714

Other specified/unspecified systemic involvement of connective tissue

116

460

2.60

19.66

2.3

126.16

128.66

g/l

0.48

366

Use of pramipexole

403

2476

1.65

19.63

2.4

2.3

126.43

127.88

g/l

0.56

325

1879

Rheumatoid arthritis, including avohilmo

644

4387

1.48

19.60

2.6

2.3

124.95

128.26

g/l

2.95

474

3351

Injuries to the neck

387

2352

1.67

19.59

2.1

2.3

132.41

131.10

g/l

0.50

319

1851

Folate deficiency anaemia

5.21

19.41

3.0

2.1

114.38

129.65

g/l

3.66

Other symptoms and signs involving the digestive system and abdomen

286

1604

1.81

19.39

2.7

2.2

126.69

128.20

g/l

0.42

233

1207

Malignant neoplasm of kidney, except renal pelvis

189

928

2.09

19.32

3.3

2.2

126.88

130.92

g/l

1.33

158

727

Pneumonia due to Streptococcus pneumoniae

284

3.05

19.28

2.8

2.0

126.74

131.49

g/l

0.98

231

Endocarditis

253

3.20

19.27

2.7

1.9

119.98

130.55

g/l

3.08

192

Valvular operations

240

1279

1.91

19.21

3.0

2.0

121.48

131.15

g/l

5.73

188

967

Rheumatism, unspecified

229

1203

1.94

19.18

2.4

2.1

128.78

128.43

g/l

0.08

175

899

Focal epilepsy

378

2297

1.67

19.17

2.3

132.15

129.80

g/l

1.21

325

1792

Degeneration of macula and posterior pole

915

5115

1.39

19.08

2.3

126.72

127.29

g/l

0.28

695

3868

Varicose veins

1041

5807

1.36

19.07

2.4

2.2

127.86

128.87

g/l

0.67

824

4398

Fracture of shoulder and upper arm

641

4380

1.48

19.06

2.5

2.3

126.45

129.15

g/l

1.75

502

3372

Abnormal findings on examination of urine, without diagnosis

104

399

2.71

18.95

3.3

2.3

130.06

129.92

g/l

0.02

316

Chronic sinusitis

680

4703

1.46

18.93

2.4

2.2

130.65

130.03

g/l

0.27

482

3684

Other blood glucose lowering drugs, excl. Insulins

287

1627

1.80

18.86

2.9

2.3

126.31

127.60

g/l

0.33

231

1226

Other disorders of white blood cells

119

488

2.52

18.86

3.3

2.3

123.12

130.01

g/l

1.88

395

Mental and behavioural disorders due to tobacco

166

783

2.17

18.84

2.6

2.4

135.38

130.56

g/l

1.23

108

614

Smoking dependency

166

785

2.17

18.72

2.6

2.4

135.38

130.68

g/l

1.18

108

617

Amputation of ankle bones

199

3.51

18.54

4.9

2.2

115.12

129.20

g/l

4.41

160

Radiculopathy

298

1716

1.77

18.53

2.4

2.2

130.25

127.98

g/l

0.81

232

1306

Secondary uncertain malignant neoplasm

259

1433

1.84

18.50

2.6

2.2

119.79

130.31

g/l

8.21

200

1127

Assault

210

1085

1.97

18.45

2.4

2.3

132.12

135.26

g/l

0.99

170

856

Nonalcoholic fatty liver disease

184

912

2.06

18.29

2.1

2.3

129.85

131.26

g/l

0.28

137

705

Polycystic ovarian syndrome, consortium definition

1055

4475

1.36

18.28

2.2

2.1

128.72

128.09

g/l

0.38

821

3482

Extrapyramidal and movement disorders

699

4904

1.44

18.26

2.1

2.3

129.61

128.10

g/l

0.90

547

3723

Focal brain injury

114

465

2.51

18.14

2.3

2.2

130.34

127.78

g/l

0.47

339

Exclusions for E4_PCOS_CONSORTIUM

1089

5068

1.35

18.14

2.3

2.2

129.48

129.67

g/l

0.09

859

3932

Duodenal ulcer

217

1144

1.94

18.07

3.1

2.3

121.50

128.57

g/l

3.66

185

896

Type 1 diabetes, strict (exclude DM2)

141

630

2.27

18.07

2.6

2.2

132.30

135.27

g/l

0.83

121

501

Other diseases of biliary tract

178

877

2.08

18.04

2.9

2.3

120.80

128.38

g/l

3.46

146

661

Mixed and other personality disorders

136

602

2.31

18.03

2.7

2.2

137.93

133.64

g/l

1.16

121

475

Asthma and allergy, excluding more controls

154

706

2.18

17.96

1.8

135.35

134.24

g/l

0.26

603

Disorders of lacrimal system

746

5218

1.42

17.96

2.1

2.2

128.34

128.48

g/l

0.05

558

4031

Non-small cell lung cancer, adenocarcinoma, helper endpoint

153

715

2.21

17.94

2.6

2.3

123.27

128.00

g/l

1.09

558

Chronic periodontitis, including avohilmo

1670

8438

1.27

17.81

2.3

2.2

131.16

130.62

g/l

0.37

1244

6543

Alzheimer’s disease (Atypical or mixed), excluding more controls

178

645

2.10

17.73

2.1

2.2

126.37

122.88

g/l

1.05

166

486

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

116

485

2.48

17.71

3.6

2.1

118.70

130.73

g/l

5.75

390

Infection due to other mycobacteria

120

4.25

17.69

2.4

1.9

123.06

130.55

g/l

1.08

Ascites

154

724

2.18

17.69

2.8

2.3

113.10

128.31

g/l

11.77

137

562

Somatoform disorder

262

1473

1.80

17.68

2.2

132.62

129.79

g/l

1.05

203

1136

Artrosis, including avohilmo

1336

5618

1.31

17.67

2.1

2.3

130.07

131.30

g/l

0.96

1031

4365

Motor neuron disease (with DMD)

133

4.02

17.66

3.0

2.2

142.60

127.34

g/l

4.67

100

Postmenopausal osteoporosis with pathological fracture

146

674

2.23

17.65

2.5

2.2

120.48

123.03

g/l

0.76

125

518

Other and unspecified tonsillitis

464

2492

1.56

17.62

2.4

2.1

136.38

134.81

g/l

0.71

379

1999

Type 1 diabetes, definitions combined

141

637

2.24

17.60

2.6

2.2

132.30

135.30

g/l

0.84

121

502

Periodontitis

1669

8440

1.27

17.52

2.3

2.2

131.11

130.61

g/l

0.33

1246

6543

Decubitus ulcer and pressure area

150

703

2.20

17.45

3.5

2.2

119.92

127.51

g/l

2.92

120

548

Asthma and opportunity respiratory infection

105

422

2.58

17.44

2.0

2.3

123.62

126.86

g/l

0.54

335

Persistent mood disorders

310

1835

1.71

17.43

2.4

2.2

130.20

129.39

g/l

0.23

237

1402

Mental disorders, not otherwise specified

139

630

2.25

17.42

1.6

2.3

134.58

132.23

g/l

0.67

120

501

Diseases of male genital organs

839

3026

1.41

17.32

2.4

2.3

133.64

134.90

g/l

0.62

664

2310

Parkinson's disease, strict definition, excluding more controls

212

1044

1.92

17.31

2.0

2.2

127.26

125.69

g/l

0.43

180

758

Polyuria

401

2539

1.60

17.30

2.4

2.3

132.09

128.67

g/l

1.83

290

1935

Renal tubulo-interstitial disorders in diseases classified elsewhere

5.36

17.27

4.0

2.0

128.10

129.65

g/l

0.10

Necrosis of pulp, including avohilmo

904

6598

1.36

17.21

2.2

2.3

133.83

131.76

g/l

1.76

719

5075

Cyst of kidney

154

734

2.16

17.15

2.5

2.2

129.63

128.59

g/l

0.22

116

576

Superficial injury of hip and thigh

292

1711

1.73

17.10

2.7

2.3

124.84

127.87

g/l

1.44

240

1341

Fracture of foot, except ankle

392

2475

1.60

17.05

2.2

130.66

131.01

g/l

0.10

312

1936

Postprocedural disorders of digestive system, not elsewhere classified

295

2.90

16.98

3.2

2.0

118.17

129.21

g/l

3.53

234

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

438

2843

1.56

16.94

2.9

2.2

123.74

127.74

g/l

2.88

313

2143

Motor neuron disease ALS

128

4.01

16.94

3.0

2.2

142.12

127.22

g/l

4.21

Benign paroxysmal vertigo

520

3503

1.50

16.88

2.3

131.42

127.10

g/l

4.27

412

2669

Panic disorder

218

1175

1.88

16.86

2.3

2.2

133.41

132.35

g/l

0.30

169

960

Benign neoplasms

1618

6971

1.27

16.86

2.4

2.2

130.15

131.82

g/l

1.76

1243

5528

Carpal tunnel syndrome

985

6399

1.34

16.72

2.1

2.2

130.46

129.72

g/l

0.44

775

4829

Right bundle-branch block

297

2.85

16.71

2.9

1.9

127.52

129.75

g/l

0.31

223

Other diseases of hard tissues of teeth

946

3605

1.37

16.70

2.3

2.2

129.96

128.70

g/l

0.75

685

2889

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

4.67

16.65

3.3

2.2

128.09

131.14

g/l

0.31

Asthma and allergy

154

728

2.11

16.62

1.8

135.35

134.18

g/l

0.28

621

Superficial injury of lower leg

437

2848

1.55

16.56

2.8

2.2

128.57

129.93

g/l

0.49

345

2211

Missing teeth due to accident, extraction or parodontitis

1085

7386

1.32

16.53

2.5

2.3

129.44

129.63

g/l

0.09

800

5659

Secondary polycythaemia

204

3.29

16.44

2.3

161.35

131.69

g/l

11.07

162

Other abnormal uterine and vaginal bleeding

369

1644

1.63

16.42

2.1

126.18

126.79

g/l

0.19

286

1253

Clear cell adenocarcinoma of kidney

109

459

2.46

16.41

2.9

2.0

128.79

132.46

g/l

0.79

366

Acute gastritis

141

660

2.19

16.39

3.0

2.2

126.77

129.10

g/l

0.38

108

522

Pneumonia derived septicemia

295

2.85

16.39

3.6

2.3

123.51

129.73

g/l

1.61

238

Spirochaetal infections, other/unspecified, including avohilmo

218

3866

0.56

16.38

1.7

2.3

131.03

129.66

g/l

0.30

112

2945

Infection due to other mycobacteria, including avohilmo

127

3.99

16.37

2.4

1.8

123.06

130.36

g/l

1.05

Lyme disease, including avohilmo

217

3850

0.56

16.33

1.7

2.3

131.35

129.58

g/l

0.41

111

2932

Lyme disease

217

3850

0.56

16.33

1.7

2.3

131.35

129.58

g/l

0.41

111

2932

Hidradenitis suppurativa

262

2.95

16.32

2.7

2.2

134.61

133.49

g/l

0.12

218

Chronic periodontitis, complicated

950

6951

1.34

16.29

2.4

2.3

130.59

130.44

g/l

0.06

690

5296

Secondary and unspecified malignant neoplasm of lymph nodes

165

822

2.05

16.28

2.9

2.2

119.62

132.03

g/l

6.68

122

645

Thyrotoxicosis, other and/or unspecified

322

1962

1.66

16.25

1.9

2.3

130.12

127.51

g/l

1.04

222

1513

In situ neoplasms

703

5043

1.41

16.24

2.6

2.2

126.58

127.83

g/l

0.69

541

3858

Benign neoplasm of colon, rectum, anus and anal canal

1123

7283

1.31

16.21

2.5

2.3

126.26

129.14

g/l

3.20

802

5597

Injuries to the knee and lower leg

2000

8803

1.23

16.21

2.4

2.2

129.46

130.90

g/l

1.70

1546

6852

Heartburn

193

1016

1.93

16.15

2.4

2.3

131.36

129.59

g/l

0.44

152

787

Haemorrhoids and perianal venous thrombosis

581

4002

1.45

16.14

2.3

2.2

129.74

129.70

g/l

0.01

458

3068

Impotence

121

537

2.32

16.11

3.1

2.2

137.81

132.68

g/l

1.26

104

398

Myalgia

373

2361

1.60

16.08

2.0

2.2

131.96

130.13

g/l

0.66

274

1806

Glaucoma

1006

6465

1.33

16.07

2.2

2.3

127.66

128.03

g/l

0.18

827

4863

Acute and transient psychotic disorders

187

976

1.95

16.06

3.0

2.2

128.88

132.09

g/l

1.00

170

757

Disorders of plasma-protein metabolism, not elsewhere classified

7.16

16.05

1.8

1.7

137.72

132.44

g/l

0.35

Other and unspecified myopathies

179

923

1.99

16.04

2.7

2.3

129.50

127.54

g/l

0.48

153

716

Other disorders of lacrimal gland

606

4248

1.44

15.96

2.1

2.3

129.38

128.44

g/l

0.40

447

3276

Other endocrine disorders

107

432

2.44

15.87

3.1

2.4

130.48

131.56

g/l

0.17

100

367

Thiazolidinediones

209

1138

1.87

15.84

2.9

2.3

127.23

128.57

g/l

0.30

160

850

Inflammatory bowel disease

492

3320

1.50

15.81

2.6

2.2

130.41

131.59

g/l

0.51

388

2569

Non-Hodgkin lymphoma, all, including Hilmo

239

1358

1.79

15.71

2.6

2.2

120.63

131.54

g/l

8.51

177

1066

Hyperosmolality and hypernatraemia

113

4.14

15.69

3.9

2.0

124.79

126.49

g/l

0.16

Orchitis and epididymitis

174

895

1.98

15.66

2.4

133.88

132.47

g/l

0.29

149

681

Umbilical hernia

457

3047

1.52

15.63

2.8

2.3

129.95

131.23

g/l

0.48

371

2368

Use of disulfiram, acamprosate or naltrexone

149

726

2.10

15.60

2.4

129.97

134.82

g/l

1.42

121

571

Open wound of ankle and foot

189

1001

1.92

15.58

2.2

2.3

125.08

131.28

g/l

2.90

150

796

Other spirochaetal diseases

224

3887

0.57

15.57

1.7

2.3

131.19

129.68

g/l

0.35

116

2964

Injuries to unspecified part of trunk, limb or body region

192

1023

1.91

15.56

2.5

2.3

126.17

129.42

g/l

0.96

143

805

Childhood asthma (age<16), excluding more controls

156

592

2.08

15.54

2.3

2.1

136.24

136.43

g/l

0.04

129

529

Oesophagitis

110

476

2.38

15.52

2.8

2.2

127.09

129.77

g/l

0.44

389

Pericarditis

237

3.00

15.49

3.7

2.0

124.34

132.10

g/l

1.55

175

Chronic viral hepatitis

356

2.59

15.39

2.7

2.1

130.03

136.40

g/l

1.50

287

Malignant neoplasm of digestive organs, including Hilmo

725

3850

1.40

15.37

2.3

2.2

120.51

131.46

g/l

24.01

565

2947

Cholangitis (primary sclerosing, PSC)

124

567

2.24

15.34

3.6

2.2

119.88

129.07

g/l

3.59

103

436

Other/unspecified seropositive rheumatoid arthritis

439

2916

1.52

15.32

2.9

2.2

123.75

127.80

g/l

2.96

314

2200

Amyloidosis

187

3.31

15.31

4.6

2.1

119.90

126.64

g/l

1.18

149

Simple and mucopurulent chronic bronchitis

311

2.71

15.29

2.8

2.2

129.93

126.08

g/l

0.80

246

Type 1 diabetes, strict definition, subgroup 1

102

427

2.42

15.29

2.2

2.3

135.19

137.58

g/l

0.50

353

Injuries to the ankle and foot

1124

7421

1.30

15.28

2.2

2.3

130.84

131.80

g/l

0.65

880

5775

Pyogenic arthritis

130

607

2.19

15.25

2.6

2.2

125.39

129.40

g/l

0.88

106

470

Sulfonylureas

600

3348

1.44

15.19

2.9

2.3

124.05

127.16

g/l

2.21

491

2539

Urolithiasis

560

3908

1.45

15.19

2.3

131.29

129.55

g/l

0.88

456

3018

Chronic ulcer of skin, not elsewhere classified

147

722

2.09

15.16

2.9

2.1

119.40

128.84

g/l

3.71

114

555

Other spirochaetal diseases, including avohilmo

229

3921

0.58

15.14

1.7

2.3

130.96

129.71

g/l

0.28

121

2990

Focal epilepsy, mode (most common among epilepsy diagnosis)

324

2016

1.63

15.09

2.4

2.3

133.19

129.47

g/l

2.22

277

1558

Other diseases of intestine

276

1650

1.70

15.09

3.0

2.3

121.84

129.60

g/l

4.97

222

1279

Other specified disorders of kidney and ureter

286

2.80

15.07

3.6

2.1

128.86

129.65

g/l

0.12

232

Seropositive rheumatoid arthritis, wide

442

2951

1.52

15.06

2.9

2.2

123.84

127.79

g/l

2.84

315

2225

Childhood asthma (age<16)

156

601

2.05

14.96

2.3

2.1

136.24

136.35

g/l

0.02

129

537

Focal epilepsy, strict definition

339

2138

1.61

14.93

2.4

2.3

132.07

129.73

g/l

1.06

289

1657

Scoliosis

153

766

2.04

14.89

2.9

2.4

127.80

129.60

g/l

0.45

127

626

Mental and behavioural disorders due to use of other stimulants, including caffeine

170

3.34

14.77

2.4

2.3

131.23

137.10

g/l

0.96

133

Somnolence, stupor and coma

364

2.55

14.77

3.3

2.3

129.12

128.67

g/l

0.06

300

Other or ill-defined heart diseases

387

2.48

14.77

2.9

2.0

128.75

131.92

g/l

0.55

292

Left bundle-branch block

129

608

2.17

14.76

2.3

2.1

129.44

129.09

g/l

0.05

451

Other viral hepatitis, including avohilmo

112

499

2.29

14.73

2.6

2.2

129.48

135.08

g/l

1.48

403

Methotrexate

219

1236

1.80

14.70

2.5

2.1

125.79

128.51

g/l

0.90

149

970

Disorders of vestibular function (Vertigo)

791

5722

1.36

14.67

2.1

2.3

131.99

128.00

g/l

4.91

615

4371

Thoracic aortic aneurysm

260

1543

1.71

14.67

2.5

2.1

131.10

130.47

g/l

0.13

195

1178

Hypoparathyroidism

325

2.65

14.64

2.7

2.1

121.71

126.79

g/l

1.01

260

Type 1 diabetes, strict definition

106

461

2.33

14.58

2.5

2.2

134.91

136.98

g/l

0.43

377

Abnormal involuntary movements

237

1375

1.75

14.51

2.0

2.3

133.00

129.06

g/l

1.66

180

1050

Other malignant neoplasms of skin (=non-melanoma skin cancer)

771

3847

1.37

14.50

2.4

2.2

127.64

131.06

g/l

3.35

579

2939

Abscess of lung

134

3.72

14.47

3.4

2.2

118.73

127.02

g/l

1.30

106

Left ventricular outflow tract obstruction (LVOTO), broad definition

170

893

1.94

14.42

3.0

2.5

130.36

133.05

g/l

0.60

129

701

Disorder of lipoprotein metabolism, unspecified

220

1253

1.78

14.36

2.3

2.2

128.91

128.98

g/l

0.01

157

956

Migraine with aura and triptan purchases

223

1274

1.77

14.32

2.1

134.87

130.78

g/l

2.45

183

1030

Adverse effects, not elsewhere classified

305

1898

1.63

14.22

2.9

2.2

130.44

130.12

g/l

0.09

239

1492

Pediculosis, acariasis and other infestations, including avohilmo

269

1622

1.68

14.21

2.4

2.3

133.73

132.17

g/l

0.59

225

1306

Phobic anxiety disorders

193

1056

1.85

14.21

2.2

135.58

133.97

g/l

0.45

159

873

Fall on same level involving ice and snow

952

7297

1.31

14.16

2.3

2.2

130.16

130.21

g/l

0.02

731

5626

Soft tissue disorders related to use, overuse and pressure

452

3072

1.49

14.10

2.4

2.2

131.51

129.51

g/l

1.02

351

2324

Other diseases of arteries and capillaries

165

866

1.94

14.06

3.0

2.1

122.82

129.26

g/l

2.74

132

674

Sciatica+with lumbago

806

5338

1.35

14.05

2.2

131.96

130.75

g/l

0.68

623

4070

Other and unspecified nerve root and plexus disorders, also in other diseases

324

2052

1.60

14.04

1.9

2.2

131.79

130.65

g/l

0.36

271

1548

Lumbar disc prolapse

997

5679

1.31

13.90

2.2

133.20

131.11

g/l

1.88

757

4325

Rotator cuff syndrome

1011

5360

1.31

13.85

2.3

2.2

131.03

130.14

g/l

0.50

760

4094

Rash and other nonspecific skin eruption

174

934

1.90

13.85

2.5

2.3

130.56

127.90

g/l

0.73

140

740

Fracture of lower leg, including ankle

894

6694

1.32

13.80

2.6

2.2

128.86

130.51

g/l

1.12

698

5170

Acute pharyngitis

219

1246

1.76

13.77

2.6

2.0

136.42

133.81

g/l

0.88

176

1005

114

525

2.21

13.76

2.0

2.3

127.83

126.80

g/l

0.20

103

414

Hypocalcemia

216

3.01

13.75

4.0

2.2

119.67

129.16

g/l

1.70

172

Other ulcerative colitis

104

464

2.30

13.69

3.6

2.3

127.94

131.64

g/l

0.96

368

Nonorganic sleeping disorders

325

2075

1.58

13.61

2.4

2.2

135.52

131.45

g/l

2.40

252

1636

Speech disturbances, not elsewhere classified

178

969

1.88

13.60

2.5

2.3

128.27

128.16

g/l

0.02

128

765

Other follicular disorders

128

622

2.10

13.56

2.6

2.2

133.26

132.02

g/l

0.20

109

499

Pleural plaque with presence of asbestos

166

887

1.92

13.55

2.4

130.77

128.20

g/l

0.57

122

693

Artificial joint operation, meniscal resection

1515

7844

1.24

13.50

2.1

2.3

128.69

130.44

g/l

1.85

1160

6001

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

787

3962

1.35

13.48

2.4

2.2

127.43

131.17

g/l

3.83

581

3031

Other viral hepatitis

104

467

2.28

13.47

2.7

2.2

129.06

135.12

g/l

1.55

378

Urticaria and erythema

542

3845

1.42

13.41

2.4

2.2

130.55

130.18

g/l

0.13

406

2974

Dislocation, sprain and strain of joints and ligaments at neck level

232

1368

1.72

13.38

2.1

2.2

135.11

132.33

g/l

1.08

194

1096

Status post-ami

435

2235

1.49

13.30

2.5

2.1

124.07

128.84

g/l

3.07

353

1665

Pneumococcal septicemia

306

2.61

13.21

3.6

2.4

123.23

129.46

g/l

1.58

246

Gingivitis and periodontal diseases

1646

6932

1.23

13.20

2.3

2.2

129.80

130.27

g/l

0.31

1221

5482

Crohn disease

200

1137

1.78

13.16

2.5

2.3

130.93

132.11

g/l

0.26

150

906

Diseases of salivary glands

507

3569

1.43

13.16

2.2

130.59

129.75

g/l

0.30

361

2720

Drug-induced hypoglycaemia without coma

123

3.67

13.15

4.2

2.3

123.22

127.88

g/l

0.58

Aspergillosis, including avohilmo

4.44

13.10

1.6

2.4

119.11

127.43

g/l

0.70

Other problems related to primary support group, including family circumstances

167

874

1.89

13.09

3.5

2.2

130.68

132.04

g/l

0.35

147

724

Covid-19 suspected case

300

1898

1.60

13.07

2.4

2.0

130.99

131.56

g/l

0.14

221

1486

Primary gonarthrosis, bilateral

905

5822

1.31

13.05

2.1

2.3

126.58

128.62

g/l

1.63

689

4413

Disorders of sclera, cornea, iris and ciliary body

870

6670

1.31

13.04

2.4

2.2

130.91

130.45

g/l

0.21

678

5144

Cerebral palsy and other paralytic syndromes

190

1068

1.81

13.03

3.0

2.3

130.14

129.33

g/l

0.17

150

842

Vascular diseases of the intestine

362

2.45

13.02

2.8

2.1

120.61

127.21

g/l

1.68

278

Other arthrosis

824

4168

1.33

13.00

2.2

129.18

131.57

g/l

1.85

607

3196

Cerebral cysts

104

475

2.24

12.97

2.6

2.4

132.92

130.35

g/l

0.49

391

Malignant neoplasm of skin, including Hilmo

844

4285

1.33

12.96

2.4

2.2

127.55

131.64

g/l

4.79

638

3287

Any dementia, excluding more controls

676

3409

1.37

12.95

2.1

2.3

126.93

126.35

g/l

0.25

560

2594

Disease of hard tissues of teeth, NOS

872

3455

1.33

12.94

2.2

132.58

129.12

g/l

3.76

668

2762

Pain associated with micturition

205

1181

1.76

12.92

2.4

2.2

128.61

128.60

g/l

0.00

165

929

Suppurative and unspecified otitis media

509

3174

1.43

12.92

2.5

2.2

134.01

132.58

g/l

0.64

411

2576

Ulcer of oesophagus

129

642

2.06

12.89

3.2

2.3

121.94

128.90

g/l

1.97

104

515

Alcohol-induced chronic pancreatitis

119

575

2.12

12.89

2.9

2.3

121.45

132.71

g/l

4.73

442

Other and unspecified local infections of skin and subcutaneous tissue

169

921

1.87

12.85

3.1

2.2

127.67

130.21

g/l

0.59

131

723

Dementia, including avohilmo

864

4493

1.32

12.84

2.2

2.4

127.92

126.54

g/l

0.90

696

3394

Carrier of infectious disease

202

2.99

12.84

3.8

2.3

123.22

130.76

g/l

1.68

161

Infective dermatitis

198

1132

1.78

12.84

2.8

2.2

129.10

129.48

g/l

0.08

174

873

Other local infections of skin and subcutaneous tissue

179

994

1.83

12.81

3.0

2.2

128.70

129.95

g/l

0.25

137

779

Ulcerative colitis

371

2473

1.52

12.79

2.7

2.2

130.85

131.27

g/l

0.13

305

1918

Calculus of kidney and ureter

504

3565

1.43

12.79

2.3

2.4

131.06

129.77

g/l

0.53

407

2763

Mouth breathing

611

4455

1.38

12.79

2.3

2.4

133.93

131.36

g/l

1.93

491

3401

General examination and investigation of persons without complaint and reported diagnosis

1035

4172

1.29

12.71

2.3

131.78

131.28

g/l

0.26

844

3379

Malignant neoplasm of skin

811

4151

1.33

12.70

2.3

2.2

127.79

131.49

g/l

3.95

610

3187

Papulosquamous disorders

621

4554

1.37

12.67

2.6

2.2

129.47

130.15

g/l

0.30

485

3435

Other extrapyramidal and movement disorders in other diseases

418

2862

1.48

12.66

2.1

2.3

131.59

128.17

g/l

2.04

313

2178

Alcohol withdrawal state with delirium

127

633

2.05

12.65

2.2

2.4

130.62

131.54

g/l

0.15

105

492

Striking against or struck by other objects

517

3672

1.42

12.64

2.2

134.76

132.85

g/l

1.01

403

2897

Aspergillosis

4.42

12.63

1.7

2.4

119.11

126.66

g/l

0.62

Stomatitis and related lesions

316

2045

1.56

12.54

2.1

2.3

133.55

129.63

g/l

1.88

224

1606

Other and unspecified disorders of white blood cells

357

2.43

12.48

3.5

2.2

118.39

130.38

g/l

3.39

292

Malignant neoplasm of bladder

140

725

1.97

12.47

2.3

2.2

127.19

131.07

g/l

0.99

112

575

Aortic valve malfunction, age under 60 years

154

824

1.90

12.43

2.9

2.5

129.14

133.35

g/l

1.04

116

642

Use of biperiden

452

2.25

12.41

2.5

2.2

129.04

131.08

g/l

0.37

353

Seropositive rheumatoid arthritis, strict definition

243

1483

1.66

12.38

2.8

2.2

122.92

128.06

g/l

2.63

165

1144

Diseases of inner ear

898

6657

1.30

12.37

2.1

2.3

132.01

128.66

g/l

3.96

686

5084

Fracture of skull and facial bones

326

2130

1.55

12.37

2.2

2.3

134.61

131.74

g/l

1.19

248

1644

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

851

5065

1.31

12.35

2.5

2.2

130.38

129.54

g/l

0.48

694

3875

Isolated proteinuria

229

2.81

12.32

3.5

2.2

127.51

131.09

g/l

0.50

181

Ulcerative ileocolitis

304

2.54

12.32

3.4

2.3

131.19

131.47

g/l

0.03

246

Toxic effect of other and unspecified substances

4.23

12.29

2.2

2.6

135.96

133.11

g/l

0.26

Superficial injury of thorax

254

1570

1.64

12.29

2.4

2.3

128.65

129.90

g/l

0.34

198

1225

Problems related to social environment

235

2.77

12.25

3.1

2.1

127.82

128.44

g/l

0.07

185

Visual disturbances and blindness

858

6617

1.30

12.25

2.3

2.2

130.50

129.16

g/l

0.83

627

5140

Other diseases of blood and blood-forming organs

130

662

2.01

12.21

2.6

2.2

147.19

129.02

g/l

7.46

107

515

Other (seronegative) rheumatoid arthritis, wide

312

2028

1.56

12.19

2.7

2.2

124.26

127.57

g/l

1.74

238

1545

214

2.88

12.18

3.2

2.1

132.76

126.86

g/l

1.04

169

Psoriatic arthropathies

158

858

1.87

12.15

2.2

2.1

130.37

131.04

g/l

0.13

120

645

Weight loss

187

1071

1.78

12.11

2.7

2.2

126.90

128.02

g/l

0.29

149

846

Other diseases of upper respiratory tract

1828

7922

1.21

12.06

2.3

131.91

129.80

g/l

2.97

1350

6269

Complications of cardiac and vascular prosthetic devices, implants and grafts

188

3.00

12.03

3.2

2.4

126.05

128.30

g/l

0.26

146

Viral hepatitis, including avohilmo

121

603

2.04

12.03

2.6

2.2

130.24

134.12

g/l

0.91

478

Psychotic depression

438

2.23

11.99

2.3

133.40

130.71

g/l

0.56

341

Disorders of oesophagus in diseases classified elsewhere

183

3.02

11.97

2.8

2.2

122.42

127.96

g/l

0.79

153

Allergic bronchopulmonary aspergillosis (ABPA)

11.44

11.96

1.6

1.5

117.21

132.14

g/l

0.94

Lichen simplex chronicus and prurigo

118

585

2.06

11.95

2.6

2.2

126.27

130.05

g/l

0.97

458

Osteonecrosis

115

565

2.08

11.94

3.1

2.2

125.40

129.40

g/l

0.82

446

Progressive systemic sclerosis

5.90

11.91

2.1

1.6

125.00

125.83

g/l

—

Disorders of synovium and tendon

818

5326

1.31

11.90

2.4

2.2

130.77

130.73

g/l

0.02

649

4104

Redundant prepuce, phimosis and paraphimosis

318

2055

1.54

11.79

2.7

2.2

132.61

136.07

g/l

1.41

266

1571

Budesonide

207

1228

1.71

11.74

2.4

2.1

126.08

130.85

g/l

1.91

144

980

Other coagulation defects

128

657

1.99

11.73

3.0

2.3

133.30

130.54

g/l

0.54

530

Alcoholic liver disease

178

1015

1.79

11.72

3.1

2.3

120.46

131.00

g/l

6.36

148

775

Medical observation and evaluation for suspected diseases and conditions

1041

4178

1.28

11.70

2.1

2.3

131.86

131.26

g/l

0.33

757

3383

Achalasia of cardia

133

3.38

11.68

2.5

2.3

125.14

127.06

g/l

0.16

111

Astigmatism

114

562

2.07

11.67

2.8

2.5

131.37

131.45

g/l

0.01

462

Toxic effects of substances chiefly nonmedicinal as to source

183

1054

1.76

11.60

2.2

2.4

134.69

131.72

g/l

1.01

150

830

Pruritus

192

1122

1.74

11.56

2.4

2.2

126.09

128.48

g/l

0.71

147

889

Visual disturbances

784

6032

1.31

11.54

2.3

130.54

129.30

g/l

0.70

581

4681

Poisoning by narcotics and psychodysleptics [hallucinogens]

3.83

11.54

3.8

2.4

129.76

130.04

g/l

0.03

Abnormal weight loss

174

991

1.79

11.53

2.6

2.3

126.42

128.04

g/l

0.44

136

782

Menorrhagia

480

1880

1.43

11.52

2.1

129.46

127.38

g/l

1.13

368

1456

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

138

732

1.92

11.51

3.2

2.3

120.03

129.32

g/l

4.05

103

577

Congenital malformations of the circulatory system

221

1303

1.67

11.46

2.7

2.4

133.10

131.81

g/l

0.32

165

1045

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

281

1568

1.57

11.45

2.0

2.2

136.61

135.10

g/l

0.61

248

1333

Glaucoma suspect

611

4543

1.36

11.45

2.3

128.12

127.63

g/l

0.18

526

3408

Car occupant injured in other and unspecified transport accidents

273

1748

1.58

11.39

2.2

2.3

131.21

131.36

g/l

0.04

217

1395

Other ill-defined and unspecified causes of mortality

187

1092

1.75

11.38

3.8

2.4

123.48

126.92

g/l

1.17

172

853

Other arterial embolism and thrombosis

233

2.71

11.38

4.7

2.0

121.69

129.32

g/l

1.31

182

Viral warts

160

892

1.82

11.35

3.5

2.3

129.66

131.11

g/l

0.31

128

715

Unspecified nephritic syndrome

189

2.92

11.31

5.1

2.1

123.98

130.48

g/l

1.04

150

Vitamin deficiency, wide

411

2.24

11.30

3.1

2.1

129.74

129.19

g/l

0.08

333

Vitamin deficiency

411

2.24

11.30

3.1

2.1

129.74

129.19

g/l

0.08

333

ILD and respiratory illness in diseases classified elsewhere

5.33

11.29

4.0

1.9

124.13

128.65

g/l

0.29

Iron deficiency

205

2.80

11.28

2.1

2.3

128.61

131.73

g/l

0.44

173

Viral hepatitis

113

563

2.04

11.27

2.7

2.2

129.89

134.31

g/l

1.04

449

Thyrotoxicosis

387

2672

1.46

11.27

2.0

2.2

129.88

127.73

g/l

0.92

272

2055

Abdominal aortic aneurysm (AAA)

191

1114

1.73

11.27

2.9

2.3

125.47

127.31

g/l

0.43

149

871

Disorders of psychological development

176

934

1.77

11.24

2.1

2.3

136.39

133.94

g/l

0.78

154

789

Enteropathic arthropathies

152

3.13

11.17

2.1

2.2

137.97

130.06

g/l

1.35

119

Total colectomy operation

331

2.39

11.17

3.3

2.3

129.41

131.28

g/l

0.25

263

Total colectomy

331

2.39

11.17

3.3

2.3

129.41

131.28

g/l

0.25

263

Chronic rhinitis, nasopharyngitis and pharyngitis

479

3439

1.40

11.16

2.1

2.2

133.95

130.08

g/l

2.72

333

2694

Basal cell carcinoma

726

3760

1.33

11.13

2.3

2.2

127.02

130.88

g/l

3.95

542

2874

Basal cell carcinoma, including Hilmo

748

3863

1.32

11.12

2.3

2.2

126.70

131.01

g/l

4.84

556

2949

Acute suppurative otitis media

348

2193

1.49

11.11

2.5

2.2

134.94

133.98

g/l

0.31

277

1819

Speech and linguistic disorders, excluding more controls

113

528

2.03

11.10

2.3

2.4

133.82

132.64

g/l

0.22

440

Inflammatory disease of uterus

190

1119

1.72

11.10

2.3

2.0

129.18

g/l

0.00

142

893

Inflammatory diseases of female pelvic organs

877

4676

1.29

11.08

2.4

2.1

128.83

128.24

g/l

0.32

641

3660

Arterial embolism and thrombosis of lower extremity artery

314

2.43

11.07

3.3

2.2

123.10

128.29

g/l

0.98

248

L01XE Protein kinase inhibitors

104

508

2.10

11.06

2.5

2.3

123.26

129.09

g/l

1.22

411

Amyloidosis, other/unspecified

154

3.12

11.00

5.1

2.2

121.23

126.73

g/l

0.79

120

Other and unspecified vasculitis limited to skin

209

2.79

10.98

4.0

2.0

126.66

127.94

g/l

0.13

164

Other fall from one level to another

352

2400

1.48

10.92

2.1

2.3

132.49

131.16

g/l

0.46

294

1895

Benign neoplasm: Adrenal gland

141

767

1.88

10.92

2.2

2.3

134.15

128.79

g/l

1.59

100

596

Disorders of refraction and accommodation

403

2808

1.44

10.91

2.7

2.2

132.04

131.28

g/l

0.26

337

2202

Other specified/unspecified bacterial intestinal infections

121

626

1.97

10.91

2.5

2.3

123.09

129.63

g/l

1.94

499

Malignant neoplasm of digestive organs

639

3667

1.34

10.88

2.3

2.2

119.80

131.20

g/l

23.42

498

2814

Other/unspecified rheumatoid arthritis

211

1287

1.67

10.87

2.8

2.2

123.07

126.40

g/l

1.22

163

985

Primary biliary cholangitis, wide definition

177

2.93

10.80

3.1

2.0

115.03

127.75

g/l

2.21

136

Testicular dysfunction

305

2.42

10.79

2.8

2.2

144.98

137.24

g/l

1.31

235

Other renal tubulo-interstitial diseases

166

2.99

10.78

3.7

1.7

122.83

131.51

g/l

1.36

131

Ill-defined and unknown causes of mortality

198

1192

1.69

10.78

3.7

2.4

123.69

127.00

g/l

1.17

182

928

Seronegative rheumatoid arthritis

180

1056

1.73

10.72

2.9

2.1

125.29

128.54

g/l

1.17

143

799

Coxarthrosis, primary

1027

6828

1.26

10.69

2.2

2.3

125.90

128.69

g/l

2.92

785

5180

Other disorders of the musculoskeletal system and connective tissue

244

1549

1.60

10.67

2.3

127.18

128.42

g/l

0.30

187

1197

Urticaria

421

2983

1.42

10.63

2.3

2.2

131.94

130.26

g/l

0.76

315

2318

Maltreatment syndromes

376

2.25

10.62

2.4

2.1

134.51

133.76

g/l

0.10

303

Psoriasis

433

3086

1.42

10.61

2.6

2.2

129.51

130.41

g/l

0.33

340

2342

Unspecified misadventure during surgical and medical care

110

557

2.02

10.59

2.6

2.2

123.34

129.67

g/l

1.53

444

Diabetic neuropathy

253

1619

1.59

10.58

3.5

2.5

122.49

129.24

g/l

3.99

207

1301

Fall involving bed

353

2.31

10.57

2.3

2.2

118.18

126.18

g/l

1.63

280

Benign neoplasm: Colon

927

6909

1.27

10.55

2.5

2.3

126.52

128.94

g/l

2.02

658

5300

Dementia

799

4241

1.30

10.52

2.2

2.4

127.72

126.63

g/l

0.61

647

3196

Lesion of ulnar nerve

215

1332

1.63

10.40

2.7

2.2

130.24

130.37

g/l

0.03

169

1005

Hepatic failure, not elsewhere classified

336

2.33

10.39

2.3

117.47

131.23

g/l

4.19

269

Pulmonary eosinophilia, not elsewhere classified

3.67

10.38

1.9

2.1

124.63

127.36

g/l

0.22

Carcinoma in situ of skin of other and unspecified parts of face

182

1084

1.71

10.38

3.0

2.2

125.21

125.59

g/l

0.07

130

836

Hyperkinetic disorders, excluding more controls

151

790

1.80

10.35

2.1

2.2

140.38

134.68

g/l

2.69

129

676

Injury of unspecified body region

136

744

1.86

10.34

2.4

2.3

126.90

129.54

g/l

0.54

589

Disorders of ocular muscles, binocular movement, accommodation and refraction

709

5416

1.30

10.32

2.4

2.2

131.49

131.17

g/l

0.13

582

4212

Paracetamol or NSAID medication

249

782

1.62

10.32

2.4

131.63

132.05

g/l

0.09

202

653

Oesophageal varices

350

2.29

10.29

3.7

2.2

111.71

130.19

g/l

6.56

278

Other specified congenital malformation syndromes affecting multiple systems

118

3.36

10.27

3.1

2.8

135.77

131.60

g/l

0.50

Other necrotizing vasculopathies (FG)

108

549

2.01

10.27

2.9

2.1

125.04

127.91

g/l

0.63

428

Event of undetermined intent

107

542

2.01

10.25

2.6

2.2

131.38

132.26

g/l

0.13

434

Primary Sclerosing Cholangitis, IBD and UDCA required

155

3.00

10.21

4.5

2.3

122.18

132.06

g/l

1.99

126

Excessive, frequent and irregular menstruation

541

2114

1.38

10.19

2.1

128.73

127.96

g/l

0.32

424

1668

Congenital malformations of heart and great arteries

194

1142

1.67

10.15

2.6

2.4

132.95

132.44

g/l

0.11

152

921

Pediculosis, acariasis and other infestations

103

517

2.03

10.14

3.3

2.3

132.94

132.36

g/l

0.09

412

5-aminosalicylic acid

283

1876

1.52

10.13

2.6

2.0

130.16

132.34

g/l

0.84

224

1493

Irregular menses

615

3481

1.33

10.12

2.1

129.56

129.25

g/l

0.12

473

2718

Unspecified jaundice

457

2.10

10.11

2.7

2.2

126.51

127.88

g/l

0.18

362

Cervical disc disorders

544

4055

1.35

10.10

2.4

2.3

130.74

130.49

g/l

0.08

422

3058

Injuries to the elbow and forearm

1122

7825

1.23

10.10

2.3

2.2

129.45

130.37

g/l

0.61

891

6065

Hodgkin lymphoma, hilmo

230

2.60

10.08

2.9

2.3

120.44

130.73

g/l

1.55

179

Nontraumatic intracranial haemmorrhage

339

2335

1.47

10.07

2.4

2.3

130.26

126.65

g/l

1.54

252

1826

5.19

10.07

4.0

1.9

121.80

128.42

g/l

0.47

Drug-induced osteoporosis

110

3.45

10.05

2.9

2.1

118.12

129.10

g/l

1.74

Spondylolisthesis/Spondylolysis

278

1841

1.53

10.04

2.2

2.3

127.62

128.95

g/l

0.37

201

1385

Diseases of spleen

157

2.99

10.04

3.6

2.3

118.91

129.65

g/l

1.22

125

Hyperaldosteronism

237

2.57

10.00

2.1

2.3

140.44

128.06

g/l

2.96

186

FESS (DNB20)

185

1115

1.68

10.00

2.4

2.1

133.59

131.17

g/l

0.73

148

868

Ethmoidectomy

191

1161

1.67

9.99

2.4

2.2

133.01

130.93

g/l

0.59

154

902

Scabies, including avohilmo

212

1322

1.62

9.97

2.4

2.3

133.97

133.43

g/l

0.15

178

1070

Ulcerative colitis, NAS

204

1261

1.64

9.97

2.9

2.3

129.01

131.73

g/l

0.97

169

994

Other aneurysm

103

521

2.02

9.96

3.6

2.1

124.04

129.67

g/l

1.56

404

Injuries to the wrist and hand

1625

9070

1.19

9.88

2.2

2.3

132.07

130.63

g/l

1.43

1240

7055

Benign neoplasm of other and unspecified endocrine glands

214

1343

1.62

9.87

2.3

133.45

128.53

g/l

2.03

158

1041

Alzheimer’s disease (Late onset), excluding more controls

238

978

1.60

9.84

2.0

2.2

127.15

124.59

g/l

0.78

185

725

Restless leg syndrome

229

1461

1.59

9.84

1.9

2.3

131.83

128.06

g/l

1.53

165

1138

Other disorders of skin and subcutaneous tissue, not elsewhere classified

240

1549

1.57

9.80

2.7

2.2

123.20

128.38

g/l

2.05

176

1193

Abnormalities of gait and mobility

220

1394

1.60

9.78

2.3

2.4

129.56

127.92

g/l

0.42

169

1071

Other necrotizing vasculopathies

130

715

1.86

9.77

3.0

2.2

125.78

127.80

g/l

0.47

571

Ovarian cyst

480

1990

1.39

9.75

2.4

2.1

128.45

127.78

g/l

0.28

377

1559

Other diseases of spinal cord

258

2.48

9.75

3.0

2.3

129.61

129.94

g/l

0.04

207

Mental and behavioural disorders due to cannabinoids

159

2.89

9.71

2.0

2.5

134.75

137.54

g/l

0.31

127

Adhesive capsulitis of shoulder

251

1640

1.55

9.68

2.3

2.2

131.78

128.84

g/l

1.16

196

1217

Chronic laryngitis and laryngotracheitis

225

1436

1.59

9.65

2.3

2.1

128.93

128.52

g/l

0.07

135

1132

Gonarthrosis,primary

1453

7316

1.20

9.59

2.2

2.3

128.79

129.76

g/l

0.71

1101

5586

Bronchitis, not specified as acute or chronic

125

682

1.86

9.58

2.2

2.1

129.84

129.36

g/l

0.08

541

Viral warts, including avohilmo

313

2146

1.47

9.53

2.7

2.2

131.67

131.26

g/l

0.10

222

1706

Arthropathic psoriasis

170

1018

1.69

9.46

2.3

2.2

130.80

g/l

0.00

127

785

Coeliac disease

183

1117

1.66

9.45

2.6

2.3

127.21

130.39

g/l

1.05

147

884

Maternal care for other conditions predominantly related to pregnancy

222

1380

1.58

9.45

2.1

1.9

131.41

131.50

g/l

0.02

181

1088

Monoamine oxidase A inhibitors

170

1018

1.69

9.44

2.8

2.2

130.74

129.19

g/l

0.40

126

770

Background retinopathy and retinal vascular changes

168

2.84

9.43

3.0

2.3

120.94

128.26

g/l

1.23

130

Testicular hypofunction

274

2.40

9.43

3.0

2.3

144.87

136.76

g/l

1.28

214

Other disorders of bone

276

1851

1.51

9.41

2.6

2.2

130.24

131.60

g/l

0.42

210

1442

Hypertrophic cardiomyopathy

397

2.15

9.40

2.9

2.3

128.97

129.56

g/l

0.07

321

Other and unspecified mood [affective] disorders

102

525

1.97

9.34

2.0

2.2

135.20

132.11

g/l

0.72

429

Crohn's disease NAS

102

526

1.97

9.32

2.8

2.4

132.00

131.73

g/l

0.03

431

Other noninfective disorders of lymphatic vessels and lymph nodes

289

2.34

9.25

2.6

2.3

116.73

128.28

g/l

2.86

232

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

142

2.99

9.25

3.1

2.1

128.09

129.51

g/l

0.15

115

Acute posthaemorrhagic anaemia

302

2.31

9.23

3.4

2.1

111.56

130.29

g/l

5.71

232

Voice disturbances

409

2963

1.39

9.19

2.3

129.20

128.53

g/l

0.22

281

2268

Pain in thoracic spine

220

1413

1.57

9.18

2.4

2.2

131.47

129.84

g/l

0.47

165

1072

Multiple myeloma and malignant plasma cell neoplasms

496

2.01

9.17

3.7

2.2

115.39

127.75

g/l

5.54

391

Systemic atrophies primarily affecting the central nervous system

408

2.11

9.14

2.8

2.2

137.94

128.92

g/l

2.97

328

Vitamin B12 deficiency anaemia

178

1090

1.66

9.11

2.3

2.2

122.31

129.30

g/l

2.86

140

845

Biological medication for rheuma

240

1574

1.54

9.11

2.7

2.2

132.13

132.86

g/l

0.20

183

1238

Any dementia

738

4002

1.28

9.08

2.1

2.3

126.83

126.30

g/l

0.23

609

3043

Artificial joint re-operation

131

740

1.81

9.07

2.4

2.3

122.83

126.64

g/l

1.02

585

Dermatographic urticaria

103

538

1.95

9.07

2.7

2.3

132.00

129.92

g/l

0.42

443

Scabies

403

2.10

9.01

3.3

2.3

134.68

133.27

g/l

0.24

318

Other secondary gonarthrosis

492

2.00

8.99

2.2

2.3

123.69

127.88

g/l

0.93

385

Other immunodeficiencies

3.77

8.99

2.8

1.9

129.36

132.74

g/l

0.30

Disorders of muscles

158

941

1.70

8.99

2.1

2.2

132.24

130.57

g/l

0.38

127

724

Disorders of myoneural junction and muscle in diseases classified elsewhere

4.26

8.97

2.5

1.7

125.93

129.44

g/l

0.25

False labour

318

1353

1.47

8.96

2.0

1.9

132.15

131.73

g/l

0.14

281

1061

Myocardial infarction, with ST-elevation

303

2094

1.46

8.95

3.1

2.3

125.49

127.80

g/l

0.76

246

1621

Diabetes mellitus in pregnancy

334

1471

1.45

8.93

2.2

1.8

130.29

132.18

g/l

0.88

285

1161

Colorectal cancer, including Hilmo

433

2961

1.37

8.92

2.2

121.04

130.50

g/l

11.32

342

2287

Open wound of abdomen, lower back and pelvis

244

2.44

8.91

2.2

2.4

134.70

132.35

g/l

0.26

196

Exclusion endpoint for clefts

145

2.92

8.89

2.9

2.8

134.67

131.41

g/l

0.38

121

Viral infections of the central nervous system

111

599

1.88

8.87

2.7

2.2

128.72

130.21

g/l

0.24

475

Recurrent aphthous stomatitis , including avohilmo

227

1482

1.55

8.85

2.3

131.70

129.26

g/l

0.73

162

1165

Mixed connective tissue disease

135

3.00

8.84

2.4

2.0

133.39

129.57

g/l

0.41

103

Neuralgia and neuritis, unspecified

433

2.05

8.83

2.2

138.10

130.13

g/l

2.78

341

Drug-induced cataract

216

2.54

8.79

3.8

2.2

124.97

131.41

g/l

0.93

172

Cluster headache, wide

258

2.37

8.75

2.7

2.2

136.64

129.73

g/l

1.24

204

Inflammatory diseases of prostate (prostatitis)

207

1329

1.58

8.72

2.9

2.3

135.60

132.21

g/l

1.09

175

986

Vasculitis limited to skin, not elsewhere classified

235

2.46

8.70

4.0

2.1

126.66

127.70

g/l

0.11

187

Disorders of vitreous body and globe

825

6261

1.25

8.68

2.4

2.3

128.02

128.77

g/l

0.40

635

4736

Other and unspecified abdominal hernia

363

2.15

8.65

2.7

2.2

125.78

128.50

g/l

0.40

294

Other female pelvic inflammatory diseases

215

1394

1.56

8.64

2.0

2.2

128.85

126.80

g/l

0.63

149

1078

Atypical mycobacterium lung infection

3.50

8.64

1.9

2.0

124.76

127.64

g/l

0.21

Diseases of middle ear and mastoid

818

5348

1.25

8.60

2.5

2.2

132.82

131.54

g/l

0.78

652

4210

Late syphilis, including avohilmo

143

2.92

8.59

3.7

2.1

122.03

129.02

g/l

0.98

115

Symptoms and signs involving the skin and subcutaneous tissue

1133

8877

1.21

8.58

2.2

2.3

131.16

129.84

g/l

1.01

837

6886

Complications following infusion, transfusion and therapeutic injection

116

3.15

8.57

3.2

2.1

124.38

129.14

g/l

0.49

Respiratory disorders in diseases classified elsewhere

127

3.06

8.57

3.3

2.2

121.60

130.08

g/l

1.10

101

Lactose intolerance

230

2.45

8.57

2.7

2.2

133.18

130.61

g/l

0.38

188

Other Crohn's disease

104

556

1.90

8.57

2.6

2.2

132.24

133.01

g/l

0.11

453

Generalized anxiety disorder

210

1355

1.56

8.54

1.9

2.2

134.66

132.31

g/l

0.76

158

1116

Injury of other and unspecified intrathoracic organs

112

615

1.86

8.52

2.0

2.3

130.61

130.25

g/l

0.05

478

Disorders of vitreous body

802

6120

1.25

8.50

2.4

2.3

128.24

128.81

g/l

0.28

618

4620

Symptoms and signs involving emotional state

231

2.44

8.49

1.8

2.5

133.09

130.66

g/l

0.30

180

Multiple myeloma, including Hilmo

468

1.99

8.49

3.8

2.2

114.60

130.48

g/l

8.22

377

Colectomy operation

276

1894

1.47

8.49

2.5

2.3

123.87

128.13

g/l

1.70

219

1454

Obsessive-compulsive disorder

487

1.96

8.47

1.9

2.2

136.24

132.80

g/l

0.78

407

Alcoholic gastritis

117

3.12

8.46

2.2

2.4

120.54

128.91

g/l

0.77

100

Selective deficiency of immunoglobulin G [IgG] subclasses

4.36

8.44

2.7

2.1

126.29

131.15

g/l

0.28

Thyroiditis, ILD-related definition

162

988

1.66

8.44

2.3

2.2

130.66

129.30

g/l

0.35

114

791

Cardiomyopathy, Hypertrophic obstructive

117

3.09

8.42

4.3

2.2

123.76

131.09

g/l

0.91

Trigger finger

210

1363

1.56

8.42

2.4

2.2

127.56

129.82

g/l

0.70

172

1013

Open wound of wrist and hand

669

5083

1.28

8.40

2.3

134.50

132.33

g/l

1.39

517

3969

Behavioural syndromes associated with physiological disturbances and physical factors

1463

8386

1.18

8.39

2.1

2.3

133.26

130.44

g/l

4.34

1126

6533

Diffuse large B-cell lymphoma, helper endpoint

491

1.96

8.38

3.2

2.1

115.25

130.93

g/l

6.20

395

Diffuse large B-cell lymphoma

491

1.96

8.38

3.2

2.1

115.25

130.93

g/l

6.20

395

Diffuse large B-cell lymphoma, including Hilmo

491

1.96

8.38

3.2

2.1

115.25

130.93

g/l

6.20

395

Other symptoms and signs involving general sensations and perceptions

381

2.09

8.38

2.7

2.4

129.15

128.13

g/l

0.13

309

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

329

1450

1.44

8.38

2.2

1.9

131.16

132.56

g/l

0.75

279

1182

Other misadventures during surgical and medical care

215

2.50

8.37

3.3

2.2

125.30

129.22

g/l

0.46

169

Other disorders of nervous system

116

648

1.82

8.35

2.7

2.4

124.42

129.46

g/l

1.32

503

Urethral stricture

105

569

1.88

8.35

2.6

2.3

125.31

129.61

g/l

0.99

437

Juvenile arthritis (FINNGEN)

302

2.22

8.33

3.1

2.3

123.58

131.28

g/l

1.77

255

Superficial injury of wrist and hand

291

2022

1.45

8.33

2.3

134.77

131.57

g/l

1.59

226

1611

Sequelae of injuries, of poisoning and of other consequences of external causes

337

2406

1.41

8.31

2.2

132.31

131.18

g/l

0.38

262

1853

Migraine without aura and triptan purchases

202

1303

1.56

8.30

2.3

2.1

134.43

130.69

g/l

1.94

152

1057

Adult respiratory distress syndrome

108

3.20

8.29

3.6

2.0

119.68

128.56

g/l

0.99

Abscess of anal and rectal regions

125

715

1.77

8.26

2.6

2.2

129.56

133.25

g/l

0.87

567

Otitis media, unspecified

163

919

1.65

8.25

3.3

2.1

132.45

132.69

g/l

0.04

145

779

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

231

1523

1.52

8.23

2.9

2.2

128.04

129.23

g/l

0.31

180

1223

Other and unspecified coagulation defects

404

2.04

8.21

2.7

2.3

133.59

131.48

g/l

0.33

328

Keratitis

534

4098

1.31

8.20

2.5

2.3

130.24

130.28

g/l

0.01

412

3156

Other shoulder lesions

141

837

1.71

8.16

2.2

132.16

130.94

g/l

0.23

101

648

Congenital iodine-deficiency syndrome/hypothyroidism

261

2.33

8.16

2.2

124.43

125.87

g/l

0.16

209

Excessive vomiting in pregnancy

101

544

1.88

8.13

2.0

133.97

130.25

g/l

1.17

435

Appendectomy

916

7126

1.23

8.12

2.4

2.2

132.74

131.34

g/l

0.97

724

5479

Heart failure and hypertrophic cardiomyopathy

183

2.62

8.08

4.0

2.2

124.59

129.10

g/l

0.55

147

Amputation of foot

244

2.37

8.04

4.2

2.4

114.12

129.22

g/l

4.63

193

Squamous cell neoplasms and carcinomas of the skin

188

1206

1.58

8.00

2.9

2.2

128.15

129.00

g/l

0.18

149

965

Chronic hepatitis, not elsewhere classified

276

2.27

7.98

2.4

2.2

125.00

130.96

g/l

1.00

220

Congenital malformations of cardiac septa

104

552

1.86

7.93

2.7

2.5

135.08

131.70

g/l

0.71

453

Mild mental retardation

196

2.52

7.92

3.1

2.8

130.04

133.89

g/l

0.52

162

Myeloid leukaemia

252

2.33

7.92

2.1

116.02

128.80

g/l

2.21

199

Prurigo nodularis

221

2.43

7.90

3.1

2.2

124.33

129.09

g/l

0.75

176

Gonarthrosis, primary, with knee surgery

962

6158

1.22

7.89

2.1

2.3

126.52

128.62

g/l

1.87

735

4675

Disturbances of skin sensation

377

2767

1.37

7.87

2.0

2.2

136.47

130.73

g/l

4.96

285

2151

Non-follicular lymphoma

165

1033

1.62

7.83

3.0

2.3

117.98

128.36

g/l

5.83

123

807

Non-Hodgkin lymphoma, all

461

1.95

7.81

2.8

2.3

112.51

130.49

g/l

9.30

371

Intracerebral haemorrhage

217

1445

1.52

7.79

2.4

2.3

132.52

126.10

g/l

2.77

160

1115

Congenital malformations and deformations of the musculoskeletal system

123

710

1.74

7.74

2.8

2.3

132.51

132.76

g/l

0.04

585

Open wound of forearm

155

958

1.64

7.72

2.8

2.2

128.67

130.53

g/l

0.44

127

751

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

395

2929

1.36

7.72

1.8

2.2

134.51

132.24

g/l

1.01

316

2295

Hydrocephalus in other diseases

4.39

7.72

2.5

2.0

140.43

129.06

g/l

1.59

Cluster headache, strict

235

2.34

7.71

2.9

2.2

135.86

129.55

g/l

0.95

185

Abnormal blood-pressure reading, without diagnosis

312

2.15

7.71

2.4

2.1

136.06

126.12

g/l

2.98

242

Gingival hyperplasia

333

2.12

7.70

4.8

2.4

130.59

130.77

g/l

0.02

270

Barrett oesophagus

463

1.94

7.70

2.2

2.3

126.75

129.67

g/l

0.44

368

Bell's palsy

177

1130

1.59

7.70

2.3

2.2

130.01

128.98

g/l

0.20

140

866

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

118

2.97

7.68

2.2

2.3

132.00

132.46

g/l

0.05

Calculus of lower urinary tract

103

571

1.84

7.68

2.4

2.2

132.50

129.75

g/l

0.49

455

Aneurysms, operations, SAH

247

1693

1.47

7.68

2.4

2.3

128.44

127.62

g/l

0.18

179

1304

Pleural plaque without asbestos

396

2.03

7.63

2.5

2.3

128.27

126.05

g/l

0.29

309

Primary open-angle glaucoma, strict

454

3438

1.33

7.62

2.2

2.3

127.91

126.56

g/l

0.54

371

2613

Maternal care for other known or suspected fetal problems

244

1033

1.49

7.54

2.0

1.8

132.20

132.33

g/l

0.03

202

819

Other maternal disorders predominantly related to pregnancy

665

3291

1.27

7.53

2.3

2.1

131.11

129.49

g/l

1.14

538

2489

Colorectal cancer

384

2732

1.36

7.51

2.2

120.66

130.55

g/l

10.87

308

2104

Primary open-angle glaucoma

542

4060

1.29

7.49

2.2

2.3

127.55

126.51

g/l

0.44

441

3066

Habit and impulse disorders

3.21

7.49

2.0

2.3

140.71

134.51

g/l

0.64

Late syphilis

115

3.00

7.47

4.2

2.2

122.29

129.94

g/l

1.00

Congenital malformations of the musculoskeletal system, not elsewhere classified

104

3.09

7.45

2.0

2.4

132.96

131.35

g/l

0.19

Coxibs

466

1842

1.34

7.41

2.0

2.6

131.55

128.18

g/l

1.94

355

1553

Spondyloarthritis

252

1745

1.46

7.41

2.5

2.2

128.16

130.47

g/l

0.79

203

1358

malignant neoplasm of male genital organs

464

2114

1.33

7.40

2.3

126.82

135.19

g/l

7.68

360

1636

Injuries involving multiple body regions

318

2.12

7.40

1.9

2.2

131.18

130.01

g/l

0.15

255

malignant neoplasm of male genital organs, including Hilmo

471

2145

1.33

7.39

2.3

126.91

135.28

g/l

7.80

367

1657

Renal agenesis and other reduction defects of kidney

4.84

7.35

5.1

2.3

124.41

132.61

g/l

0.59

Pure hyperglyceridaemia

167

2.59

7.35

2.2

2.4

135.64

130.33

g/l

0.65

132

Persons encountering health services for examination and investigation

1008

4178

1.21

7.34

2.3

131.10

131.26

g/l

0.07

768

3383

Other obstetric conditions, not elsewhere classified

332

1506

1.40

7.33

2.2

1.9

131.35

132.67

g/l

0.70

281

1224

Other diseases of lip and oral mucosa

614

4872

1.27

7.30

2.2

129.84

g/l

0.00

435

3738

Other diseases of stomach and duodenum

105

594

1.80

7.30

2.9

2.3

122.46

128.77

g/l

1.46

474

Primary biliary cholangitis (PBC)

168

2.58

7.27

3.0

2.0

113.37

127.32

g/l

2.74

130

Psoriasis vulgaris

269

1894

1.43

7.26

2.7

2.2

128.94

130.61

g/l

0.55

212

1454

Unspecified chronic bronchitis

255

2.24

7.22

2.9

2.1

130.22

127.06

g/l

0.42

212

Acute laryngitis and tracheitis

147

897

1.63

7.20

2.4

2.0

133.12

133.80

g/l

0.15

121

732

Atopic dermatitis, strict definition with reimbursement

376

2686

1.35

7.20

2.3

2.1

134.17

132.65

g/l

0.63

278

2166

Crohn's disease of large intestine

390

1.98

7.16

2.9

2.4

130.31

131.60

g/l

0.17

312

Anterior Iridocyclitis

294

2109

1.41

7.14

2.4

2.3

131.49

129.74

g/l

0.64

232

1628

Viral infections of the central nervous system, including avohilmo

113

657

1.74

7.14

2.7

2.2

129.21

129.81

g/l

0.08

526

Otitis externa, unspecified

166

1064

1.58

7.13

2.7

2.3

128.49

130.54

g/l

0.49

125

836

Bitten or struck by other mammals

158

1001

1.60

7.13

2.2

2.3

134.08

131.46

g/l

0.81

120

804

Other enthesopathies

402

3027

1.34

7.12

2.2

132.40

130.45

g/l

0.94

304

2300

Microscopic polyangiitis

3.97

7.10

3.5

2.4

119.46

125.81

g/l

0.42

Disorders of skin appendages

704

5659

1.24

7.10

2.3

2.2

130.59

131.11

g/l

0.21

542

4411

Other disorders of eyelid

724

5536

1.24

7.09

2.1

2.3

128.07

127.49

g/l

0.25

538

4251

Inflammatory diseases of the central nervous system

126

758

1.69

7.03

2.7

2.3

130.00

130.69

g/l

0.10

604

Hydrocele

186

1228

1.53

7.00

2.4

2.3

128.32

130.81

g/l

0.49

151

922

Acute drug-induced interstitial lung disorder

3.55

7.00

2.5

2.3

130.06

123.20

g/l

0.60

SLE (Finngen)

246

2.24

6.98

1.9

2.3

131.14

127.66

g/l

0.49

193

Assault by blunt object

3.20

6.94

1.9

2.1

127.77

134.54

g/l

0.67

Cushing syndrome

3.38

6.94

3.3

1.6

128.95

129.02

g/l

0.00

Spontaneous rupture of synovium and tendon

128

776

1.67

6.94

2.8

2.2

127.52

128.91

g/l

0.24

104

589

Tumor necrosis factor alpha inhibitors

206

1391

1.49

6.94

2.9

2.2

131.37

132.95

g/l

0.49

159

1099

Somnolence

3.08

6.92

3.6

2.2

126.30

131.37

g/l

0.49

Sleep disorders

1382

8165

1.17

6.91

2.1

2.3

133.31

130.43

g/l

4.26

1051

6352

KRA_PSY_EATING, excluding more controls

524

1.81

6.91

2.7

2.2

133.43

132.24

g/l

0.26

447

Necrotizing fasciitis

4.54

6.89

4.2

2.0

115.41

135.44

g/l

2.65

D07AA Corticosteroids, weak (group I)

207

1400

1.49

6.86

2.3

131.94

131.04

g/l

0.21

172

1142

Caries of enamel

1091

8436

0.84

6.86

2.3

2.2

132.64

131.43

g/l

0.90

707

6640

Acute and subacute iridocyclitis

275

1967

1.41

6.82

2.4

2.3

131.35

129.58

g/l

0.62

219

1520

Type1 diabetes, definitions combined, early onset

416

1.92

6.80

2.6

2.5

133.40

137.14

g/l

0.79

348

Faecal incontinence

143

897

1.61

6.77

2.5

2.1

126.91

125.99

g/l

0.17

107

689

Other psoriatic arthropathies

145

913

1.61

6.76

2.2

2.3

129.90

130.86

g/l

0.19

111

711

Assault by bodily force

106

615

1.75

6.75

2.2

2.3

131.81

135.69

g/l

0.77

491

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

524

3564

1.28

6.73

2.4

2.1

129.44

129.82

g/l

0.14

434

2694

Herpesviral [herpes simplex] infections

167

1087

1.55

6.73

2.8

2.2

125.95

129.23

g/l

0.95

129

859

Non-small cell lung cancer, squamous

492

1.84

6.72

2.3

2.2

122.29

131.30

g/l

2.70

391

Car occupant injured in noncollision transport accident

270

2.15

6.70

2.1

2.3

129.94

130.99

g/l

0.10

221

Ehlers-Danlos syndrome

3.70

6.68

2.0

1.8

131.00

130.18

g/l

0.07

Psoriatic arthropathies, ICD10

149

947

1.59

6.68

2.2

2.3

129.98

130.77

g/l

0.15

114

736

Enthesopathies of lower limb, excluding foot

310

2269

1.38

6.68

2.1

2.2

131.63

131.02

g/l

0.16

238

1736

Certain zoonotic bacterial diseases, including avohilmo

271

2.16

6.67

2.2

2.3

131.63

130.30

g/l

0.14

221

Iridocyclitis

329

2434

1.36

6.64

2.4

2.3

131.37

129.57

g/l

0.73

263

1865

Tobacco use

465

1.86

6.64

3.0

2.3

129.53

130.95

g/l

0.14

369

Bacterial, viral and other infectious agents, including avohilmo

126

770

1.66

6.63

3.3

2.2

127.42

133.56

g/l

1.59

101

616

Superficial injury of forearm

147

933

1.59

6.62

1.9

2.3

131.18

131.33

g/l

0.03

114

744

Brachial plexus disorders

119

717

1.68

6.60

2.2

134.64

131.38

g/l

0.91

107

552

Benign neoplasm: Colon, unspecified

404

3084

1.32

6.60

2.6

2.3

125.90

128.08

g/l

0.97

310

2332

709

5201

1.23

6.57

2.5

2.3

126.73

126.84

g/l

0.04

529

3984

Arthropod-borne viral fevers and viral haemorrhagic fevers

142

897

1.60

6.56

2.0

2.4

133.56

130.68

g/l

0.82

126

699

Acute bronchiolitis

452

1.82

6.53

3.2

2.3

131.08

133.98

g/l

0.59

394

Nonpyogenic thrombosis of intracranial venous system

3.44

6.53

3.3

2.1

124.53

129.31

g/l

0.32

Discitis, unspecified

154

2.56

6.47

2.8

2.4

118.81

128.35

g/l

1.18

124

Crohn's disease of small intestine

549

1.77

6.46

2.3

133.50

133.12

g/l

0.05

442

Polymyalgia rheumatica

226

1579

1.45

6.46

2.5

2.3

125.37

126.28

g/l

0.23

178

1230

Injury of nerves and spinal cord at neck level

197

2.35

6.46

2.0

2.3

129.05

128.76

g/l

0.03

157

Lactose intolerance, other/unspecified

203

2.32

6.45

2.9

2.3

133.28

130.36

g/l

0.47

165

Injury of intra-abdominal organs

197

2.34

6.44

2.2

2.5

132.97

132.75

g/l

0.02

163

Primary hyperparathyroidism

169

1116

1.53

6.42

2.2

2.3

126.08

126.60

g/l

0.10

142

846

Insomnia

1340

8030

1.16

6.41

2.1

2.3

133.37

130.45

g/l

4.36

1023

6255

Asthma mixed form (mode), excluding more controls

281

2.09

6.40

1.6

1.9

135.22

131.04

g/l

0.55

229

Infection of intervertebral disc (pyogenic)

114

2.83

6.39

2.5

124.22

129.10

g/l

0.40

Cervicalgia

295

2159

1.38

6.39

2.3

2.2

131.78

129.25

g/l

0.96

230

1644

Other and unspecified injuries of lower leg

114

687

1.68

6.36

2.4

130.06

130.34

g/l

0.04

551

Pre-eclampsia or poor fetal growth

330

2447

1.35

6.35

2.6

2.0

130.81

130.51

g/l

0.09

282

1888

Fracture of neck

106

628

1.72

6.34

2.4

2.3

125.88

128.77

g/l

0.52

502

Nosocomial condition (hospital)

3.75

6.32

2.7

2.1

112.77

127.10

g/l

1.05

Carcinoma in situ of other and unspecified sites

431

1.88

6.30

2.5

2.3

123.23

129.19

g/l

1.11

341

Other infestations, including avohilmo

156

2.52

6.30

1.9

2.2

133.03

129.70

g/l

0.36

121

Suggestive for eosinophilic asthma

130

812

1.62

6.30

2.8

2.2

132.69

129.18

g/l

0.86

626

Manic episode

218

2.25

6.29

3.1

2.3

132.02

132.49

g/l

0.05

176

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

259

1861

1.40

6.28

2.0

2.4

134.07

129.70

g/l

2.00

170

1443

Paralytic ileus

353

1.97

6.28

3.9

2.2

124.76

128.96

g/l

0.72

289

Carbimazole or st.post thyroidectomy, condition for graves disease

280

2039

1.38

6.27

1.9

2.2

131.18

128.69

g/l

0.88

196

1565

Tuberculosis, wide

121

744

1.65

6.27

2.5

2.3

120.56

126.46

g/l

1.83

580

Exposure to other and unspecified animate mechanical forces

226

2.21

6.19

1.8

2.3

137.75

131.93

g/l

1.12

192

Fissure and fistula of anal and rectal regions

327

2445

1.35

6.18

2.2

130.60

131.12

g/l

0.14

242

1887

Lesion of lateral popliteal nerve

426

1.86

6.16

2.3

2.4

124.39

129.36

g/l

0.75

339

Acquired absence of limb

3.21

6.15

3.2

1.9

105.56

130.18

g/l

3.18

Other abnormalities of plasma proteins

146

2.56

6.14

3.4

2.3

123.97

129.02

g/l

0.50

116

Chronic myeloid leukaemia, including Hilmo

3.30

6.13

1.9

2.1

127.56

132.35

g/l

0.26

Acute nephritic syndrome

164

2.45

6.13

3.6

2.4

127.12

131.08

g/l

0.45

131

Other and unspecified glaucoma

126

788

1.62

6.12

2.1

2.3

124.88

126.72

g/l

0.32

101

610

Other localized connective tissue disorders

152

2.51

6.12

2.5

1.9

120.89

128.30

g/l

1.35

120

Tuberculosis, wide, including avohilmo

122

757

1.64

6.11

2.5

2.2

120.74

126.43

g/l

1.75

590

Other benign neoplasm of uterus: Other parts/unspecified

407

1.89

6.10

2.4

2.3

125.74

123.04

g/l

0.54

318

Neovascular glaucoma

385

1.91

6.09

2.7

2.2

123.41

127.59

g/l

0.60

304

Subjective visual disturbances

370

2823

1.32

6.09

2.1

2.3

132.20

128.92

g/l

1.65

250

2163

Meralgia paraesthetica

295

2.04

6.07

1.9

2.2

130.02

129.43

g/l

0.06

231

Other and unspecified psoriasis

105

628

1.70

6.07

2.6

2.3

128.72

129.74

g/l

0.17

492

Autoimmune hyperthyroidism

464

1.81

6.06

2.0

2.2

130.23

128.61

g/l

0.27

364

Other and unspecified urticaria

259

1874

1.39

6.05

2.1

2.2

132.99

130.03

g/l

1.19

191

1481

Disorders of continuity of bone

138

883

1.58

6.05

2.4

2.1

125.31

131.37

g/l

2.14

101

704

Postprocedural musculoskeletal disorders, not elsewhere classified

118

729

1.64

6.03

2.6

2.3

122.56

127.76

g/l

1.63

102

575

Other noninflammatory disorders of uterus, except cervix

304

1493

1.37

6.02

2.2

127.12

126.22

g/l

0.25

229

1123

Use of antiglaucoma preparations and miotics

140

903

1.57

5.97

2.2

124.73

125.75

g/l

0.17

109

697

Olecranon bursitis

563

1.73

5.97

2.8

2.3

132.43

131.06

g/l

0.20

425

Cluster headache, wide,, including avohilmo

416

1.86

5.96

2.6

2.2

134.12

132.73

g/l

0.19

329

Tuberculosis, IBD comorbidity

114

700

1.65

5.96

2.6

2.3

120.90

127.35

g/l

2.05

547

Anosmia

3.11

5.96

2.0

1.4

127.11

133.38

g/l

0.67

Organ-limited amyloidosis

4.05

5.96

3.4

2.1

117.55

123.00

g/l

0.36

Other benign neoplasms of uterus

512

1.77

5.96

2.4

2.2

125.43

123.75

g/l

0.32

395

Renal agenesis and other reduction defects of kidney, including avohilmo

4.03

5.94

5.1

2.1

124.41

131.47

g/l

0.51

Fitting and adjustment of other devices

524

3682

1.26

5.94

2.0

127.38

130.09

g/l

1.73

416

2705

Other maltreatment syndromes

198

2.27

5.91

1.9

2.2

138.52

133.97

g/l

0.52

155

Infections with a predominantly sexual mode of transmission

352

2671

1.32

5.91

2.6

2.1

129.60

132.34

g/l

1.51

257

2119

Complications of genitourinary prosthetic devices, implants and grafts

218

2.21

5.90

2.4

2.2

129.03

128.08

g/l

0.09

173

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

230

2.17

5.90

3.1

2.6

136.68

134.37

g/l

0.32

189

Mucosal proctocolitis

163

1088

1.51

5.89

2.7

2.3

128.99

132.76

g/l

1.25

134

874

Carcinoma in situ, bladder

405

1.87

5.88

2.3

124.68

129.30

g/l

0.73

319

Nonsuppurative otitis media

306

1979

1.35

5.80

2.7

2.2

130.12

132.28

g/l

0.85

235

1646

Other juvenile arthritis

252

2.10

5.80

3.1

2.4

124.48

131.86

g/l

1.62

208

Benign neoplasm of other and unspecified intrathoracic organs

3.09

5.79

2.0

2.3

126.47

126.98

g/l

0.03

Bacterial, viral and other infectious agents

115

713

1.63

5.78

3.1

2.2

127.61

133.80

g/l

1.49

566

Nonspecific lymphadenitis

442

1.81

5.78

2.8

2.3

130.69

131.21

g/l

0.06

348

Campylobacter enteritis

220

2.19

5.77

2.0

129.86

131.01

g/l

0.10

177

Malignant neoplasm of prostate

445

2055

1.29

5.76

2.3

2.4

126.56

134.69

g/l

7.22

352

1594

Vasomotor and allergic rhinitis

497

3871

1.26

5.76

2.2

133.84

130.92

g/l

2.33

367

3098

Non-allergic asthma

130

831

1.58

5.74

2.4

2.3

137.05

129.97

g/l

2.29

101

674

Spirochaetal infections, other/unspecified

891

0.48

5.73

2.0

2.3

129.36

128.60

g/l

0.08

696

Pregnancy hypertension

460

3245

1.27

5.72

2.4

2.1

129.64

129.93

g/l

0.10

385

2466

Superficial injury of shoulder and upper arm

172

1169

1.49

5.71

2.4

2.3

131.52

130.59

g/l

0.20

128

927

Dementia in Alzheimer disease

331

2095

1.33

5.70

2.2

2.3

125.04

124.91

g/l

0.03

298

1623

Adalimumab

128

817

1.58

5.69

3.1

2.2

130.57

133.35

g/l

0.83

100

646

Endometriosis

430

1943

1.29

5.69

2.1

128.68

127.69

g/l

0.36

329

1516

Early complications of trauma

387

1.87

5.68

2.9

2.4

123.31

131.54

g/l

1.97

304

!Aliquae complicationes praecoces traumatis

387

1.87

5.68

2.9

2.4

123.31

131.54

g/l

1.97

304

Syphilis

202

2.23

5.67

3.8

2.4

125.21

131.75

g/l

0.90

161

Syphilis, including avohilmo

202

2.23

5.67

3.7

2.4

125.21

131.75

g/l

0.90

161

Injury of eye and orbit

182

1253

1.46

5.65

2.1

2.3

132.50

133.25

g/l

0.15

143

982

Malignant neoplasm of colon, including Hilmo

285

2111

1.36

5.64

1.9

2.2

119.75

130.21

g/l

8.92

224

1643

Trochanteric bursitis

207

1461

1.43

5.63

2.4

2.2

130.76

128.16

g/l

1.00

159

1095

Septal defects

538

1.72

5.63

2.7

2.5

133.58

131.29

g/l

0.44

442

Malignant neoplasm of prostate, including Hilmo

450

2082

1.28

5.62

2.3

126.65

134.94

g/l

7.48

356

1613

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

143

933

1.54

5.61

2.9

2.3

131.32

131.99

g/l

0.13

112

766

Coxarthrosis, primary, with hip surgery

759

5878

1.20

5.61

2.2

2.3

125.93

128.01

g/l

1.45

578

4442

IBD patients in KELA-register

292

2181

1.35

5.60

2.6

2.2

130.61

132.34

g/l

0.63

231

1707

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

483

1.76

5.59

2.4

1.8

130.49

132.55

g/l

0.43

384

Paraplegia, diplegia of upper limbs

191

2.26

5.56

3.9

2.0

123.18

129.85

g/l

0.96

149

Biological medicines for asthma

153

2.41

5.54

2.0

2.2

139.56

133.13

g/l

0.86

124

Skin changes due to chronic exposure to nonionizing radiation

668

4997

1.22

5.53

2.5

2.3

127.00

126.71

g/l

0.11

498

3835

Exposure to other specified factors

1204

8959

1.16

5.52

2.3

2.2

132.60

131.12

g/l

1.24

899

6981

Tuberculosis

102

622

1.66

5.52

2.5

2.2

120.27

127.08

g/l

2.14

483

Infections of genitourinary tract in pregnancy

111

692

1.62

5.46

2.9

2.1

130.39

128.73

g/l

0.37

548

Infections with a predominantly sexual mode of transmission, including avohilmo

471

3432

1.26

5.46

2.5

2.1

132.31

132.68

g/l

0.13

356

2745

Persistent delusional disorders

111

693

1.62

5.46

2.4

2.2

128.93

129.13

g/l

0.03

536

Cluster headache, strict, including avohilmo

385

1.85

5.44

2.7

2.2

133.29

133.03

g/l

0.03

305

Ehlers-Danlos syndrome, including avohilmo

3.10

5.44

2.0

1.8

131.00

130.19

g/l

0.07

Autonomic disorders

206

2.19

5.42

1.8

2.3

136.57

130.44

g/l

0.90

162

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

484

3826

1.25

5.42

2.2

133.83

132.66

g/l

0.54

385

3040

Glaucoma secondary to other eye disorders

401

1.83

5.41

2.7

2.2

123.41

128.57

g/l

0.81

320

Actinic keratosis

653

4911

1.22

5.39

2.5

2.3

126.84

126.62

g/l

0.08

488

3770

Nonsuppurative otitis media, including avohilmo

406

2753

1.28

5.35

2.5

2.2

131.71

131.82

g/l

0.03

320

2235

Spondylopathies (FG)

166

1136

1.47

5.34

2.1

132.39

131.99

g/l

0.08

133

878

Other inflammatory liver diseases

589

1.67

5.34

3.2

2.3

121.03

129.92

g/l

3.38

465

Struck by thrown, projected or falling objec

469

1.75

5.32

2.0

2.4

135.87

131.63

g/l

0.88

375

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

204

1452

1.42

5.31

2.6

2.3

130.60

132.69

g/l

0.63

167

1146

Dermatophytosis

207

1480

1.41

5.28

3.3

2.3

129.09

130.22

g/l

0.26

158

1143

Use of trihexyphenidyl

9.63

5.28

6.8

1.1

128.60

122.29

g/l

—

Asthma mixed form (mode)

303

1.94

5.26

1.6

1.8

135.22

130.62

g/l

0.63

253

Thyrotoxicosis with diffuse goitre

182

1272

1.44

5.26

2.0

2.2

131.82

128.18

g/l

1.38

143

981

Other peripheral vascular diseases

111

700

1.60

5.25

2.1

125.67

129.11

g/l

0.59

553

Follicular lymphoma, hilmo

391

1.83

5.23

2.5

2.4

121.19

128.89

g/l

1.58

312

Disorders of optic nerve and visual pathways

127

827

1.55

5.22

2.7

2.2

127.85

129.53

g/l

0.34

102

653

Etanercept

524

1.70

5.22

2.9

2.3

126.58

131.65

g/l

1.52

412

Amenorrhoea

471

1.74

5.21

2.4

2.2

128.48

130.10

g/l

0.27

384

malignant neoplasm of female genital organs, including Hilmo

240

1677

1.37

5.21

2.4

2.1

124.22

127.45

g/l

1.49

195

1278

Speech and linguistic disorders

117

716

1.58

5.20

2.3

133.69

133.95

g/l

0.04

605

Hyperfunction of pituitary gland

362

1.85

5.19

2.7

2.0

130.84

130.95

g/l

0.01

293

Cramp and spasm

399

1.81

5.18

1.8

2.3

134.05

130.12

g/l

0.65

320

Haemolytic anaemias

306

1.93

5.18

3.1

2.2

121.16

129.38

g/l

1.24

248

Conjunctivitis (acute, non atopic)

382

2982

1.28

5.17

2.6

2.3

131.75

130.41

g/l

0.52

302

2343

Hypermetropia

107

671

1.61

5.17

3.1

2.5

126.54

130.83

g/l

1.20

553

Seborrhoeic dermatitis

147

991

1.50

5.15

2.8

2.2

132.06

130.46

g/l

0.32

109

771

Impaction of intestines

3.33

5.14

2.5

2.0

137.47

125.64

g/l

0.95

Dermatophytosis, including avohilmo

971

8176

1.17

5.13

2.5

2.2

130.65

131.51

g/l

0.47

700

6382

Systemic lupus erythematosus

279

1.97

5.12

1.9

2.3

131.14

130.22

g/l

0.10

228

Other other unspecified disorders of the circulatory system

329

1.89

5.10

2.6

2.2

124.17

130.23

g/l

0.89

260

Hypothyroidism due to medicaments and other exogenous substances

111

2.62

5.06

3.8

2.2

138.76

126.75

g/l

1.15

Ulcerative colitis (strict definition, require KELA)

209

1510

1.39

5.01

2.6

2.3

131.15

132.77

g/l

0.46

171

1188

Sleep disorders, other/unspecified

267

1.98

5.01

2.7

2.2

138.44

131.70

g/l

1.90

220

Other disorders of optic [2nd] nerve and visual pathways

585

1.65

4.99

2.5

2.3

130.01

130.11

g/l

0.01

470

Post-traumatic wound infection, not elsewhere classified

234

2.05

4.96

2.9

2.3

121.00

130.64

g/l

2.10

186

130

2.44

4.94

2.0

2.6

134.04

134.85

g/l

0.11

113

Ventricular septal defect, a heart condition

174

2.23

4.93

2.3

2.8

131.72

132.38

g/l

0.06

146

Nummular dermatitis

127

839

1.53

4.93

2.8

2.3

126.91

129.95

g/l

0.62

655

Other neurotic disorders

413

1.77

4.92

2.4

2.3

126.76

129.91

g/l

0.48

332

L04AC Interleukin inhibitors

518

1.68

4.91

2.2

133.76

133.17

g/l

0.08

408

Conjunctivitis (acute, non atopic), including avohilmo

1578

8456

1.13

4.89

2.2

2.3

132.62

130.55

g/l

2.49

1150

6676

Dermatitis due to substances taken internally

481

1.71

4.89

2.7

2.3

127.88

130.37

g/l

0.41

387

Chronic iridocyclitis

399

1.78

4.89

2.2

2.3

129.94

129.28

g/l

0.11

322

Pre-eclampsia or eclampsia

230

1695

1.37

4.88

2.5

2.0

130.44

130.02

g/l

0.12

194

1285

Deviated nasal septum

467

3772

1.24

4.88

2.1

2.3

134.67

131.40

g/l

1.80

325

2946

Corneal ulcer

249

1859

1.35

4.87

2.7

2.3

130.35

130.50

g/l

0.03

201

1450

Postprocedural disorders of nervous system

496

1.69

4.87

2.3

2.1

132.25

131.25

g/l

0.12

400

Primary coxarthrosis, bilateral

460

3720

1.24

4.84

2.2

2.3

124.78

127.27

g/l

1.20

352

2818

Idiopathic thrombocytopenic purpura

257

1.99

4.84

3.1

2.3

123.79

130.05

g/l

1.09

206

Pre-eclampsia

211

1537

1.38

4.82

2.6

1.9

130.39

130.07

g/l

0.08

181

1175

Abnormal findings on diagnostic imaging of central nervous system

408

1.77

4.82

2.3

2.2

125.87

130.46

g/l

0.85

337

Visual field defects

131

878

1.51

4.77

2.4

2.3

133.35

127.92

g/l

1.49

104

685

SLE, ICD10

266

1.95

4.73

1.9

2.2

129.65

129.63

g/l

0.00

215

SLE, strict definition

266

1.95

4.73

1.9

2.2

129.65

129.63

g/l

0.00

215

Dislocation, sprain and strain of joint and ligaments of hip

353

1.82

4.69

3.0

2.2

126.65

127.88

g/l

0.15

278

Inflammatory bowel disease, strict (require KELA)

292

2243

1.31

4.69

2.6

2.2

130.61

132.30

g/l

0.61

231

1758

Salpingitis and oophoritis

207

1512

1.38

4.68

2.8

2.1

129.13

127.33

g/l

0.54

149

1135

Other injuries of spine and trunk, level unspecified

3.01

4.68

2.0

2.2

124.13

130.38

g/l

0.51

Diffuse brain injury

225

2.03

4.68

2.8

2.1

130.44

128.96

g/l

0.14

169

Postpartum care and examination

141

594

1.50

4.68

2.2

1.9

130.44

134.11

g/l

1.38

127

496

Acute lymphadenitis

442

1.72

4.66

2.5

2.2

130.90

131.91

g/l

0.12

363

Outcome of delivery

705

0.58

4.66

1.4

1.9

130.53

133.94

g/l

0.56

572

Lymphoid leukaemia

573

1.63

4.66

2.5

2.3

116.87

128.21

g/l

3.29

464

Lichen planus

183

1312

1.41

4.65

2.4

2.2

129.37

127.72

g/l

0.42

136

1005

Generalized epilepsy

310

1.87

4.65

2.2

2.4

130.68

132.12

g/l

0.25

258

Personal history of medical treatment

2.70

4.64

2.6

2.1

126.53

129.69

g/l

0.20

Hemiplegia

428

1.73

4.63

2.6

2.2

130.29

129.69

g/l

0.07

347

Open wound of shoulder and upper arm

160

2.24

4.62

2.4

2.5

123.19

129.84

g/l

0.94

131

Other congenital malformations

110

715

1.55

4.60

2.7

2.4

131.76

131.86

g/l

0.01

587

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

220

1628

1.36

4.59

2.0

2.4

134.40

129.57

g/l

2.00

139

1271

Viral haemorrhagic fevers, not elsewhere classified/unspecified

110

717

1.55

4.57

2.0

2.2

133.69

130.45

g/l

0.82

562

Other/unspecified enthesopathies of lower limb, excluding foot

583

1.61

4.56

2.3

2.2

133.54

130.33

g/l

0.64

456

Fall on and from stairs and steps

376

2994

1.26

4.56

2.2

2.3

130.08

129.03

g/l

0.33

285

2308

Panniculitis affecting regions of neck and back

291

1.89

4.55

2.0

2.1

131.17

131.36

g/l

0.02

244

Pneumoconiosis due to asbestos and other mineral fibres

208

2.07

4.55

2.4

2.3

138.50

126.16

g/l

1.87

164

Sequelae of other external causes

499

1.67

4.54

3.2

2.3

127.05

130.48

g/l

0.67

400

Disorders of tooth development and eruption

196

1156

1.39

4.51

2.3

2.0

133.10

130.52

g/l

0.71

142

925

Postzoster neuralgia

149

2.28

4.51

3.6

2.3

118.96

125.80

g/l

0.85

113

Procreative management

402

2650

1.25

4.51

2.1

2.2

133.56

133.94

g/l

0.12

298

2105

Disturbance of activity and attention

148

1001

1.45

4.51

2.1

2.2

140.60

135.16

g/l

2.48

126

857

Other acquired deformities of musculoskeletal system and connective tissue

380

1.76

4.49

1.8

2.3

135.24

129.71

g/l

0.92

307

Other and unspecified injuries of head

111

728

1.54

4.49

2.0

2.4

124.94

129.38

g/l

1.06

568

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

406

3269

1.25

4.46

2.3

133.16

131.10

g/l

0.91

317

2522

Allergic rhinitis

368

2891

1.26

4.46

2.0

2.2

132.94

132.40

g/l

0.20

271

2320

Respiratory tuberculosis

533

1.64

4.45

2.2

2.3

120.27

127.35

g/l

1.86

423

Respiratory tuberculosis, confirmed and not-confirmed

533

1.64

4.45

2.2

2.3

120.27

127.35

g/l

1.86

423

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

220

1637

1.35

4.44

2.6

2.3

130.82

132.62

g/l

0.55

178

1284

Diseases of appendix

1048

8184

1.15

4.44

2.5

2.2

132.38

131.47

g/l

0.59

841

6295

Non-small cell lung cancer, squamous, helper endpoint

557

1.62

4.44

2.3

122.29

127.22

g/l

1.07

431

Amputation of thigh

294

1.87

4.43

3.7

2.2

115.11

126.06

g/l

1.83

234

Viral meningitis

251

1.94

4.43

2.2

2.3

129.79

131.47

g/l

0.19

208

Polyhydramnios

279

1.89

4.43

2.0

1.8

127.68

132.53

g/l

0.66

223

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

266

1.92

4.42

4.1

2.2

112.14

130.70

g/l

6.85

216

Multiple myeloma

266

1.92

4.42

4.1

2.2

112.14

130.70

g/l

6.85

216

Pyoderma gangrenosum

3.00

4.42

3.0

2.1

119.00

129.44

g/l

1.19

Polyarthritis, unspecified

287

1.88

4.41

2.7

2.4

127.43

127.81

g/l

0.03

222

Appendicitis, broad definition

1038

8134

1.15

4.41

2.5

2.2

132.45

131.53

g/l

0.61

833

6255

Pilonidal cyst

636

1.57

4.38

2.3

2.1

140.74

137.31

g/l

0.74

507

Adenocarcinoma and Papillary adenocarcinoma of kidney

101

2.57

4.38

4.7

2.4

122.20

133.02

g/l

0.89

Unspecified privation

148

1034

1.44

4.38

1.9

2.3

129.70

129.82

g/l

0.01

808

Personality and behavioural disorders due to brain disease, damage and dysfunction

119

2.42

4.38

2.9

2.3

134.77

130.83

g/l

0.35

Lichen simplex chronicus

288

1.87

4.38

2.0

2.2

130.24

131.35

g/l

0.12

238

Flat foot [pes planus] (acquired)

124

837

1.50

4.37

2.5

2.2

129.97

128.69

g/l

0.25

637

Benign neoplasm of major salivary glands

140

969

1.46

4.37

2.3

128.10

128.78

g/l

0.11

110

755

Strabismus

346

2739

1.27

4.32

2.3

131.11

130.39

g/l

0.22

282

2133

Sequelae of infectious and parasitic diseases, including avohilmo

101

655

1.56

4.31

2.9

2.1

129.61

129.74

g/l

0.02

506

Malignant neoplasm of colon

231

1741

1.34

4.31

1.9

2.2

118.75

130.29

g/l

8.35

182

1354

Myocardial infarction, unclassifiable

361

2571

1.26

4.30

3.0

2.3

123.53

126.27

g/l

1.27

310

2019

Chondrocostal junction syndrome [Tietze]

326

1.81

4.30

2.3

2.1

135.74

129.34

g/l

1.40

270

Agoraphobia

205

2.03

4.30

1.9

2.1

133.00

133.16

g/l

0.01

167

Sequelae of infectious and parasitic diseases

640

1.56

4.29

2.9

2.1

129.53

129.82

g/l

0.04

495

Malignant neoplasm of breast, including Hilmo

506

2665

1.22

4.29

2.0

124.47

129.28

g/l

4.33

368

2043

Malignant neoplasm of corpus uteri, including Hilmo

132

907

1.47

4.28

2.7

2.2

124.50

126.55

g/l

0.47

101

698

Other/unspecified disorders of vestibular function

386

1.74

4.28

1.5

2.2

134.21

127.52

g/l

1.29

305

Malignant neoplasm of breast, HER2-negative

498

2639

1.22

4.26

2.0

124.67

129.22

g/l

3.89

363

2024

Small fibre neuropathy

284

1.87

4.25

2.4

2.3

136.18

131.27

g/l

0.70

227

Inflammatory disorders of breast

485

1.65

4.24

3.0

2.1

129.48

129.95

g/l

0.07

393

Malignant neoplasm of breast

498

2641

1.22

4.22

2.0

124.70

129.23

g/l

3.87

364

2025

Rare circulating lymphoid malignancy, including Hilmo

263

1.90

4.22

2.3

117.86

132.69

g/l

4.78

216

Meningitis

410

1.71

4.21

2.4

2.2

130.42

130.32

g/l

0.01

331

Herpesviral [herpes simplex] infections, including avohilmo

315

2481

1.28

4.21

2.3

2.1

129.88

130.23

g/l

0.09

226

1945

Malignant neoplasm of breast, HER2-negative, including Hilmo

505

2665

1.22

4.21

2.0

124.44

129.28

g/l

4.36

367

2043

Viral meningitis, including avohilmo

263

1.89

4.20

2.2

2.3

129.79

131.21

g/l

0.15

219

Other complications of labour and delivery, not elsewhere classified

745

0.54

4.20

1.4

2.1

133.05

131.98

g/l

0.18

634

Bullous pemphigoid

215

2.00

4.18

3.2

2.2

125.76

128.17

g/l

0.35

168

Benign neoplasm: salivary glands, exclude unknown (D119)

125

855

1.48

4.17

2.3

2.2

127.38

128.77

g/l

0.24

669

Wegener granulomatosis

135

2.29

4.16

3.7

2.1

121.95

129.39

g/l

0.81

108

Malignant neoplasm of rectum

147

1037

1.43

4.15

2.4

2.2

124.58

131.15

g/l

2.37

119

823

Fistulae involving female genital tract

135

2.28

4.15

2.5

2.0

127.40

125.91

g/l

0.12

104

Nontoxic multinodular goitre

270

2092

1.30

4.14

2.3

2.2

127.27

125.70

g/l

0.53

215

1587

Benign neoplasm: Parotid gland

115

775

1.50

4.14

2.3

2.2

127.79

128.75

g/l

0.15

605

Colorectal adenocarcinoma

304

2360

1.28

4.13

2.2

122.08

130.48

g/l

6.47

238

1831

Wet age-related macular degeneration

302

2289

1.28

4.12

2.3

124.52

125.25

g/l

0.21

239

1772

Cerebral aneurysm, nonruptured

118

800

1.49

4.11

2.4

2.2

128.98

128.52

g/l

0.07

624

Arthropathy in ulcerative colitis

2.52

4.11

2.0

1.8

136.95

130.87

g/l

0.71

Temporomandibular joint disorders, including avohilmo

559

4539

1.20

4.09

2.1

2.2

133.53

130.71

g/l

2.21

420

3561

Bullous disorders

561

1.59

4.09

2.8

2.3

128.08

128.56

g/l

0.07

448

Other skin changes

302

2378

1.28

4.09

2.3

2.4

128.10

127.95

g/l

0.04

228

1845

Acute appendicitis, no complications

725

6177

1.17

4.09

2.4

2.2

133.30

132.05

g/l

0.72

583

4779

Myeloproliferative diseases

124

851

1.47

4.08

2.1

2.2

129.29

127.46

g/l

0.25

667

Lesion of radial nerve

310

1.80

4.06

3.1

2.2

133.81

129.21

g/l

0.54

246

Other eating disorders

361

1.74

4.06

3.0

2.4

134.05

130.91

g/l

0.78

311

Combined immunodeficiencies

2.62

4.04

1.5

2.0

119.53

124.92

g/l

0.34

Benign thyroid growths and nodules

452

3457

1.22

4.03

2.2

127.49

127.06

g/l

0.14

356

2646

Congenital obstruction of the pelviureteric junction

2.92

4.03

1.9

1.7

127.54

127.57

g/l

0.00

Alcohol-induced acute pancreatitis

311

1.80

4.03

2.8

2.3

125.52

132.89

g/l

1.06

240

Blepharochalasis

434

3564

1.22

4.02

2.2

2.3

126.92

127.03

g/l

0.03

325

2726

Other orthopaedic follow-up care

454

1.65

4.01

2.4

2.0

130.33

131.10

g/l

0.09

347

Other surgical follow-up care

246

1.90

4.00

2.7

2.0

124.61

132.87

g/l

1.84

194

Injury of nerves at wrist and hand level

290

1.82

3.98

1.7

2.2

134.10

133.85

g/l

0.03

232

Acetic acid derivatives and related substances

429

1802

1.24

3.97

2.2

2.6

130.39

127.97

g/l

1.07

328

1515

Examination and observation for other reasons

849

4142

1.16

3.96

1.9

2.3

131.39

131.33

g/l

0.02

554

3354

Malignant neoplasm of bone and articular cartilage, including Hilmo

151

2.17

3.96

2.2

2.3

119.56

132.05

g/l

1.46

124

Autoimmune hepatitis, wide definition

342

1.75

3.95

3.3

2.2

122.09

129.65

g/l

1.93

265

Eating disorder

635

1.54

3.95

2.8

2.2

133.36

131.67

g/l

0.41

546

Other and unspecified injuries of shoulder and upper arm

291

1.82

3.95

2.6

2.2

132.28

131.33

g/l

0.11

234

Premature rupture of membranes

206

1093

1.35

3.94

2.3

1.9

130.99

131.51

g/l

0.15

175

854

Hyperkinetic disorders

152

1061

1.40

3.93

2.1

2.2

140.25

135.17

g/l

2.32

130

909

Special screening examination for infectious and parasitic diseases

161

1612

0.73

3.92

2.0

2.1

133.30

135.39

g/l

0.42

1339

Urethritis and urethral syndrome

165

2.10

3.91

2.6

2.4

138.88

129.65

g/l

1.52

141

Chronic lymphocytic leukaemia, helper endpoint

285

1.83

3.90

2.7

2.2

111.33

131.89

g/l

4.79

235

Chronic lymphocytic leukaemia

285

1.83

3.90

2.7

2.2

111.33

131.89

g/l

4.79

235

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

285

1.83

3.90

2.7

2.2

111.33

131.89

g/l

4.79

235

Sequelae of injuries of head

458

1.64

3.90

1.8

2.3

135.59

132.26

g/l

0.58

359

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

179

2.06

3.90

3.1

2.2

129.75

127.91

g/l

0.17

148

Eating disorders

120

824

1.46

3.89

2.7

2.2

133.28

131.24

g/l

0.55

107

693

Superficial injury of ankle and foot

154

1109

1.40

3.88

2.3

133.56

132.33

g/l

0.25

119

899

Acute myeloid leukaemia and myelodysplastic syndromes

214

1.96

3.87

2.5

2.3

105.10

130.48

g/l

5.22

174

Vulvovaginal ulceration/inflammation in other diseases

506

1.60

3.84

2.7

2.2

128.35

129.93

g/l

0.32

426

Trigeminal neuralgia

483

1.61

3.84

2.0

2.2

136.00

127.92

g/l

2.82

376

Spasmodic torticollis

272

1.83

3.83

1.6

2.2

126.26

128.95

g/l

0.35

221

Pedestrian injured in transport accident

634

1.53

3.83

1.9

2.3

131.67

130.49

g/l

0.16

505

Malignant neoplasm of rectum, including Hilmo

175

1291

1.37

3.82

2.7

2.2

123.72

131.08

g/l

3.29

136

1010

Degenerative macular diseases

186

1386

1.35

3.82

2.2

2.3

127.42

125.51

g/l

0.48

145

1087

Secondary malignant neoplasm of respiratory and digestive organs

167

2.09

3.82

1.9

2.3

115.83

130.44

g/l

2.64

133

Benign neoplasm of other and ill-defined parts of digestive system

255

1986

1.29

3.80

2.6

2.3

123.67

127.85

g/l

1.73

197

1513

Other disorders of penis

134

945

1.43

3.80

2.6

2.3

135.76

133.01

g/l

0.57

100

725

Other/unspecified enthesopathies, not elsewhere classified

114

781

1.47

3.80

2.3

2.2

130.53

129.01

g/l

0.29

598

Carcinoma in situ of other and unspecified digestive organs

447

1.64

3.78

2.8

2.2

125.31

128.95

g/l

0.63

357

Other and specified injuries of hip and thigh

188

2.01

3.77

1.7

2.1

124.50

129.33

g/l

0.54

149

Reactive arthropathies

109

741

1.48

3.77

2.4

2.2

128.84

130.96

g/l

0.42

567

Ingrowing nail

462

1.62

3.77

2.7

2.2

129.77

131.14

g/l

0.18

375

Parkinson's disease, including avohilmo

246

1911

1.30

3.76

2.2

2.4

127.40

126.84

g/l

0.14

209

1473

Malignant immunoproliferative diseases

103

2.42

3.75

3.7

2.5

114.89

126.00

g/l

0.97

Other congenital malformations of the digestive system, including avohilmo

444

1.63

3.74

3.2

2.6

130.47

130.56

g/l

0.01

372

Unspecific neurodegenerative disorder

726

4282

1.17

3.74

2.1

2.3

127.02

125.94

g/l

0.57

593

3257

Generalized skin eruption due to drugs and medicaments

341

1.73

3.73

2.6

2.3

124.10

129.43

g/l

0.89

275

Other mental disorders due to brain damage and dysfunction and to physical disease

187

1400

1.35

3.73

2.0

2.3

128.11

126.33

g/l

0.44

157

1066

Colonic or urogenital fistula

359

2916

1.24

3.73

2.2

2.3

129.41

129.97

g/l

0.16

265

2242

Syndrome of inappropriate secretion of antidiuretic hormone

3.01

3.72

3.1

2.1

124.06

123.76

g/l

0.02

Certain conditions originating in the perinatal period

103

614

1.50

3.72

3.2

2.2

130.31

133.72

g/l

0.77

545

Myositis

210

1.94

3.72

2.5

2.2

129.76

130.40

g/l

0.05

173

Fracture of forearm

790

6168

1.15

3.70

2.3

2.2

128.49

129.60

g/l

0.61

622

4757

Prepatellar bursitis

388

1.67

3.68

2.2

2.5

133.33

133.14

g/l

0.02

297

Gestational [pregnancy-induced] hypertension

252

1963

1.29

3.67

2.3

1.9

129.57

130.53

g/l

0.27

214

1531

Atopic dermatitis, strict definition

341

2696

1.24

3.67

2.3

2.2

134.43

132.34

g/l

0.93

253

2186

Gastrojejunal ulcer

104

2.37

3.65

2.7

2.0

128.24

126.94

g/l

0.09

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

207

1576

1.32

3.65

2.3

2.1

128.84

129.22

g/l

0.09

165

1262

Diplopia

184

1379

1.34

3.64

2.2

2.3

128.66

128.72

g/l

0.01

146

1085

Gluteal tendinitis

351

1.70

3.64

2.2

2.1

130.53

129.01

g/l

0.19

280

Impetigo

351

1.70

3.63

2.5

2.4

128.54

132.27

g/l

0.55

287

Special screening examination for other diseases and disorders

170

1258

1.36

3.63

2.5

2.4

129.29

129.79

g/l

0.10

126

1021

Atrophic disorders of skin

205

1561

1.32

3.63

2.3

2.2

132.38

128.25

g/l

1.89

154

1189

Visual impairment including blindness (binocular or monocular)

103

699

1.49

3.63

2.6

2.3

128.36

127.40

g/l

0.14

568

Neuroendocrine tumor and carcinoma of lung

2.60

3.62

1.4

2.0

138.38

131.44

g/l

—

Perforation of tympanic membrane

135

964

1.41

3.62

2.9

2.2

127.06

129.74

g/l

0.59

101

759

Alcohol induced polyneuropathy

2.58

3.61

3.1

2.7

128.23

132.18

g/l

0.26

Hallux valgus (acquired)

427

2522

1.22

3.60

2.2

127.93

128.97

g/l

0.41

319

1937

Striae atrophicae

2.64

3.60

1.3

2.0

136.23

129.95

g/l

0.66

Calcific tendinitis of shoulder

476

1.59

3.59

2.2

2.1

129.52

130.26

g/l

0.10

376

Parkinson's disease

236

1836

1.30

3.58

2.1

2.4

127.33

126.79

g/l

0.14

201

1413

Acute appendicitis

952

7795

1.14

3.58

2.5

2.2

132.60

131.70

g/l

0.54

762

5991

Other appendicitis

109

750

1.47

3.58

2.6

2.3

132.22

130.32

g/l

0.38

586

Nail disorders

112

775

1.46

3.57

2.4

2.3

129.28

130.60

g/l

0.23

620

malignant neoplasm of female genital organs

207

1548

1.32

3.56

2.4

2.1

123.57

127.44

g/l

1.78

171

1183

Viral encephalitis, not elsewhere classified/unspecified

172

2.02

3.54

3.2

2.3

128.33

127.73

g/l

0.05

143

Unknown and unspecified causes of morbidity

501

1.57

3.54

3.2

2.1

132.79

131.17

g/l

0.26

376

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

539

1.54

3.53

2.4

134.57

133.87

g/l

0.12

448

Carcinoma in situ of skin

135

970

1.41

3.52

2.3

2.2

125.46

126.57

g/l

0.18

102

758

Hypoplasia of dental enamel , including avohilmo

268

1.78

3.52

5.4

2.3

130.05

135.12

g/l

1.04

234

Postviral fatigue syndrome

2.97

3.51

1.7

2.3

142.47

133.95

g/l

1.40

Retinal vascular disorders

187

1415

1.33

3.49

2.9

2.3

126.41

125.73

g/l

0.15

155

1092

UC patients in KELA-register (code 208), prior to 1994

371

1.67

3.49

2.7

2.2

128.74

130.38

g/l

0.20

297

Complications predominantly related to the puerperium

263

2079

1.27

3.49

2.2

2.1

130.59

129.72

g/l

0.31

203

1610

Acute generalized exanthematous pustulosis

394

1.65

3.49

2.5

2.3

123.70

129.56

g/l

1.12

319

Respiratory tuberculosis, not confirmed

371

1.67

3.49

2.1

2.3

121.94

126.66

g/l

0.83

297

Other specified/unspecified inflammatory spondylopathies

340

1.70

3.49

1.9

2.1

131.98

132.21

g/l

0.03

275

Otitis externa

306

2463

1.25

3.49

2.6

2.2

131.60

130.00

g/l

0.58

239

1904

Other/unspecified synovitis and tenosynovitis

145

1055

1.38

3.48

2.4

2.1

129.61

129.92

g/l

0.06

117

808

Carcinoma in situ of skin of scalp and neck

312

1.74

3.45

2.8

2.3

125.44

126.40

g/l

0.11

249

Pain and other conditions associated with female genital organs and menstrual cycle

239

1558

1.29

3.45

2.0

2.1

129.96

129.35

g/l

0.18

183

1238

Hypogonadotropic hypogonadism

230

1.85

3.45

2.5

2.3

142.47

137.73

g/l

0.55

180

Sequelae of injuries of neck and trunk

245

1.83

3.44

2.2

2.4

126.62

129.00

g/l

0.30

196

Respiratory tuberculosis, bacteriologically and histologically confirmed

167

2.02

3.44

2.4

2.1

117.40

128.13

g/l

1.29

133

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

252

1.81

3.43

2.8

2.4

132.67

132.91

g/l

0.03

208

Occupational exposure to risk-factors

297

1.75

3.43

2.0

2.4

144.20

130.37

g/l

4.02

237

Reactive arthropathies, FINNGEN

561

1.53

3.43

2.4

2.2

129.21

131.41

g/l

0.38

434

Other protozoal intestinal diseases, including avohilmo

160

2.04

3.43

2.1

2.4

134.59

130.78

g/l

0.40

133

Juvenile rheumatoid arthirtis

133

2.14

3.42

2.4

2.0

122.50

132.54

g/l

1.09

104

Retinal vascular occlusion

184

1394

1.33

3.42

2.8

2.3

126.53

125.76

g/l

0.17

153

1078

Benign neoplasm: Skin of trunk

373

1.66

3.42

2.5

2.2

127.44

129.88

g/l

0.36

300

Other disorders of cornea

134

966

1.40

3.42

2.4

2.3

131.17

128.61

g/l

0.53

101

750

Other congenital malformations, including avohilmo

153

1126

1.37

3.42

2.4

2.3

131.38

131.41

g/l

0.00

115

912

Other congenital malformations of the digestive system

378

1.65

3.41

3.3

2.7

130.92

131.10

g/l

0.02

311

Other secondary coxarthrosis

290

1.75

3.41

3.0

2.1

127.13

129.01

g/l

0.21

225

Glucosamine medication

718

4979

1.16

3.40

2.2

2.3

126.76

126.88

g/l

0.04

528

3787

Other bursopathies

176

1326

1.34

3.39

3.1

2.2

129.62

129.12

g/l

0.09

143

992

Other sexually transmitted chlamydial diseases

431

0.44

3.39

1.4

2.1

135.77

135.46

g/l

0.03

356

Chondropathies

188

1431

1.32

3.37

2.6

2.3

131.07

131.37

g/l

0.06

140

1132

Carcinoma in situ of skin of trunk

360

1.67

3.37

2.6

2.3

124.86

126.29

g/l

0.16

283

Other nonthrombocytopenic purpura

2.49

3.36

2.4

1.9

131.62

128.87

g/l

0.23

Other specified/unspecified soft tissue disorders

429

1.60

3.36

2.3

2.1

129.36

128.58

g/l

0.09

345

Malignant neoplasm of testis

108

2.27

3.36

3.3

2.4

130.81

137.52

g/l

0.45

Acne vulgaris

611

1.50

3.35

2.4

2.2

133.46

134.57

g/l

0.19

519

Mental and behavioural disorders due to hallucinogens

4.51

3.35

4.4

2.0

126.40

136.50

g/l

—

Other and unspecified follicular disorders

352

1.67

3.35

2.4

2.3

130.22

131.82

g/l

0.18

282

Poor fetal growth

117

826

1.42

3.35

2.7

2.0

131.93

131.80

g/l

0.02

105

677

Malignant neoplasm of corpus uteri

118

836

1.43

3.35

2.7

2.2

124.33

126.61

g/l

0.53

644

6-mercaptopurine

225

1.84

3.34

2.2

2.0

135.90

133.58

g/l

0.25

184

Malignant neoplasm of heart, mediastinum and pleura

115

2.23

3.34

1.7

2.1

119.25

131.43

g/l

0.91

Anorexia (incl.atypical)

453

1.58

3.33

2.8

2.3

133.89

130.99

g/l

0.52

385

Myelodysplastic syndrome, including Hilmo

300

1.73

3.33

2.6

2.1

102.76

130.84

g/l

8.39

243

Respiratory tuberculosis, not confirmed, including avohilmo

376

1.65

3.33

2.1

2.3

121.94

126.70

g/l

0.84

301

Congenital malformations of the nervous system

162

2.01

3.33

2.3

2.4

134.29

132.23

g/l

0.16

135

Congenital malformations of great arteries

159

2.01

3.32

4.4

2.6

138.35

134.31

g/l

0.28

130

Fall on and from ladder

113

796

1.44

3.32

1.9

2.4

130.46

130.80

g/l

0.04

625

Sequelae of other and unspecified infectious and parasitic diseases

415

1.61

3.31

2.9

2.1

130.24

132.37

g/l

0.29

324

Other and unspecified intracranial injuries

256

1.79

3.29

1.6

2.5

131.21

129.43

g/l

0.14

209

Cardiac murmurs and other cardiac sounds

110

762

1.44

3.29

2.4

2.3

124.37

129.12

g/l

1.15

620

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

163

2.01

3.29

2.2

2.3

121.19

131.62

g/l

1.01

129

Mesothelioma, including Hilmo

116

2.22

3.28

1.8

2.5

120.00

132.11

g/l

0.86

Specific development disorders of scholastic skills

309

1.70

3.28

2.0

2.7

137.43

135.50

g/l

0.26

265

Subarachnoid haemorrhage

147

1085

1.37

3.27

2.3

128.39

127.58

g/l

0.13

109

839

Inguinal hernia

865

5063

1.14

3.27

2.4

2.3

132.56

131.41

g/l

0.64

676

3943

Cutaneous lupus erythematosus

192

1.91

3.24

2.4

2.1

131.04

128.96

g/l

0.23

154

Degeneration of the brain due to alcohol

214

1.86

3.23

2.6

2.4

128.87

131.51

g/l

0.19

169

Malignant neoplasm of endocrine gland, including Hilmo

101

700

1.46

3.23

2.6

2.3

125.85

130.83

g/l

1.09

550

Raynaud syndrome

111

783

1.43

3.23

1.8

2.3

131.64

129.80

g/l

0.27

627

Dislocation, sprain and strain of joints and ligaments of thorax

295

1.72

3.22

2.8

2.3

128.47

130.95

g/l

0.33

238

Femoral hernia

411

1.60

3.21

2.0

2.3

128.07

127.58

g/l

0.06

331

Degenerative diseases of the nervous system

623

3869

1.16

3.21

2.1

2.3

127.16

125.89

g/l

0.63

521

2965

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

193

1.91

3.20

2.2

129.57

131.90

g/l

0.22

156

Molar incisor enamel hypoplasia

289

1.71

3.20

5.4

2.3

129.23

135.20

g/l

1.35

254

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

419

1.59

3.19

2.9

2.1

130.24

132.18

g/l

0.26

327

Other and unspecified injuries of thorax

144

2.05

3.19

2.8

2.3

130.22

130.17

g/l

0.00

118

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

146

1081

1.36

3.19

2.5

2.2

123.22

131.03

g/l

3.06

117

860

Nonalcoholic steatohepatitis

2.61

3.17

1.6

2.2

139.58

137.98

g/l

0.08

Other disorders of patella

184

1409

1.31

3.17

1.8

2.1

130.56

132.37

g/l

0.40

127

1092

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

654

1.47

3.17

1.9

2.1

122.44

130.84

g/l

1.77

518

Other meningitis

131

2.11

3.16

2.3

1.9

126.50

131.58

g/l

0.37

108

Malignant neoplasm of endocrine gland

605

1.48

3.15

2.6

2.3

126.70

131.09

g/l

0.82

478

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

671

1.46

3.14

2.3

2.1

127.47

127.82

g/l

0.05

516

Gonococcal infection, including avohilmo

275

1.73

3.13

2.1

2.2

136.24

132.34

g/l

0.47

218

Haemolytic-uraemic syndrome

5.37

3.13

7.5

2.5

117.62

132.50

g/l

—

Malignant neoplasm of small intestine

202

1.87

3.12

3.8

2.3

114.42

132.48

g/l

3.82

164

Chorioretinal inflammation

231

1.80

3.11

2.4

125.00

126.81

g/l

0.18

179

Benign neoplasm: Rectum, anus and anal canal

293

2382

1.24

3.11

2.8

2.3

125.20

127.94

g/l

1.10

207

1826

Heterophoria

689

1.45

3.11

2.2

2.4

132.44

130.74

g/l

0.33

562

Intermittent heterotropia

469

1.55

3.10

2.5

2.4

132.79

132.05

g/l

0.14

390

Alzheimer’s disease (Atypical or mixed)

188

1432

1.31

3.10

2.1

2.4

126.10

123.88

g/l

0.66

176

1103

Psoriasis (vulgaris), strict definition

261

1.75

3.09

2.1

125.30

131.27

g/l

1.08

207

Left ventricular outflow tract obstruction, narrow definition

447

1.56

3.08

2.7

2.5

132.24

132.84

g/l

0.08

357

Acquired haemolytic anaemia

210

1.84

3.08

3.7

2.1

118.69

128.84

g/l

1.47

165

Suppurative otitis media, unspecified

188

1.89

3.08

2.0

2.2

131.59

129.46

g/l

0.23

152

Caught, crushed, jammed or pinched in or between objects

463

1.55

3.08

2.5

2.4

137.18

131.68

g/l

1.11

371

Keratoconus

174

1.93

3.08

2.1

2.3

137.16

132.51

g/l

0.44

137

Ulcerative rectosigmoiditis

100

699

1.44

3.08

2.5

2.3

131.91

132.01

g/l

0.01

559

Drug-induced hypopituitarism

11.34

3.07

5.4

132.40

139.00

g/l

—

Other specified/unspecified spondylopathies

225

1.81

3.07

2.4

2.3

120.43

129.22

g/l

1.21

189

Whooping cough

3.45

3.06

3.3

2.0

136.33

131.37

g/l

0.42

Cerebral palsy

106

2.21

3.06

3.3

2.6

131.17

132.57

g/l

0.09

Pemphigoid

270

1.74

3.06

3.1

2.2

126.50

126.85

g/l

0.04

214

Malignant neoplasm of testis, including Hilmo

126

2.10

3.06

3.4

2.3

130.65

138.68

g/l

0.63

101

Systemic lupus erythematosus, unspecified

240

1.78

3.05

1.9

2.2

130.89

130.51

g/l

0.03

191

Other and unspecified injuries of ankle and foot

346

1.64

3.05

2.3

2.4

128.67

131.83

g/l

0.52

284

Ovarian dysfunction

528

1.51

3.04

2.5

1.9

132.15

131.33

g/l

0.17

436

Other erythematous conditions

308

1.68

3.04

2.7

2.1

129.17

129.81

g/l

0.07

251

Benign neoplasm: Skin of upper limb, including shoulder

168

1.94

3.04

1.9

2.2

133.64

129.02

g/l

0.40

132

Sudden idiopathic hearing loss

139

1031

1.36

3.03

2.6

2.3

130.28

128.10

g/l

0.49

109

780

Toxic liver disease

120

2.13

3.02

3.0

2.2

132.85

127.99

g/l

0.41

Other and unspecified types of non-Hodgkin lymphoma, hilmo

402

1.59

3.02

2.5

2.3

123.92

129.01

g/l

0.94

321

Other and unspecified epidermal thickening

226

1.80

3.02

2.8

2.4

128.61

129.95

g/l

0.10

176

Other strabismus

263

2111

1.25

3.02

2.5

2.3

131.86

130.81

g/l

0.31

216

1666

Benign neoplasm of urinary organs

450

1.55

3.00

2.1

2.2

131.44

128.40

g/l

0.36

362

Convalescence

402

1.58

3.00

2.3

2.0

125.98

131.92

g/l

1.04

315

Gonococcal infection

249

1.75

2.98

2.2

2.1

133.77

131.25

g/l

0.28

197

Ankylosing spondylitis

103

729

1.42

2.97

2.2

132.85

133.10

g/l

0.03

569

Adenomyosis (Endometriosis of uterus)

165

1256

1.32

2.97

2.1

127.40

127.13

g/l

0.05

133

951

Personal history of other diseases and conditions

119

859

1.39

2.96

2.5

2.0

131.94

132.28

g/l

0.06

699

Mesothelioma

2.28

2.96

1.6

2.4

118.50

130.81

g/l

0.79

Amblyopia ex anopsia

373

1.60

2.94

3.0

2.4

128.39

131.51

g/l

0.56

312

Degeneration of nervous system due to alcohol

221

1.80

2.94

2.6

2.4

128.87

131.38

g/l

0.18

177

Respiratory tuberculosis, confirmed, including avohilmo

163

1.94

2.94

2.5

2.1

118.68

127.78

g/l

1.01

129

Otalgia

109

781

1.41

2.94

2.1

2.3

129.71

129.17

g/l

0.09

622

Sequelae of intentional self-harm, assault and events of undetermined intent

3.54

2.93

1.7

2.5

136.82

135.30

g/l

0.08

Malignant neoplasm of breast, ER-negative, including Hilmo

259

1955

1.25

2.93

2.1

125.08

127.80

g/l

0.94

186

1488

Mantle cell lymphoma

2.32

2.93

2.4

2.2

116.00

134.38

g/l

3.83

Benign neoplasm: Kidney

343

1.63

2.91

2.1

2.2

136.89

128.70

g/l

1.25

278

Meningitis, viral

3.31

2.91

3.0

2.3

116.57

126.45

g/l

—

Other prurigo

2.31

2.91

3.0

2.2

117.79

129.05

g/l

1.39

Seminoma of testis, including Hilmo

2.65

2.91

3.9

2.4

133.70

137.57

g/l

—

Preterm labour and delivery

262

2120

1.24

2.90

2.0

2.1

130.41

129.66

g/l

0.23

214

1604

Hypotension due to drugs

143

2.01

2.90

2.1

2.2

126.17

125.36

g/l

0.08

112

Other abnormal findings of blood chemistry

438

1.55

2.90

3.0

2.3

124.49

130.14

g/l

0.99

354

Retinal detachments and breaks

523

4512

1.16

2.89

2.6

2.3

128.90

128.75

g/l

0.05

399

3407

Dystonia

495

1.51

2.88

1.5

2.3

128.49

128.93

g/l

0.05

395

Respiratory tuberculosis, clinically confirmed

116

2.12

2.87

1.8

2.3

123.21

123.44

g/l

0.02

Other and unspecified diseases of blood and blood-forming organs

238

1.75

2.85

3.4

2.1

134.17

129.60

g/l

0.39

187

L01XX Other antineoplastic agents

603

1.46

2.85

2.5

2.2

122.88

127.76

g/l

0.88

476

Unspecified/other endometriosis

654

1.43

2.84

2.0

130.82

129.30

g/l

0.24

522

Erosion of teeth , including avohilmo

316

2614

1.21

2.84

2.6

2.2

133.11

131.83

g/l

0.42

230

2067

L02BX Other hormone antagonists and related agents

687

1.43

2.84

2.8

2.3

120.75

129.40

g/l

2.64

529

Childhood allergy (age < 16)

157

983

1.32

2.84

2.3

135.66

134.63

g/l

0.27

135

875

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

194

1.84

2.84

2.6

2.3

120.10

133.15

g/l

2.49

151

Patellar tendinitis

103

2.17

2.83

2.3

2.5

130.80

132.21

g/l

0.07

Leiomyoma of uterus

762

3768

1.14

2.83

2.1

128.17

127.57

g/l

0.29

567

2861

Dronedarone medication

231

1.76

2.83

1.5

1.9

136.17

129.84

g/l

0.70

172

Excessive attrition of teeth

811

7138

1.13

2.81

2.4

2.2

133.63

131.43

g/l

1.74

633

5499

Malignant neoplasm of tongue, including Hilmo

239

1.75

2.81

2.3

2.2

128.03

132.37

g/l

0.53

194

Lateral epicondylitis

145

1095

1.33

2.81

1.9

2.2

136.95

130.95

g/l

2.67

113

817

Hypersensitivity pneumonitis due to organic dust

131

2.03

2.79

3.0

2.2

139.25

128.08

g/l

0.95

103

Sequelae of injuries of upper limb

123

908

1.36

2.79

2.3

132.30

131.57

g/l

0.12

719

Other intracranial haemorrhages

332

1.62

2.78

2.1

2.3

130.51

127.60

g/l

0.39

260

Monoarthritis, not elsewhere classified

324

1.62

2.77

2.1

2.5

128.31

128.25

g/l

0.01

251

Anankastic personality disorder

270

1.69

2.77

1.4

2.0

134.38

133.29

g/l

0.12

221

Acne

115

836

1.38

2.76

2.7

2.1

133.72

133.83

g/l

0.02

100

706

Puerperal sepsis

138

1039

1.34

2.75

2.2

130.96

128.17

g/l

0.93

110

770

Respiratory tuberculosis, confirmed

160

1.91

2.75

2.5

2.1

117.67

128.06

g/l

1.16

127

Use of levodopa decarboxylase inhibitor

213

1699

1.26

2.74

1.9

2.4

127.93

126.59

g/l

0.37

178

1306

Panniculitis, unspecified

2.29

2.74

3.3

2.0

128.15

131.23

g/l

0.23

Algoneurodystrophy

233

1.74

2.74

1.9

2.1

133.66

130.77

g/l

0.34

189

Contact with sharp glass

294

1.65

2.74

1.8

2.1

133.90

134.05

g/l

0.02

239

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

3.98

2.73

6.3

2.2

128.11

127.75

g/l

—

Complications following abortion and ectopic and molar pregnancy

256

1.70

2.73

3.2

2.2

125.10

127.76

g/l

0.18

197

Dislocation, sprain and strain of joints and ligaments of head

302

1.64

2.73

3.5

2.3

134.34

131.45

g/l

0.35

242

Inguinal or femoral hernia, bilateral

158

1217

1.31

2.70

2.5

2.4

131.56

130.11

g/l

0.29

124

948

Injury of muscle and tendon at wrist and hand level

164

1269

1.30

2.69

2.2

2.3

131.95

132.00

g/l

0.01

136

997

Early lumbar disc prolapse, operated

659

1.42

2.69

2.0

2.1

141.91

136.84

g/l

1.46

512

Benign neoplasm: Descending colon

103

745

1.40

2.68

2.7

2.2

125.87

128.90

g/l

0.54

580

Granulomatous disorders of skin and subcutaneous tissue

220

1.75

2.68

3.1

2.3

129.41

129.54

g/l

0.01

176

Social phobias

626

1.43

2.68

1.8

2.1

136.25

134.16

g/l

0.40

519

Ulcerative colitis (strict definition, all Crohn cases excluded)

164

1271

1.30

2.66

2.6

2.3

130.50

132.64

g/l

0.57

137

1005

Lesion of femoral nerve

2.73

2.66

2.1

1.9

135.92

128.85

g/l

0.62

Benign neoplasm: Bronchus and lung

120

2.05

2.65

1.8

2.2

134.43

126.26

g/l

0.51

Melanocytic naevi, other sites/unspecified

103

746

1.39

2.65

3.5

2.3

128.80

130.87

g/l

0.42

591

Vascular dementia (undefined)

452

1.51

2.63

2.1

2.4

122.50

123.19

g/l

0.07

343

Anogenital herpesviral [herpes simplex] infection

456

1.50

2.63

2.2

2.1

130.87

132.61

g/l

0.28

368

Other keratitis

138

1047

1.33

2.62

2.7

2.3

126.91

130.37

g/l

0.66

105

819

Maternal care for known or suspected abnormality of pelvic organs

229

1241

1.25

2.62

2.3

1.9

131.83

131.73

g/l

0.03

196

965

Polycystic ovarian syndrome

384

1.55

2.62

2.7

1.9

134.06

131.93

g/l

0.49

323

Right hemicolectomy

589

1.44

2.61

2.6

2.2

119.45

127.66

g/l

1.78

469

Haemorrhage in early pregnancy

270

2156

1.22

2.60

2.1

2.0

131.76

129.67

g/l

0.93

209

1632

Mucinous and mucinous cystic tumor of rectum

2.85

2.60

2.0

112.83

129.18

g/l

1.34

Oligomenorrhoea

260

1.67

2.59

2.4

2.2

135.17

129.02

g/l

1.45

210

Ptosis of eyelid

161

1251

1.30

2.59

2.1

2.3

129.36

127.20

g/l

0.44

111

982

Other deformities of toe(s)

299

1.63

2.58

2.6

2.2

129.14

125.55

g/l

0.43

230

Scleritis and episcleritis

499

1.48

2.58

1.9

2.3

131.68

130.32

g/l

0.18

394

Malignant neoplasm of thyroid gland

557

1.45

2.58

2.6

2.3

126.16

131.24

g/l

0.94

441

Donors of organs and tissues

2.26

2.56

1.1

2.0

131.25

134.64

g/l

0.29

Fracture at wrist and hand level

448

3849

1.16

2.54

2.3

2.2

132.51

131.87

g/l

0.20

336

2993

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

129

1.98

2.53

2.2

2.6

133.95

130.93

g/l

0.23

107

Exfoliative dermatitis

2.16

2.53

2.0

2.2

132.43

129.66

g/l

0.20

Inguinal hernia, bilateral

155

1203

1.30

2.53

2.5

2.4

132.06

130.17

g/l

0.40

121

935

Unspecified urinary incontinence

119

890

1.35

2.52

2.3

2.4

126.92

126.61

g/l

0.04

701

Burns and corrosions

163

1273

1.29

2.52

2.6

2.4

133.23

132.73

g/l

0.09

138

1009

Cervicobrachial syndrome

259

2131

1.22

2.51

2.3

2.2

130.63

130.21

g/l

0.10

208

1616

Other acute viral hepatitis

2.24

2.50

2.4

1.9

120.25

131.57

g/l

1.49

Dislocation of lens

144

1.91

2.50

2.8

2.3

125.09

128.48

g/l

0.28

111

Sixth [abducent] nerve palsy

310

1.60

2.50

1.9

2.5

128.63

128.16

g/l

0.05

248

Benign leiomyoma with endometriosis

186

1479

1.26

2.49

2.5

2.2

126.28

125.92

g/l

0.06

137

1116

Abnormal findings in nipple discharge synovial fluid wound secretions

123

1.99

2.49

1.9

2.0

129.35

128.39

g/l

0.07

Herpesviral keratitis and keratoconjunctivitis

390

1.53

2.48

3.3

2.2

125.51

128.91

g/l

0.48

310

Malignant neoplasm of breast, HER-negative

237

1858

1.23

2.48

2.2

2.1

124.99

127.61

g/l

0.84

171

1415

All dysplastic lesions of the vulva

334

1.57

2.48

2.4

2.1

121.00

128.78

g/l

1.52

263

Other disorders of conjunctiva

199

1597

1.25

2.47

2.2

2.3

129.95

128.05

g/l

0.47

149

1244

Unspecified dementia

178

1263

1.27

2.47

2.1

2.4

123.68

124.17

g/l

0.11

145

975

Other noninflammatory disorders of vulva and perineum

111

824

1.36

2.47

2.1

2.2

125.87

127.36

g/l

0.24

626

Postmenopausal bleeding

339

1488

1.20

2.46

2.2

2.1

126.99

126.29

g/l

0.22

257

1115

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

672

1.40

2.46

2.4

2.2

120.40

131.30

g/l

3.93

539

Malignant neoplasm of mesothelium and soft tissue

375

1.54

2.45

2.0

2.1

120.79

131.24

g/l

1.43

305

Malignant neoplasm of small intestine, including Hilmo

288

1.62

2.45

3.4

2.1

114.65

131.85

g/l

4.25

236

Congenital malformations of aortic and mitral valves

375

1.54

2.45

2.4

2.5

130.62

133.27

g/l

0.38

297

Overexertion and strenuous or repetitive movements

120

904

1.34

2.43

1.8

2.2

133.30

131.56

g/l

0.28

717

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

6.80

2.43

2.2

3.4

146.40

132.00

g/l

—

Pedestrian injured in collision with car, pick-up truck or van

212

1.72

2.42

1.6

2.1

129.07

129.91

g/l

0.05

171

Pollen allergy

202

1603

1.25

2.42

1.9

2.2

133.57

133.98

g/l

0.10

142

1321

Other and unspecified disorders of vitreous body

590

5089

1.14

2.42

2.2

2.3

130.54

128.08

g/l

1.81

433

3811

Other superficial mycoses

160

1.84

2.41

3.5

2.4

129.62

131.99

g/l

0.18

125

Other salmonella infections

289

1.61

2.41

2.6

2.2

129.06

130.23

g/l

0.11

236

Recurrent dislocation of patella

320

1.57

2.41

2.4

2.3

132.28

132.73

g/l

0.05

261

Colon adenocarcinoma

173

1371

1.27

2.40

2.0

2.2

120.27

129.89

g/l

4.77

135

1085

Benign neoplasm: Rectum

256

2117

1.22

2.40

2.8

2.3

125.93

127.97

g/l

0.65

179

1624

Additional codes for the location of defect, injury or illness

541

1.44

2.40

1.8

2.4

131.29

129.67

g/l

0.25

440

Paralytic strabismus

701

1.38

2.39

2.1

2.3

127.55

128.89

g/l

0.19

551

Ectopic pregnancy

173

1371

1.27

2.39

2.4

2.1

129.76

129.96

g/l

0.04

126

1048

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

212

1719

1.24

2.39

2.7

2.1

131.55

133.15

g/l

0.47

159

1405

Benign neoplasm: Transverse colon

153

1196

1.29

2.38

2.0

2.4

128.30

128.65

g/l

0.05

106

929

Malignant neoplasm of brain, including Hilmo

418

1.50

2.38

2.0

2.2

131.49

132.11

g/l

0.06

339

Benign lipomatous neoplasm

385

3301

1.17

2.38

1.9

2.3

132.59

129.00

g/l

2.23

290

2505

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

140

1.90

2.36

2.8

2.1

136.19

125.07

g/l

1.97

106

Marginal zone B-cell lymphoma, including Hilmo

140

1.90

2.35

3.6

2.3

113.85

131.23

g/l

2.04

111

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

331

1.56

2.35

2.0

2.1

121.82

128.02

g/l

1.00

263

Parkinson's disease, strict definition

212

1725

1.24

2.34

2.0

2.4

127.26

126.78

g/l

0.11

180

1322

Secondary malignant neoplasm of other and unspecified sites

177

1.79

2.34

1.7

2.3

126.96

131.20

g/l

0.46

142

Hypertrophy of breast in women and men

214

1743

1.23

2.32

2.0

2.2

131.20

129.83

g/l

0.45

168

1336

Oesophageal obstruction

324

1.56

2.32

2.3

2.2

120.67

129.30

g/l

1.58

265

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

713

1.37

2.30

2.6

2.2

128.49

127.46

g/l

0.15

556

Varicella [chickenpox]

349

1.53

2.28

3.3

2.3

130.05

135.55

g/l

0.84

277

Other enthesopathy of foot (+metatarsalgia)

121

922

1.32

2.28

2.4

2.1

129.73

129.28

g/l

0.08

693

Carcinoma in situ of skin of lower limb, including hip

224

1.68

2.28

2.4

2.1

125.93

124.48

g/l

0.12

173

Other congenital malformations of circulatory system

216

1.69

2.28

3.1

2.3

131.25

130.89

g/l

0.02

170

Hyperhidrosis

208

1.70

2.28

2.6

2.2

128.41

132.04

g/l

0.45

164

Hypertension, Pulmonary Arterial

2.33

2.28

3.7

1.8

126.33

124.79

g/l

—

Benign neoplasm: Caecum

155

1222

1.28

2.27

1.9

2.3

126.59

127.67

g/l

0.19

105

941

Need for immunization against other single viral diseases

149

1.84

2.27

2.3

2.1

130.36

127.53

g/l

0.15

116

Other articular cartilage disorders

186

1.75

2.27

2.1

2.2

128.15

127.78

g/l

0.03

145

Polyp of the female genital tract

356

1714

1.18

2.26

2.1

126.82

126.95

g/l

0.04

272

1305

Hypertrophy of breast

180

1444

1.25

2.26

1.9

2.1

130.89

129.44

g/l

0.46

142

1096

Postpartum hemorraghe, all women as controls

234

1881

1.22

2.26

2.0

132.43

131.41

g/l

0.36

183

1521

Benign neoplasm of middle ear and respiratory system

103

769

1.35

2.25

2.4

2.3

130.00

128.90

g/l

0.16

598

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

549

1.42

2.23

2.2

129.59

126.76

g/l

0.51

436

Undefined dementia

182

1350

1.25

2.23

2.1

2.3

123.34

124.14

g/l

0.19

148

1053

Pregnancy, childbirth and the puerperium

401

1798

1.17

2.23

2.2

2.1

125.79

126.33

g/l

0.20

331

1428

Other and unspecified vascular occlusions

139

1084

1.29

2.23

3.0

2.3

125.71

125.93

g/l

0.04

121

841

Cerebral atherosclerosis

121

1.93

2.22

2.3

2.1

120.93

125.62

g/l

0.26

conjunctival haemorrhage

106

797

1.34

2.22

2.5

2.2

129.40

128.52

g/l

0.14

620

Specific development disorders of speech and language

481

1.43

2.21

2.4

2.5

131.95

133.27

g/l

0.19

404

Colitis due to radiation

115

1.97

2.20

2.3

2.2

127.53

126.60

g/l

0.05

Benign neoplasm: Small intestine

394

1.49

2.19

2.7

2.3

122.07

128.49

g/l

1.29

314

Ulcerative proctitis

493

1.43

2.17

2.1

2.4

133.61

131.50

g/l

0.31

395

Malignant neoplasm of thyroid gland, including Hilmo

628

1.38

2.17

2.6

2.2

126.41

130.80

g/l

0.83

494

Contact with sharp object, undetermined intent

181

1.74

2.17

2.1

2.2

132.43

133.31

g/l

0.07

144

Adenocarcinoma and papilloma adenocarcinoma of rectum

134

1044

1.29

2.17

2.5

2.2

124.41

131.05

g/l

2.16

105

831

Benign neoplasm: Rectosigmoid junction

395

1.49

2.16

2.3

123.59

128.61

g/l

0.81

318

Other and unspecified erythematous conditions

282

1.58

2.16

2.3

2.1

130.59

130.18

g/l

0.04

231

Other conjunctival vascular disorders and cysts

212

1.68

2.16

1.6

2.3

130.52

127.96

g/l

0.25

171

Hypermobility syndrome

370

1.50

2.16

2.4

2.3

133.60

131.36

g/l

0.46

308

Contusion of ankle

338

1.52

2.15

2.6

2.4

137.73

132.64

g/l

0.80

276

Abrasion of teeth

449

3927

1.15

2.15

2.0

2.2

132.84

130.08

g/l

1.59

322

2974

Other hammer toe(s) (acquired)

218

1632

1.22

2.14

2.1

126.01

127.61

g/l

0.44

148

1241

Myopia

141

1107

1.28

2.14

2.4

2.3

135.40

132.19

g/l

0.90

122

902

Dissection of aorta

283

1.57

2.13

2.0

2.1

125.30

129.95

g/l

0.42

220

Oter anti-inflammatory and antirheumatic agents, non-steroids

327

1526

1.18

2.13

2.0

2.6

128.35

126.85

g/l

0.50

256

1264

Disorders of conjunctiva

1179

8404

1.09

2.12

2.3

2.2

132.42

130.47

g/l

1.88

856

6598

Patent foramen ovale

175

1.74

2.12

3.4

2.7

133.79

131.75

g/l

0.19

142

Polycythaemia vera

308

1.55

2.11

2.0

2.1

137.43

130.16

g/l

0.76

249

Female genital prolapse

344

1633

1.17

2.10

1.9

2.1

128.07

126.69

g/l

0.55

268

1233

Listeriosis

3.00

2.10

3.9

2.1

113.78

129.14

g/l

—

Listeriosis, including avohilmo

3.00

2.10

3.9

2.1

113.78

129.14

g/l

—

Vascular dementia

154

1182

1.26

2.10

2.1

2.3

124.58

124.05

g/l

0.09

130

905

Tuberculosis of other organs, strict

214

1.66

2.09

3.6

2.0

121.61

125.01

g/l

0.37

165

Erectile dysfunction

117

902

1.31

2.08

2.7

2.5

127.02

129.17

g/l

0.34

702

Cysts of oral region, not elsewhere classified

540

1.40

2.08

2.1

2.3

131.63

130.96

g/l

0.07

432

Erythema intertrigo

230

1.63

2.07

3.3

2.2

129.04

128.41

g/l

0.07

185

Other specified/unspecified dorsopathies

285

1.56

2.07

2.5

2.2

134.35

129.70

g/l

0.81

237

Corneal scars and opacities

238

1.62

2.07

2.2

2.1

131.10

129.24

g/l

0.15

188

Other sexually transmitted chlamydial diseases, including avohilmo

748

0.68

2.05

1.6

2.1

138.73

135.01

g/l

0.97

636

Mitochondrial myopathy

3.19

2.04

1.5

1.7

151.38

121.94

g/l

—

Malignant neoplasm of pancreas, including Hilmo

118

913

1.30

2.04

2.2

114.93

130.00

g/l

8.74

721

Mixed specific developmental disorders

156

1.74

2.04

2.4

3.0

137.79

138.29

g/l

0.04

133

Metatarsalgia

112

860

1.31

2.04

2.4

2.1

130.53

129.13

g/l

0.27

651

Disorders of eyelid in diseases classified elsewhere

279

1.56

2.02

1.9

2.3

127.79

128.55

g/l

0.08

225

Retinal breaks without detachment

203

1674

1.22

2.02

2.1

2.2

131.90

128.85

g/l

0.99

138

1266

Carcinoma in situ of skin of upper limb, including shoulder

280

1.56

2.01

3.5

2.2

121.97

125.90

g/l

0.54

222

Ocular pain

100

758

1.33

2.00

2.0

2.3

130.59

129.71

g/l

0.14

605

Any event in hilmo or specialist outpatient

5.68

2.00

2.0

1.2

135.00

135.20

g/l

—

Vascular dementia (subcortical)

394

1.46

2.00

1.6

2.3

124.43

123.95

g/l

0.06

298

Granuloma annulare

119

1.88

1.99

3.8

2.1

133.53

129.54

g/l

0.18

Benign neoplasm of bone and articular cartilage

733

1.33

1.99

2.2

2.3

130.07

130.64

g/l

0.09

577

Benign neoplasm: Skin, unspecified

353

1.49

1.99

1.9

2.2

124.91

129.46

g/l

0.69

279

Haemorrhagic disorder due to circulating anticoagulants

134

1.83

1.98

3.0

2.1

124.14

126.33

g/l

0.09

101

Hordeolum and other deep inflammation of eyelid

528

1.39

1.98

2.3

130.31

129.97

g/l

0.03

427

Spontaneous abortion

493

2913

1.14

1.98

2.2

2.1

130.42

129.08

g/l

0.75

399

2247

Other congenital malformations of intestine, including avohilmo

2.02

1.98

1.7

2.3

127.00

129.56

g/l

0.17

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

2.67

1.98

1.6

1.9

—

125.74

—

Entropion and trichiasis of eyelid

127

997

1.28

1.98

2.0

2.3

127.56

126.32

g/l

0.22

785

Other and unspecified mononeuropathies of upper limb

241

1.60

1.97

1.9

2.2

125.97

129.65

g/l

0.41

193

Malignant neoplasm of oral cavity, including Hilmo

403

1.45

1.97

2.1

123.66

131.63

g/l

1.35

324

Disorders of breast

588

4627

1.12

1.97

2.2

2.1

129.56

127.96

g/l

1.06

451

3561

Benign neoplasm: Stomach

127

998

1.28

1.96

2.5

2.3

123.03

127.44

g/l

1.05

104

772

Impacted teeth

214

1523

1.21

1.96

2.1

136.09

134.14

g/l

0.81

187

1283

Ménière disease

121

945

1.29

1.96

2.3

137.60

127.46

g/l

4.01

741

Other contact dermatitis

709

1.33

1.96

2.5

2.2

131.55

129.92

g/l

0.25

561

Acquired clawhand, clubhand, clawfoot and clubfoot

2.80

1.95

2.6

1.5

136.44

130.92

g/l

—

Other and unspecified disorders of adult personality and behaviour

3.03

1.95

2.5

132.25

130.33

g/l

—

Fibroblastic disorders

309

2654

1.17

1.94

2.4

2.3

128.18

129.11

g/l

0.26

227

1999

Tuberculosis of other organs, strict, including avohilmo

219

1.62

1.93

3.6

2.0

121.61

125.48

g/l

0.44

169

Myelodysplastic syndrome

128

1.83

1.93

2.8

2.0

101.67

129.62

g/l

3.13

101

Other disorders of central nervous system

1.96

1.93

2.9

2.3

139.00

128.61

g/l

1.49

Thyrotoxicosis with toxic multinodular goitre

574

1.37

1.92

2.0

2.1

131.05

125.80

g/l

1.12

441

Lichen planus, including avohilmo

242

2040

1.19

1.92

2.3

129.77

128.15

g/l

0.50

180

1539

Pustulosis palmaris et plantaris

356

1.47

1.92

3.6

2.1

129.89

130.21

g/l

0.03

283

Carcinoma in situ of skin of ear and external auricular canal

166

1.72

1.91

2.7

2.2

129.00

125.43

g/l

0.33

131

Other superficial mycoses, including avohilmo

117

914

1.29

1.89

2.3

2.2

134.24

132.30

g/l

0.38

742

Other proliferative retinopathy

2.73

1.89

2.8

2.2

113.44

125.91

g/l

—

Other salmonella infections, including avohilmo

349

1.47

1.89

2.5

2.2

129.95

130.62

g/l

0.06

281

Peritonsillar abscess

231

1942

1.19

1.88

2.4

2.2

136.40

131.48

g/l

2.34

188

1556

Benign neoplasm of mouth and pharynx

135

1075

1.26

1.88

2.4

2.2

130.67

129.04

g/l

0.32

834

Atopic dermatitis

722

5208

1.11

1.88

2.2

132.54

132.31

g/l

0.09

497

4090

Cervicocranial syndrome

127

1004

1.27

1.87

2.0

2.2

132.49

128.22

g/l

1.23

773

Chylothorax

3.72

1.87

1.7

125.17

125.90

g/l

—

Myeloproliferative diseases (CML excluded)

101

776

1.31

1.87

2.2

129.63

127.84

g/l

0.22

607

Dentofacial anomalies [including malocclusion]

885

6334

1.09

1.87

2.2

133.19

131.45

g/l

1.35

675

4910

Traumatic amputation of wrist and hand

383

1.45

1.87

3.1

2.4

135.63

131.18

g/l

0.50

298

Other diseases of peritoneum

375

1.45

1.86

3.1

2.1

127.89

129.01

g/l

0.14

298

Noninflammatory disorders of female genital tract

479

2122

1.14

1.86

2.2

129.28

127.97

g/l

0.69

387

1675

Contact with nonpowered hand tool

367

1.46

1.85

2.0

2.5

137.35

131.98

g/l

0.67

290

Alzheimer’s disease (Early onset), excluding more controls

268

1.52

1.85

1.8

2.3

126.63

123.22

g/l

0.48

193

Pustular psoriasis

409

1.43

1.84

3.4

2.3

129.22

130.02

g/l

0.10

322

Diseases of thymus

3.20

1.84

1.4

1.8

125.57

125.61

g/l

—

Unspecified event, undetermined intent

183

1.66

1.83

2.5

134.32

132.14

g/l

0.16

147

Other specific arthropathies, wide

145

1.75

1.83

3.1

1.9

129.85

129.49

g/l

0.03

117

L02BB Anti-androgens

142

1143

1.25

1.82

2.1

2.5

117.08

128.82

g/l

6.19

115

886

Scleritis

1.95

1.82

1.6

2.0

138.18

130.05

g/l

0.51

Viral infections of central nervous system, not elsewhere classified/unspecified

2.04

1.82

2.1

2.2

129.55

129.09

g/l

0.02

Congenital malformations of cardiac chambers and connections

2.63

1.82

2.0

3.4

139.44

130.73

g/l

—

Spermatocele

762

1.31

1.82

2.3

129.37

130.66

g/l

0.17

572

Contact with machinery

140

1125

1.25

1.82

2.2

2.4

132.15

132.59

g/l

0.06

113

868

Biomechanical lesions, not elsewhere classified

461

1.40

1.81

2.3

2.2

128.67

129.14

g/l

0.04

368

Disorders of iron metabolism

116

1.84

1.80

3.4

2.1

139.31

129.61

g/l

0.72

Chronic Coagulation defects

184

1.65

1.80

3.3

2.2

136.80

130.64

g/l

0.64

152

Muscle strain

271

1.53

1.80

2.2

2.4

131.82

130.73

g/l

0.12

222

Haemangioma and lymphangioma, any site

108

842

1.29

1.80

2.0

2.3

132.41

129.75

g/l

0.45

663

Other peripheral vertigo

118

931

1.28

1.79

2.0

2.3

131.76

127.46

g/l

1.06

727

Other and unspecified paralytic syndromes

109

1.87

1.79

2.9

2.1

128.47

127.73

g/l

0.04

Benign neoplasm of meninges

132

1056

1.26

1.79

2.1

2.3

125.10

126.61

g/l

0.34

814

Varicose veins of other sites

556

1.36

1.78

2.1

2.2

126.27

131.99

g/l

1.03

437

Benign neoplasm: Ascending colon

195

1626

1.21

1.78

2.1

2.3

124.73

127.89

g/l

0.85

127

1244

Acute nasopharyngitis (common cold)

122

959

1.27

1.78

2.5

2.1

136.33

135.07

g/l

0.22

747

Other diseases of gallbladder

404

1.42

1.77

3.4

2.3

122.95

128.76

g/l

1.42

309

Benign neoplasm: Pituitary gland, craniopharyngeal duct

446

1.40

1.77

2.6

2.3

133.12

130.66

g/l

0.37

361

Alzheimer disease, including avohilmo

622

3885

1.11

1.77

2.0

2.3

126.84

125.52

g/l

0.66

511

2966

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

170

1.67

1.76

2.3

2.2

129.91

126.55

g/l

0.29

134

Chronic mastoiditis

225

1.58

1.75

2.7

2.2

119.40

127.39

g/l

1.51

175

Recurrent dislocation and subluxation of joint

489

1.38

1.75

1.9

2.3

137.19

133.38

g/l

0.57

379

Impacted maxillary molar

430

1.40

1.75

2.5

2.2

132.25

133.57

g/l

0.26

368

Pregnancy with abortive outcome

808

3841

1.10

1.74

2.2

2.1

126.97

127.88

g/l

0.52

626

3015

Triptan medication for migraine, min. 3 purchases

632

4269

1.11

1.74

2.2

133.98

131.24

g/l

2.67

496

3322

Felty syndrome

2.37

1.74

1.7

1.6

107.33

128.89

g/l

—

Disorders of speech understanding and production

365

1.44

1.73

2.1

2.4

131.15

131.96

g/l

0.08

298

Torticollis

103

1.87

1.73

1.3

2.5

134.17

129.98

g/l

0.28

Single delivery by caesarean section

165

768

1.23

1.72

2.2

2.0

130.85

131.28

g/l

0.10

141

599

Haemangioma, any site

102

795

1.29

1.72

2.1

2.3

132.41

129.86

g/l

0.40

627

Malignant neoplasm of anus and anal canal, including Hilmo

111

1.84

1.71

4.7

2.0

123.64

130.16

g/l

0.51

Varicella [chickenpox], including avohilmo

415

1.41

1.71

3.2

2.3

130.96

135.50

g/l

0.66

330

Other abnormal products of conception

293

1656

1.16

1.71

2.0

130.70

131.62

g/l

0.40

235

1328

Pregnancy examination and test

137

681

1.25

1.70

2.1

1.8

132.87

134.09

g/l

0.34

113

565

Encephalitis

251

1.53

1.70

2.7

2.0

126.40

130.08

g/l

0.38

200

Lack of expected normal physiological development

116

1.75

1.69

2.7

2.4

128.74

137.39

g/l

1.72

106

Maternal care for known or suspected malpresentation of fetus

149

863

1.23

1.68

2.3

1.8

132.15

132.61

g/l

0.11

117

679

Family history of certain disabilities and chronic diseases leading to disablement

333

1.45

1.68

2.6

2.0

134.82

133.83

g/l

0.11

268

Other and unspecified corneal deformities and disorders

268

1.51

1.67

1.6

2.2

137.60

129.26

g/l

1.57

212

Mumps

188

1.61

1.67

2.7

2.0

140.65

131.84

g/l

1.11

143

Malignant neoplasm of breast, ER-positive, including Hilmo

367

2398

1.14

1.67

2.0

2.1

125.18

128.78

g/l

2.36

271

1829

Normotensive glaucoma

127

1023

1.25

1.65

2.2

2.3

126.13

126.05

g/l

0.01

775

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

277

1.49

1.65

2.7

2.3

132.46

130.68

g/l

0.20

226

Other menopausal disorders

226

1483

0.85

1.65

2.0

2.1

129.72

127.52

g/l

0.83

164

1110

Rhabdomyosarcoma, including Hilmo

3.77

1.64

3.0

1.3

127.20

131.13

g/l

—

Burns and corrosions of external body surface, specified by site

126

1014

1.25

1.64

2.9

2.3

134.16

132.27

g/l

0.37

109

806

Moderate visual impairment, binocular

294

1.48

1.64

2.3

2.1

122.72

126.46

g/l

0.34

237

Accidental poisoning by and exposure to alcohol

135

1.73

1.64

1.7

2.4

131.70

129.63

g/l

0.15

109

Follicular cysts of skin and subcutaneous tissue

226

1925

1.18

1.64

2.2

2.3

130.38

130.04

g/l

0.07

152

1492

Other/unspecified soft tissue disorders related to use, overuse and pressure

237

1.53

1.64

1.8

2.2

132.77

132.71

g/l

0.01

196

Malignant neoplasm of breast, HER-positive

366

2398

1.14

1.63

2.0

2.1

125.26

128.78

g/l

2.27

270

1829

Postpartum haemorrhage

234

1647

1.17

1.61

2.0

2.1

132.43

131.17

g/l

0.46

183

1320

Mumps, including avohilmo

198

1.58

1.61

2.7

2.2

140.65

131.99

g/l

1.09

150

Episcleritis

429

1.39

1.61

2.1

2.3

130.62

129.69

g/l

0.11

335

Other hyperalimentation

2.79

1.60

2.7

2.2

131.14

124.50

g/l

—

Atypical facial pain

421

1.39

1.60

2.1

2.3

136.63

127.84

g/l

2.12

327

Other disorders of iris and ciliary body

255

1.51

1.59

2.9

2.2

127.27

127.92

g/l

0.06

204

Hyphaema and other vascular disorders of iris and ciliary body

175

1.62

1.59

2.8

2.2

124.74

127.22

g/l

0.19

137

Benign neoplasm: Connective and other soft tissue, unspecified

1.88

1.58

2.4

2.2

127.73

128.37

g/l

0.04

Scar conditions and fibrosis of skin

338

1.43

1.58

1.8

2.2

132.94

130.74

g/l

0.27

274

Use of other anti-dementia drugs

459

3308

1.12

1.58

2.1

2.3

127.53

124.95

g/l

1.50

388

2556

Use of memantine

459

3308

1.12

1.58

2.1

2.3

127.53

124.95

g/l

1.50

388

2556

Dislocation, sprain and strain of joints and ligaments of elbow

551

1.33

1.58

2.1

2.3

137.19

131.52

g/l

1.05

438

Hyperprolactinaemia

215

1.55

1.57

2.2

2.0

132.96

133.14

g/l

0.01

173

Macular pucker

223

1907

1.18

1.56

2.4

129.30

126.81

g/l

0.77

162

1465

Other bullous disorders

240

1.52

1.56

2.3

2.2

127.48

130.06

g/l

0.24

193

Other encephalitis

240

1.52

1.56

2.5

2.0

124.91

130.17

g/l

0.57

192

Allergic urticaria

683

1.30

1.56

2.5

2.2

129.96

130.22

g/l

0.03

548

Carcinoma in situ of colon

298

1.46

1.55

2.2

2.3

124.13

128.57

g/l

0.46

238

Injury of muscle and tendon at hip and thigh level

117

941

1.25

1.55

2.5

2.3

133.18

131.44

g/l

0.30

737

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

553

1.33

1.54

2.5

2.3

130.46

131.98

g/l

0.21

440

Other specified/unspecified deforming dorsopathies

130

1.71

1.54

1.5

1.9

122.24

130.75

g/l

0.72

111

Fenamates

197

1131

1.19

1.54

2.1

2.7

127.66

126.73

g/l

0.21

151

946

Follow-up examination after treatment for malignant neoplasms

147

1213

1.22

1.54

2.7

2.4

124.91

126.97

g/l

0.47

117

964

Aphakia

115

1.76

1.53

2.8

2.2

128.40

130.33

g/l

0.12

Malignant neoplasm of oropharynx, including Hilmo

177

1.60

1.53

2.0

2.4

111.65

134.17

g/l

3.06

142

Benign neoplasm of brain and other parts of central nervous system

580

1.32

1.53

2.3

2.4

130.51

129.36

g/l

0.16

463

Meningococcal infection

0.00

1.53

0.0

2.0

—

133.55

—

Periodontal disease, other/unspecified

233

1.52

1.53

1.8

2.3

135.07

127.88

g/l

0.74

186

Family history of other conditions

1.85

1.53

2.2

2.1

129.17

135.67

g/l

0.60

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

580

1.32

1.52

1.9

2.3

135.22

133.36

g/l

0.25

444

Ectropion of eyelid

460

1.36

1.52

2.0

2.3

120.40

125.03

g/l

0.76

364

Benign neoplasm: Cerebral meninges

118

953

1.25

1.52

2.2

2.3

125.53

126.81

g/l

0.26

735

Other lack of coordination

154

1.65

1.52

2.1

2.3

125.90

129.46

g/l

0.31

115

Other and unspecified visual disturbances

130

1061

1.23

1.52

1.9

2.3

131.57

128.40

g/l

0.72

839

Carcinoma in situ of vulva

1.99

1.51

3.6

1.6

116.25

128.48

g/l

—

Mixed conductive and sensorineural hearing loss

158

1316

1.21

1.51

2.2

2.3

128.16

127.18

g/l

0.17

119

1010

Juvenile cataract

2.52

1.50

3.8

2.1

122.44

128.83

g/l

—

Other and unspecified injuries of wrist and hand

308

1.44

1.50

2.2

2.1

130.81

131.84

g/l

0.09

252

Melanocytic naevi of trunk

146

1207

1.22

1.50

3.2

2.3

131.87

130.20

g/l

0.39

116

948

Alzheimer disease

544

3524

1.11

1.49

2.0

2.3

126.20

125.28

g/l

0.39

457

2708

Social disorders starting during childhood or adolecense, excluding more controls

2.47

1.49

3.6

2.4

120.89

130.83

g/l

—

Hypertrophic scar

410

1.37

1.49

2.1

2.2

132.11

130.62

g/l

0.22

334

Gestational diabetes (for exclusion)

328

1984

1.14

1.49

2.0

132.49

131.47

g/l

0.40

270

1590

Other and unspecified mononeuropathies, also in other diseases

243

1.50

1.48

3.1

2.2

126.39

127.91

g/l

0.12

194

Other/unspecified reactive arthropathies

566

1.32

1.48

2.4

127.47

130.83

g/l

0.64

459

Other specified disorders of muscle

235

1.50

1.48

2.0

2.2

137.63

130.88

g/l

1.22

187

Renal cell carcinoma of kidney

310

1.43

1.47

3.7

2.2

127.00

131.04

g/l

0.57

253

HSIL lesion of the vulva

140

1.67

1.46

2.8

1.9

118.00

128.32

g/l

1.08

109

Injury of nerves at lower leg level

1.91

1.46

2.5

2.1

131.86

127.45

g/l

—

Conjunctivitis

1019

7640

1.07

1.46

2.3

2.2

132.73

130.55

g/l

2.04

731

6014

Ankylosing spondylitis, ICD10

752

1.27

1.46

2.2

134.37

132.16

g/l

0.41

596

Other inflammation of eyelid

177

1495

1.19

1.46

2.2

2.3

131.05

128.37

g/l

0.78

113

1183

Postpartum hemorraghe, parous women as controls

234

1687

1.16

1.45

2.0

2.1

132.43

130.90

g/l

0.61

183

1368

Atrial septal defect

317

1.42

1.45

3.4

2.6

135.97

130.72

g/l

0.82

257

Malignant neoplasm of head and neck, including Hilmo

120

977

1.23

1.44

3.1

2.2

119.48

131.50

g/l

4.91

765

Injury of muscle and tendon at shoulder and upper arm level

483

4369

1.11

1.44

2.0

2.4

134.21

130.70

g/l

2.20

362

3312

Nontoxic goitre/thyroid nodule

371

3309

1.12

1.43

2.2

126.57

126.51

g/l

0.02

295

2491

Synovial cyst of popliteal space [Baker]

675

1.28

1.43

2.5

2.2

131.68

127.72

g/l

0.60

526

Benign neoplasm of other and unspecified female genital organs

354

1.40

1.42

2.0

2.1

132.35

127.35

g/l

0.96

277

Infectious mononucleosis, including avohilmo

613

1.29

1.42

2.8

2.0

135.36

135.39

g/l

0.00

509

Infectious mononucleosis

613

1.29

1.42

2.8

2.0

135.36

135.39

g/l

0.00

509

Pedestrian injured in collision with pedal cycle

254

1.47

1.42

1.7

2.2

134.52

131.12

g/l

0.36

207

Other bursitis of hip

181

1.57

1.41

2.1

2.0

128.33

129.77

g/l

0.11

149

Right side

2.07

1.41

1.8

2.1

127.17

127.80

g/l

0.03

Complications of labour and delivery

583

3550

0.91

1.41

2.1

2.2

128.27

128.91

g/l

0.29

453

2698

Other and unspecified disorders of autonomic nervous system

2.48

1.41

2.0

2.8

140.00

126.20

g/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

281

2467

1.14

1.40

2.4

2.3

129.07

128.56

g/l

0.13

207

1852

Convergent concomitant strabismus

432

1.35

1.40

2.1

2.2

131.74

132.81

g/l

0.10

348

Divergent concomitant strabismus

633

1.29

1.39

2.3

131.69

130.96

g/l

0.10

505

Other disorders of Eustachian tube

255

1.46

1.39

2.4

2.2

132.88

129.04

g/l

0.48

211

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

642

1.28

1.39

2.1

2.2

131.12

131.68

g/l

0.07

519

Other conditions related to polyarteritis nodosa

2.72

1.39

1.8

2.3

134.67

131.17

g/l

—

Toxic effect of alcohol

166

1.58

1.38

2.3

2.2

129.60

130.83

g/l

0.08

138

Early lumbar disc prolapse operation

749

1.26

1.38

2.0

2.2

142.20

136.53

g/l

1.78

588

Lichen sclerosus et atrophicus

134

1110

1.21

1.38

2.6

2.2

131.90

127.20

g/l

1.64

105

854

Benign neoplasm: Skin of scalp and neck

223

1.50

1.37

2.5

2.2

128.46

129.00

g/l

0.04

183

Crohn disease (strict definition, require KELA, min 2 HDR)

503

1.32

1.37

2.7

2.3

131.89

131.72

g/l

0.02

401

Stenosis and insufficiency of lacrimal passages

116

948

1.23

1.37

2.2

2.3

126.72

127.13

g/l

0.06

759

Other disorders of amniotic fluid and membranes

106

827

1.24

1.37

2.5

1.9

132.39

131.59

g/l

0.19

653

Endometriosis of pelvic peritoneum

159

1216

1.19

1.36

2.2

2.1

130.93

128.82

g/l

0.63

125

927

Communicating hydrocephalus

196

0.50

1.36

1.6

2.2

133.60

127.59

g/l

—

154

Congenital hypothyroidism without goiter

2.19

1.36

1.6

2.0

133.90

126.75

g/l

—

Disorders of synovium and tendon in diseases classified elsewhere

175

1.56

1.36

2.7

2.4

139.10

132.86

g/l

0.69

148

Acute alcohol intoxication ICD-9

290

1.43

1.35

2.3

2.2

127.00

131.45

g/l

0.42

232

Osteitis due to dental implant

1.95

1.35

5.4

2.2

133.88

126.53

g/l

—

Malignant melanoma, including Hilmo

220

1905

1.16

1.35

2.2

128.06

131.10

g/l

1.02

173

1477

Malignant neoplasm of other and unspecified parts of tongue

128

1.67

1.35

2.1

2.2

122.75

131.90

g/l

0.91

103

Inhalation and ingestion of other objects causing obstruction of respiratory tract

2.09

1.35

1.7

2.4

137.00

127.00

g/l

—

Mantle cell lymphoma, including Hilmo

136

1.64

1.34

2.4

115.45

133.39

g/l

4.55

112

Diseases of tongue

575

1.29

1.34

2.1

130.93

126.71

g/l

0.76

462

Medical abortion

754

3768

1.08

1.34

2.2

2.1

127.69

127.78

g/l

0.03

560

2949

Crohn disease (strict definition, require KELA)

514

1.31

1.33

2.6

2.3

131.83

131.79

g/l

0.00

410

Localized scleroderma [morphea]

113

1.71

1.33

3.1

2.0

119.82

128.35

g/l

1.14

Golimumab

241

1.46

1.33

2.7

2.3

133.96

132.04

g/l

0.16

194

Acne, including avohilmo

226

1585

1.16

1.33

2.5

2.2

132.85

132.94

g/l

0.02

193

1338

Other predominantly sexually transmitted diseases, not elsewhere classified

164

1390

1.18

1.32

2.6

2.1

130.21

132.89

g/l

0.83

117

1128

Triptan medication for migraine, single purchase ok

928

5858

1.07

1.32

2.1

2.2

133.93

131.68

g/l

2.35

718

4530

Migraine, single triptan purchase ok & required. ICD-code if available is included

928

5858

1.07

1.32

2.1

2.2

133.93

131.68

g/l

2.35

718

4530

Plantar fascial fibromatosis

105

853

1.24

1.32

1.9

2.2

132.80

129.52

g/l

0.72

646

Maternal care for known or suspected fetal abnormality and damage

123

858

1.22

1.31

2.4

1.9

129.97

131.88

g/l

0.58

678

Mandibular retrognathia

523

1.30

1.31

2.4

2.3

129.08

133.28

g/l

0.92

434

Effects of other external causes

201

1.50

1.30

2.7

2.3

135.59

134.60

g/l

0.07

156

Other inflammation of eyelid, including avohilmo

551

5045

1.09

1.30

2.2

132.79

130.60

g/l

1.18

374

3977

Malignant neoplasm of oral cavity

318

1.40

1.30

1.9

2.2

119.85

131.87

g/l

2.16

255

Benign neoplasm: Duodenum

243

1.46

1.29

2.5

2.3

124.35

127.79

g/l

0.38

194

Hypertrophic disorders of skin

447

1.33

1.29

2.1

2.3

131.77

130.57

g/l

0.18

364

Other acute skin changes due to ultraviolet radiation

310

1.40

1.29

2.2

2.1

124.39

129.07

g/l

0.62

246

Foreign body or object entering through skin

553

1.29

1.28

2.5

2.2

132.85

132.31

g/l

0.06

437

Benign neoplasm: Skin of lip

107

1.71

1.27

1.7

2.4

129.42

128.22

g/l

0.12

Malignant neoplasm of cervix uteri, including Hilmo

178

1.53

1.27

2.3

1.9

130.10

129.15

g/l

0.07

149

Papillary adenocarcinoma of thyroid gland

414

1.34

1.27

2.7

2.2

129.68

131.10

g/l

0.14

330

Carcinoma in situ of cervix uteri

732

1.25

1.26

2.4

2.0

132.92

131.13

g/l

0.35

603

Polymyositis

1.90

1.26

3.2

2.2

114.88

129.91

g/l

—

Female infertility, associated with anovulation

475

1.31

1.26

3.0

2.1

130.86

131.53

g/l

0.10

392

Beningn neoplasm: Meninges, unspecified

131

1.63

1.25

1.4

2.2

120.15

127.14

g/l

0.53

100

Other obstructed labour

555

1.29

1.25

2.2

2.0

127.89

129.51

g/l

0.34

444

Encephalopathy

1.80

1.25

5.6

2.3

127.13

129.40

g/l

0.09

Benign neoplasm: Conjunctiva

287

1.41

1.24

2.7

2.2

130.31

128.73

g/l

0.15

230

Other epidermal thickening

433

1.33

1.24

2.7

2.3

130.31

128.67

g/l

0.16

351

Thyroiditis

591

1.28

1.24

2.1

2.3

131.02

128.32

g/l

0.58

475

Benign neoplasm of eye and adnexa

131

1097

1.20

1.24

2.4

2.3

127.03

127.72

g/l

0.12

851

Motorcycle rider injured in other and unspecified transport accidents

468

1.31

1.24

2.0

2.3

132.57

135.33

g/l

0.40

379

Disorders of optic nerve, not elsewhere classified

188

1.51

1.23

2.3

2.1

129.63

128.30

g/l

0.08

146

Left hemicolectomy

221

1.47

1.23

2.4

119.45

127.66

g/l

0.86

172

Inguinal hernia, unilateral

246

1.44

1.22

2.0

2.2

131.96

127.22

g/l

0.58

201

Femoral hernia, unilateral

246

1.44

1.22

2.0

2.2

131.96

127.22

g/l

0.58

201

Inguinal of femoral hernia, unilateral

246

1.44

1.22

2.0

2.2

131.96

127.22

g/l

0.58

201

Other benign neoplasms of skin

500

4577

1.09

1.22

2.4

2.3

127.25

128.32

g/l

0.44

371

3477

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

496

1.30

1.21

2.1

2.2

121.43

132.26

g/l

2.59

398

Carcinoma in situ of other and unspecified genital organs

164

1.54

1.21

2.9

1.9

122.47

127.93

g/l

0.47

129

Benign neoplasm: Oesophagus

101

1.71

1.21

2.9

2.2

111.17

127.77

g/l

1.88

Giant cell arteritis

409

1.33

1.21

2.4

2.2

130.34

126.43

g/l

0.78

322

Endometriosis ASRM stages 1,2

165

1412

1.17

1.21

2.2

2.0

130.66

129.49

g/l

0.31

130

1108

Dislocation, sprain and strain of joints and ligaments of knee

759

6383

1.08

1.21

2.1

2.2

134.41

132.61

g/l

1.27

584

4949

Medial epicondylitis

297

1.39

1.21

2.3

2.2

134.32

131.85

g/l

0.23

236

Marginal zone B-cell lymphoma

1.78

1.21

4.2

2.2

119.13

132.44

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

612

1.27

1.20

2.2

2.4

126.16

129.74

g/l

0.59

483

HSIL lesion of the cervix uteri, vagina or vulva

177

1524

1.16

1.20

2.5

2.0

129.83

130.03

g/l

0.04

129

1221

Disorders of aromatic amino-acid metabolism

2.38

1.20

5.0

1.8

131.00

128.00

g/l

—

Contact with heat and hot substances

453

1.31

1.20

3.6

2.4

125.32

131.25

g/l

1.18

358

Malignant neoplasm, without specification of site, including Hilmo

488

1.30

1.20

2.1

2.3

121.12

129.99

g/l

2.18

391

Intentional self-harm by jumping from a high place

2.15

1.19

2.1

2.2

135.62

127.45

g/l

—

Benign neoplasm: Tongue

256

1.42

1.19

2.5

2.3

133.42

129.66

g/l

0.39

207

Malignant neoplasm of oropharynx

141

1.58

1.18

2.0

2.3

110.47

135.49

g/l

2.57

112

Follow-up care involving plastic surgery

274

0.62

1.18

1.6

1.9

121.00

131.17

g/l

—

206

Endometriosis of rectovaginal septum and vagina

640

1.26

1.18

1.9

2.3

128.98

126.42

g/l

0.51

487

Achilles tendinitis

117

975

1.20

1.17

2.0

2.1

132.24

130.75

g/l

0.27

742

Congenital malformations of eye, ear, face and neck

525

1.28

1.17

2.2

2.4

130.19

132.04

g/l

0.27

430

Prolonged pregnancy

123

877

1.20

1.17

2.8

1.9

129.92

131.75

g/l

0.59

102

696

Eustachian salpingitis and obstruction

579

1.27

1.16

2.7

2.1

133.93

134.01

g/l

0.01

463

Thyroiditis, unspecified

118

1.63

1.16

2.2

2.1

134.71

129.07

g/l

0.73

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

360

1.34

1.16

1.9

2.3

130.31

129.67

g/l

0.07

294

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

742

1.23

1.14

1.9

2.3

134.48

129.00

g/l

1.07

577

Ulcer of vagina/vulva

216

1.45

1.14

2.9

2.0

125.80

127.57

g/l

0.16

182

Benign neoplasm: Bladder

1.78

1.14

2.3

2.4

121.22

124.66

g/l

—

Other specified/unspecified disorders of bone/cartilage

233

1.43

1.14

3.5

2.3

130.22

132.04

g/l

0.19

193

Benign neoplasm: Cranial nerves

250

1.41

1.14

2.0

2.2

130.44

128.45

g/l

0.16

200

Open bite

422

1.31

1.13

2.3

2.5

136.40

133.81

g/l

0.38

362

Factitial dermatitis

2.04

1.13

2.3

2.0

131.00

127.42

g/l

—

Retinal haemorrhage

242

1.42

1.13

3.0

2.2

127.63

125.84

g/l

0.13

188

All dysplastic lesions of the cervix uteri, vagina or vulva

269

2336

1.13

2.2

2.0

128.95

130.64

g/l

0.60

195

1832

Tuberculosis of other organs

192

1.47

1.13

4.2

2.0

123.09

125.20

g/l

0.20

150

Melanocytic naevi of eyelid, including canthus

1.81

1.12

2.5

1.8

119.25

126.25

g/l

—

Ankylosing spondylitis, strict definition

293

1.37

1.12

2.5

2.1

138.68

135.21

g/l

0.40

225

Other specified/unspecified disorders of tympanic membrane

2.32

1.12

1.3

2.1

134.43

129.21

g/l

—

Malignant neoplasm of oesophagus, including Hilmo

345

1.34

1.12

2.5

2.2

120.51

132.60

g/l

2.04

278

Graves disease, strict definition

102

844

1.21

1.11

2.0

2.3

132.73

129.71

g/l

0.72

674

Bacterial meningitis

285

1.38

1.11

2.3

135.07

129.42

g/l

0.56

229

Other and unspecified acute skin changes due to ultraviolet radiation

226

1.43

1.11

2.2

2.1

122.25

127.91

g/l

0.57

176

Multiple gestation

574

1.26

1.11

2.3

1.9

132.51

131.41

g/l

0.21

443

Dermatopolymyositis (FG)

104

1.66

1.10

3.7

1.9

121.56

129.68

g/l

—

Benign lipomatous neoplasm of other sites/unspecified

104

864

1.21

1.10

1.8

2.3

133.04

127.73

g/l

1.74

677

Malignant neoplasm, without specification of site

329

1.35

1.09

2.1

2.4

120.47

130.17

g/l

1.73

265

Other and unspecified rosacea

101

837

1.21

1.09

2.0

2.3

128.11

129.13

g/l

0.15

664

Residual foreign body in soft tissue

416

1.31

1.09

2.5

2.4

127.39

132.87

g/l

0.96

325

Anogenital herpesviral [herpes simplex] infection, including avohilmo

108

902

1.20

1.08

2.0

2.1

135.97

131.82

g/l

1.31

736

Melanoma in situ

462

1.29

1.07

2.2

2.3

128.19

128.36

g/l

0.02

368

Twin gestation

559

1.26

1.07

2.1

1.9

133.32

131.42

g/l

0.42

430

Malignant neoplasm of oesophagus

262

1.39

1.06

2.6

2.3

118.97

132.40

g/l

2.24

212

Burns and corrosions of multiple and unspecified body regions

178

1.47

1.06

1.9

2.4

138.16

132.11

g/l

0.57

144

Corns and callosities

641

1.24

1.06

2.3

2.2

130.62

129.41

g/l

0.17

503

Toxic effect of ethanol

305

1.35

1.06

2.5

2.4

131.50

132.44

g/l

0.08

244

Malignant melanoma

191

1675

1.14

1.05

2.2

128.23

131.00

g/l

0.79

150

1303

Abnormal serum enzyme levels

436

3859

1.09

1.05

2.3

2.4

125.68

131.17

g/l

4.42

331

2964

Benign neoplasm of breast

129

1099

1.18

1.04

2.0

2.2

127.96

126.70

g/l

0.26

848

Adrenomedullary hyperfunction

2.33

1.04

4.2

2.0

118.80

135.00

g/l

—

Malignant neoplasm of tongue

179

1.47

1.04

2.2

2.3

122.70

132.13

g/l

1.18

143

Malignant neoplasm of adrenal gland

2.10

1.04

2.1

2.3

127.00

132.40

g/l

—

Postpartum haemorrhage due to retained placenta

107

897

1.20

1.04

2.0

134.74

131.07

g/l

1.39

727

Other retinal artery occlusion

221

1.42

1.04

2.1

2.3

126.95

127.35

g/l

0.02

177

Viral agents as the cause of diseases classified to other chapters, including avohilmo

221

1.42

1.03

2.4

2.1

130.70

129.45

g/l

0.08

180

Hyperkinetic disorders (excl. ADHD)

128

1.55

1.03

2.8

3.0

145.80

136.72

g/l

1.82

112

Hydrocephalus

798

1.21

1.03

2.5

2.3

135.87

126.79

g/l

3.26

628

Endometriosis ASRM stages 3,4

231

2054

1.13

1.03

1.9

2.1

128.17

127.78

g/l

0.09

173

1568

Benign neoplasm: Sigmoid colon

246

2197

1.12

1.02

2.4

2.3

126.75

128.03

g/l

0.29

155

1682

Cleft lip, lip and palate or palate

106

0.47

1.02

2.6

2.2

127.60

132.97

g/l

—

Benign neoplasm: Anus and anal canal

256

1.38

1.01

3.9

2.2

123.21

127.81

g/l

0.52

204

Erythema nodosum

239

1.39

1.01

2.7

2.1

118.09

129.48

g/l

0.84

197

Dysplasia of cervi uteri

234

1462

1.13

1.01

2.1

128.55

128.93

g/l

0.08

177

1137

Other disorders of pigmentation

413

1.29

1.01

3.3

2.2

127.82

128.56

g/l

0.09

332

Diseases of external ear

467

4308

1.09

1.00

2.4

2.3

130.24

129.54

g/l

0.25

361

3307

Antepartum haemorrhage, not elsewhere classified

520

1.25

0.99

1.7

1.9

127.49

131.47

g/l

0.93

415

Other and unspecified postprocedural disorders of eye and adnexa

0.00

0.99

0.0

2.0

—

124.50

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

148

1.50

0.99

2.8

2.1

127.33

131.32

g/l

0.40

120

Female infertility, uterine origin

0.00

0.98

0.0

1.9

—

133.16

—

Open wound of hip and thigh

266

1.36

0.98

1.8

2.3

137.43

132.09

g/l

0.65

209

Disturbances of smell and taste

353

1.31

0.98

2.0

2.3

130.85

129.37

g/l

0.17

279

Birth trauma

1.89

0.98

3.6

2.6

133.60

131.69

g/l

—

Other inflammation of vagina/vulva

249

1.37

0.98

1.9

2.2

135.00

128.63

g/l

1.37

208

Helminthiases

132

1.53

0.98

2.3

129.57

127.79

g/l

0.13

105

Colon adenocarcinoma, helper endpoint

173

1517

1.14

0.98

2.0

2.3

120.27

127.01

g/l

2.66

135

1178

Vestibular neuronitis

102

858

1.19

0.97

2.0

2.4

129.57

128.74

g/l

0.13

671

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

0.97

0.0

2.4

—

126.22

—

Embedded and impacted teeth

277

2024

1.11

0.97

2.3

2.2

134.43

134.20

g/l

0.06

231

1697

Malignant neoplasm of other connective and soft tissue, including Hilmo

380

1.30

0.97

2.3

2.1

121.66

131.06

g/l

1.27

310

Malignant melanoma of skin, including Hilmo

175

1536

1.14

0.97

2.1

2.2

128.28

131.09

g/l

0.79

137

1202

Congenital varicose veins

0.00

0.97

0.0

2.1

—

129.00

—

Pervasive developmental disorders excl. Autism + Asperger

1.64

0.97

1.8

3.3

141.67

138.88

g/l

0.24

Embolic stroke with flimmer

224

1.39

0.97

2.5

2.4

126.64

126.68

g/l

0.00

177

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.96

0.0

2.3

—

125.21

—

Bicuspidal aortic valve syndrome

328

1.32

0.96

2.0

2.4

129.76

132.54

g/l

0.32

259

Exposure to controlled fire, not in building or structure

2.29

0.95

4.5

1.6

140.00

130.42

g/l

—

Burn and corrosion of wrist and hand

294

1.33

0.95

2.3

139.94

132.60

g/l

0.82

234

N06DA Anticholinesterases

560

4020

1.08

0.94

2.1

2.3

128.03

125.51

g/l

1.79

452

3092

Use of anticholinesterases

560

4020

1.08

0.94

2.1

2.3

128.03

125.51

g/l

1.79

452

3092

Other and unspecified acne

1.63

0.94

2.6

2.2

130.07

133.07

g/l

0.28

Other osteochondropathies

597

1.23

0.94

2.9

2.2

129.56

132.31

g/l

0.48

474

Generalized epilepsy, mode (most common among epilepsy diagnosis)

217

1.39

0.94

2.1

2.5

128.44

131.95

g/l

0.43

184

Use of donepezil

321

2789

1.10

0.93

2.1

2.3

128.46

124.72

g/l

2.24

252

2180

Epiphora

209

1.40

0.93

2.9

2.2

118.13

128.69

g/l

1.15

172

Vascular syndromes of brain in cerebrovascular disorders

454

1.26

0.93

1.9

2.3

128.00

126.58

g/l

0.15

356

Sequelae of injuries of lower limb

835

1.19

0.93

2.3

130.76

131.09

g/l

0.04

657

Other specified and unspecified disorders of conjunctiva

1.65

0.92

2.0

2.1

128.67

130.75

g/l

—

Other lesions of median nerve

244

1.36

0.91

2.1

2.2

128.27

125.22

g/l

0.28

193

Endometriosis of ovary

171

1417

1.14

0.91

1.9

2.1

127.74

127.84

g/l

0.02

129

1075

Helminthiases, including avohilmo

322

1.31

0.91

1.7

2.3

136.67

130.42

g/l

0.96

262

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

102

1.58

0.91

2.1

129.55

129.41

g/l

0.01

Malignant neoplasm of other and unspecified parts of biliary tract

143

1.49

0.91

3.2

2.2

121.69

131.80

g/l

1.28

114

Family history of malignant neoplasm

103

874

1.18

0.90

1.7

2.0

130.82

130.30

g/l

0.10

668

Anoxic brain damage

127

1.51

0.89

2.6

2.3

125.14

129.20

g/l

0.33

Postinfectious hypothyroidism

1.94

0.89

3.7

1.5

136.50

125.87

g/l

—

Ulcerative enterocolitis

245

1.36

0.89

2.3

132.00

131.47

g/l

0.05

201

Memory loss

1034

0.84

0.89

2.1

2.3

124.45

126.66

g/l

0.21

795

Female infertility, cervical, vaginal, other or unspecified origin

209

1497

0.89

2.2

2.1

128.58

129.21

g/l

0.18

162

1148

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

105

895

1.18

0.89

2.3

127.94

128.59

g/l

0.09

699

Convergence insufficiency and excess

1.60

0.88

2.3

2.2

136.67

131.52

g/l

0.59

Adenocarcinoma and ductal carcinoma of pancreas

351

1.29

0.88

2.4

2.1

110.25

131.33

g/l

6.64

284

Oral lichen planus and hypothyroidism or thyroxine medication

161

1.44

0.87

2.1

1.9

127.13

127.62

g/l

0.03

128

Primary angle-closure glaucoma

441

1.26

0.86

1.5

2.3

129.67

127.04

g/l

0.31

344

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

531

1.23

0.86

2.7

2.2

118.73

132.07

g/l

4.52

427

Obstructed labour due to maternal pelvic abnormality

105

1225

0.85

0.86

1.8

2.2

129.62

128.53

g/l

0.18

924

Congenital ptosis

1.98

0.85

1.8

3.5

135.83

132.44

g/l

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

1.98

0.85

6.3

3.0

105.17

130.71

g/l

—

Arteriovenous malformation of cerebral vessels

1.61

0.85

1.2

2.1

133.86

128.38

g/l

—

Idiopathic hypercalciuria

1.81

0.85

2.3

1.9

144.25

130.00

g/l

—

HSIL lesion of the cervix uteri

153

1346

1.14

0.85

2.5

2.0

131.10

130.41

g/l

0.14

115

1088

Temporal arteritis

362

1.28

0.85

2.3

129.30

125.43

g/l

0.69

288

Foreign body entering into or through eye or natural orifice

724

1.19

0.85

2.0

2.3

136.03

132.68

g/l

0.53

574

Malignant neoplasm of head and neck

816

1.18

0.84

2.6

2.2

117.79

131.43

g/l

4.90

638

Glaucoma, exfoliation

151

1329

1.14

0.84

2.1

2.3

125.73

125.05

g/l

0.14

125

1016

Complications of other internal prosthetic devices, implants and grafts

380

1.27

0.84

2.7

2.2

127.32

128.88

g/l

0.13

300

Disorders of acoustic nerve

222

1.36

0.84

1.8

2.0

130.86

129.48

g/l

0.09

170

Contact with other hot fluids

248

1.34

0.84

3.3

2.5

127.11

131.75

g/l

0.80

202

Presbyopia

688

1.20

0.84

2.9

2.3

135.00

131.69

g/l

0.57

535

Other disorders of thyroid

121

1.50

0.83

1.8

2.1

121.42

126.82

g/l

0.42

Anuria and oliguria

1.72

0.83

6.8

2.2

122.91

122.86

g/l

0.00

Cardiomyopathy in other diseases

1.77

0.83

5.3

1.8

119.13

130.28

g/l

—

Benign neoplasm: Pharynx, unspecified

1.72

0.83

2.1

2.2

127.60

126.71

g/l

—

L02BA Anti-estrogens

137

1562

0.87

0.83

1.8

2.2

125.41

126.51

g/l

0.22

1174

Narcolepsy and cataplexy

1.76

0.83

3.0

2.5

134.50

127.87

g/l

—

Other and unspecified disease of Bartholin gland

214

1.37

0.83

2.2

2.1

124.65

127.32

g/l

0.21

171

Myotonic dystrophy (Steinert)

1.92

0.83

3.8

2.0

130.67

132.29

g/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

197

1.38

0.83

1.9

2.3

138.85

128.45

g/l

1.76

162

Chorioretinal scars

1.91

0.83

3.3

2.1

118.83

120.16

g/l

—

Hereditary sideroblastic anaemia

1.91

0.83

1.7

2.1

110.00

123.10

g/l

—

Other sideroblastic anaemias

1.91

0.83

2.5

2.2

124.00

124.39

g/l

—

Xanthelasma of eyelid

1.67

0.82

1.6

1.8

133.17

127.69

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

148

1303

1.14

0.82

1.8

2.2

134.44

129.65

g/l

1.74

117

1007

Bicipital tendinitis

408

1.26

0.82

1.7

2.4

131.08

130.95

g/l

0.01

316

Ganglion

218

1964

1.11

0.82

2.4

2.2

134.50

130.65

g/l

1.59

164

1490

Other chondrocalcinosis

130

1.48

0.82

3.4

2.2

129.26

125.44

g/l

0.32

102

Other and unspecified mononeuropathies of lower limb

232

1.35

0.82

3.2

2.2

126.65

127.74

g/l

0.05

189

Atopic conjunctivitis

373

1.27

0.81

1.9

2.3

134.76

131.57

g/l

0.50

305

Polycystic ovarian syndrome, broad definition

773

1.18

0.81

2.7

2.1

131.70

131.96

g/l

0.04

645

Malignant neoplasm of liver and intrahepatic bile ducts

320

1.29

0.81

2.5

2.2

116.29

132.17

g/l

3.91

254

Foreign body in respiratory tract

445

1.24

0.81

1.8

2.2

130.91

131.28

g/l

0.03

357

Tooth agenesis EXCLUDE clefts and syndromes

293

1.30

0.81

2.2

2.6

134.42

133.93

g/l

0.06

254

Nasal polyp

229

2072

1.11

0.81

2.4

2.3

132.56

129.72

g/l

1.01

170

1636

Malignant neoplasm of brain

285

1.31

0.80

1.7

2.3

137.10

133.16

g/l

0.45

233

Cicatricial pemphigoid

0.00

0.80

0.0

1.8

—

122.18

—

Benign neoplasm: Long bones of lower limb

250

1.33

0.80

2.5

2.3

132.93

130.77

g/l

0.19

204

Other benign neoplasms of connective and other soft tissue

108

932

1.16

0.80

2.0

2.3

132.85

129.24

g/l

0.99

728

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.80

0.0

2.0

—

124.06

—

Other specified and unspecified disorders of eye and adnexa

317

0.72

0.80

1.6

2.0

119.00

129.22

g/l

1.25

251

Injury of blood vessels of thorax

1.85

0.80

3.7

2.1

125.00

121.08

g/l

—

Malignant neoplasm of pancreas

729

1.18

0.80

2.4

2.2

114.06

130.85

g/l

7.70

579

Radial styloid tenosynovitis [de Quervain]

419

1.25

0.79

2.7

2.0

130.26

131.14

g/l

0.12

335

Infections of breast associated with childbirth

233

1.34

0.79

2.8

2.0

131.48

132.39

g/l

0.10

190

Small cell lung cancer, helper endpoint

242

1.33

0.79

2.4

2.2

116.82

127.75

g/l

0.66

188

Maxillary hypoplasia

0.00

0.79

0.0

3.0

—

135.24

—

Abscess of mediastinum

0.00

0.79

0.0

2.6

—

124.45

—

Deep endometriosis

813

1.17

0.79

1.8

2.2

129.55

126.71

g/l

0.68

645

Other and unspecified nail disorders

199

1.37

0.79

1.9

2.4

126.90

130.59

g/l

0.42

163

977

0.85

0.79

2.4

121.05

129.73

g/l

2.05

755

Chronic drug-induced interstitial lung disorders

2.29

0.78

1.2

2.1

—

123.31

—

Other specified and unspecified retinal disorders

331

1.28

0.78

2.6

2.2

129.70

127.25

g/l

0.25

262

Giant cell arteritis with polymyalgia rheumatica

367

1.26

0.78

2.3

129.30

125.36

g/l

0.71

289

Viral agents as the cause of diseases classified to other chapters

191

1.37

0.77

2.7

2.2

128.86

129.08

g/l

0.01

154

Benign neoplasm: Short bones of upper limb

115

1.49

0.77

1.6

2.3

129.91

131.29

g/l

0.08

Idiopathic hypoparathyroidism

1.81

0.77

2.5

2.2

117.50

122.69

g/l

—

Essential (haemorrhagic) thrombocythaemia

332

1.27

0.76

2.3

2.1

130.51

131.54

g/l

0.09

268

Cytomegaloviral pneumonitis

2.17

0.76

9.0

2.2

112.20

127.79

g/l

—

Other obstetric trauma

348

0.74

0.76

1.3

2.0

120.40

132.58

g/l

1.99

286

Disorders of orbit

377

1.25

0.76

2.3

2.1

135.45

128.57

g/l

1.06

311

Social disorders starting during childhood or adolescence

1.72

0.76

3.6

2.2

120.89

135.23

g/l

—

Other congenital malformations of face and neck

218

1.34

0.75

2.2

126.52

131.59

g/l

0.49

177

Drug-induced dystonia

2.13

0.75

2.6

2.2

127.00

132.94

g/l

—

Benign neoplasm: Pancreas

271

1.30

0.75

3.0

2.2

129.61

127.58

g/l

0.17

217

Vasomotor rhinitis (mode)

642

1.19

0.75

2.8

2.3

137.17

129.32

g/l

2.14

510

Central retinal artery occlusion

210

1.34

0.74

2.5

2.3

125.35

126.62

g/l

0.08

163

Moderate mental retardation

1.66

0.74

1.6

2.9

128.33

132.24

g/l

—

LSIL lesion of the vulva

219

1.33

0.74

2.0

1.8

121.04

130.64

g/l

1.50

172

Otorrhoea

2.05

0.73

7.2

2.6

128.20

135.63

g/l

—

Exposure to uncontrolled fire in building or structure

1.63

0.73

1.6

2.7

128.56

132.33

g/l

—

Autoimmune thyroiditis

142

1.42

0.73

2.1

2.0

126.33

129.92

g/l

0.26

111

Other specified/unspecified hearing loss

109

951

1.15

0.72

1.9

2.2

132.18

127.44

g/l

1.15

725

Malignant neoplasm of rectosigmoid junction, including Hilmo

264

1.30

0.72

2.9

2.2

116.75

131.57

g/l

1.97

216

Sacroiliitis, not elsewhere classified

335

1.26

0.72

1.8

2.1

132.52

132.88

g/l

0.04

278

Erythema multiforme

194

1.35

0.72

2.8

2.2

126.00

128.75

g/l

0.22

156

Other otitis externa (chronic)

599

1.19

0.72

2.7

2.3

132.11

130.34

g/l

0.24

479

Other, unspecified and serous retinal detachments

291

1.28

0.71

3.1

2.2

124.41

127.65

g/l

0.34

232

Male infertility

291

1.28

0.71

4.5

2.0

127.03

142.44

g/l

2.47

226

Glaucoma-related operations

628

1.18

0.70

1.8

2.3

127.24

126.05

g/l

0.15

492

Retinal detachment with retinal break

158

1415

1.12

0.70

2.7

2.3

130.27

128.28

g/l

0.51

124

1084

Unspecified lump in breast

162

1454

1.12

0.69

2.2

2.3

129.63

126.67

g/l

1.02

123

1096

Other disorders of breast

107

1221

0.87

0.69

1.8

2.1

130.76

127.97

g/l

0.63

926

Allergic purpura

239

1.30

0.69

2.5

2.4

131.83

129.94

g/l

0.19

195

Chronic suppurative otitis media, including avohilmo

731

1.17

0.69

2.2

2.3

129.68

130.48

g/l

0.11

594

Other disorders of prostate

319

0.75

0.69

2.9

2.3

135.37

129.38

g/l

0.90

242

Unspecified organic or symptomatic mental disorder

1.88

0.69

7.2

3.1

119.80

129.85

g/l

—

Optic atrophy, wide definition

144

1.40

0.68

2.4

2.1

131.42

130.34

g/l

0.08

115

Benign neoplasm: Skin of lower limb, including hip

240

1.30

0.68

2.8

2.2

125.52

128.24

g/l

0.26

197

Use of rasagiline

258

1.29

0.68

1.4

2.3

123.93

127.81

g/l

0.36

207

Exclusion endpoint for supernumerary teeth

0.54

0.67

3.2

2.5

139.60

134.11

g/l

—

Precocious central puberty

1.65

0.67

5.3

1.9

133.14

134.94

g/l

—

Acute appendicitis, with complications

227

2078

1.09

0.67

2.9

2.3

130.29

130.09

g/l

0.04

179

1594

Presence of other devices

267

2847

0.92

0.67

1.9

2.2

129.67

127.65

g/l

0.73

187

2151

Sequelae of inflammatory diseases of the central nervous system

1.82

0.67

6.2

2.7

127.60

124.82

g/l

—

Small cell lung cancer, including Hilmo

250

1.29

0.66

2.4

2.3

116.82

131.50

g/l

0.99

202

Small cell lung cancer

250

1.29

0.66

2.4

2.3

116.82

131.50

g/l

0.99

202

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

146

1.38

0.64

2.4

2.2

123.07

130.17

g/l

0.67

117

Congenital deformities of feet, including avohilmo

287

1.26

0.64

3.8

2.1

131.97

133.40

g/l

0.16

232

Supervision of high-risk pregnancy

167

905

1.11

0.63

2.3

1.9

133.76

132.59

g/l

0.39

133

730

Other bursitis of elbow

1.54

0.63

2.8

2.2

127.14

132.52

g/l

—

Use of selegiline

442

1.21

0.63

1.8

2.3

123.39

127.70

g/l

0.60

353

Brain meningioma

433

1.21

0.63

1.8

2.1

127.77

128.83

g/l

0.13

339

Benign neoplasm of other and unspecified sites

279

1.26

0.62

2.7

2.1

133.28

129.30

g/l

0.42

225

Single delivery by forceps and vacuum extractor

610

0.87

0.62

1.8

2.0

131.16

132.14

g/l

0.18

478

Absence of one kidney, including avohilmo

1.70

0.62

4.8

2.3

112.20

135.00

g/l

—

Benign neoplasm: Renal pelvis

0.00

0.61

0.0

2.4

—

117.73

—

Disorder of external ear, unspecified

298

1.25

0.61

2.6

2.2

133.81

129.62

g/l

0.56

243

Folliculitis decalvans

0.00

0.61

0.0

2.5

—

124.67

—

Use of peginterferon beta-1a

0.00

0.61

0.0

1.4

—

131.00

—

Hepatocellular carcinoma

227

1.29

0.60

2.7

2.2

118.87

132.55

g/l

2.64

184

Other congenital malformations of heart

1.55

0.60

2.3

2.4

140.38

132.32

g/l

—

Contraceptive management

373

2778

0.94

0.60

1.8

2.2

133.03

134.33

g/l

0.48

294

2175

Persons encountering health services in circumstances related to reproduction

590

4155

0.95

0.58

2.1

2.3

134.37

133.84

g/l

0.21

450

3245

Findings of drugs and other substances, not normally found in blood

1.74

0.58

2.2

132.00

127.76

g/l

—

Diving or jumping into water causing injury other than drowning or submersion

1.74

0.58

1.3

2.9

150.33

134.66

g/l

—

Inflammation of lacrimal passages (acute and unspecified)

149

1.35

0.58

1.8

2.0

132.69

128.56

g/l

0.33

122

Contusion of other and unspecified parts of foot

428

1.20

0.58

2.4

2.3

130.03

132.61

g/l

0.29

347

Exposure to other and unspecified inanimate mechanical forces

688

1.15

0.58

3.0

2.2

127.56

132.75

g/l

0.86

552

Brain meningioma, including Hilmo

456

1.19

0.57

1.8

2.1

127.46

128.89

g/l

0.20

357

Malignant neoplasm of other connective and soft tissue

229

1.27

0.57

2.6

2.3

118.45

130.17

g/l

1.18

189

Malignant neoplasm of eye, brain and central nervous system

365

1.21

0.56

1.7

2.2

137.19

132.76

g/l

0.58

302

Rare circulating lymphoid malignancy

1.47

0.56

4.0

1.8

115.38

132.67

g/l

—

Malignant neoplasm of ovary, including Hilmo

541

1.17

0.56

1.9

2.2

121.00

127.35

g/l

1.62

419

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

133

1.36

0.55

1.5

1.9

121.67

129.95

g/l

0.66

102

conjunctival degenerations and deposits

194

0.72

0.55

2.0

2.2

127.44

126.87

g/l

—

155

Impacted cerumen

119

1323

0.90

0.55

2.1

2.3

127.72

128.32

g/l

0.09

1026

Dementia in other diseases classified elsewhere

477

1.18

0.55

2.1

2.3

126.71

126.46

g/l

0.03

361

Malignant neoplasm of gum, including Hilmo

1.48

0.55

1.3

2.1

118.86

132.17

g/l

—

Disorder of thyroid, unspecified

116

1.39

0.55

1.9

2.1

118.70

124.97

g/l

—

Malaria

1.60

0.55

2.0

2.2

143.33

124.04

g/l

—

Benign neoplasm: Brain, supratentorial

116

1.39

0.55

1.3

2.1

140.50

128.92

g/l

—

Demyelinating diseases of the central nervous system

654

1.15

0.55

2.4

2.1

129.73

131.33

g/l

0.27

515

Operations for atrial fibrillation

151

1.34

0.54

1.6

2.5

126.09

128.19

g/l

0.10

119

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

376

1.20

0.54

1.6

2.0

131.05

128.47

g/l

0.34

297

All dysplastic lesions of the cervix uteri

220

2004

1.08

0.54

2.2

2.0

129.87

130.81

g/l

0.26

164

1598

Hand

1.55

0.53

1.8

2.3

130.00

127.59

g/l

—

Foreign body in alimentary tract

516

1.17

0.53

2.3

126.24

129.95

g/l

0.43

418

Pedal cyclist injured in collision with motor vehicle

268

1.24

0.53

1.9

2.3

135.29

131.38

g/l

0.54

220

MS-disease / Multiple Sclerosis

526

1.16

0.52

2.3

2.1

130.47

131.10

g/l

0.08

416

Desensitization to allergens

392

0.81

0.52

1.5

2.2

132.19

134.71

g/l

0.26

326

therapeutic use

287

1.23

0.52

2.0

2.2

123.81

127.65

g/l

0.47

232

Hereditary corneal dystrophies

342

1.21

0.51

3.3

2.2

130.48

127.67

g/l

0.31

271

Injury of muscle and tendon at lower leg level

165

1514

1.09

0.51

2.5

2.2

131.36

131.83

g/l

0.09

116

1171

Pedal cyclist injured in other and unspecified transport accidents

120

1085

1.11

0.50

2.0

2.3

128.78

131.35

g/l

0.49

856

Use of ropinirole

343

1.20

0.50

2.1

2.4

128.38

128.87

g/l

0.05

270

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

352

1.20

0.50

2.0

2.2

135.19

132.10

g/l

0.51

280

Nontoxic diffuse goitre

279

1.22

0.50

1.7

2.2

128.45

126.31

g/l

0.17

216

Dermatopolymyositis

127

1.35

0.50

3.7

2.1

121.56

131.01

g/l

—

103

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

270

1.23

0.50

1.5

2.2

138.13

130.97

g/l

0.81

219

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

1.44

0.50

4.6

2.3

121.33

127.73

g/l

—

Disorder of the sleep-wake schedule

127

1.35

0.50

2.4

2.7

136.08

128.54

g/l

0.43

103

Palmar fascial fibromatosis [Dupuytren]

188

1738

1.08

0.50

2.5

2.3

126.54

128.32

g/l

0.42

136

1316

Optic atrophy

136

1.33

0.49

2.4

2.2

133.30

130.97

g/l

—

109

Uterine polyps

304

1669

1.07

0.48

2.1

128.13

126.89

g/l

0.43

222

1268

Juvenile osteochondrosis

226

1.24

0.48

2.3

2.4

128.29

132.43

g/l

0.29

188

Oxicams

307

1639

1.06

0.48

2.1

2.6

130.31

127.41

g/l

1.24

228

1366

Chronic diseases of tonsils and adenoids

917

5982

0.97

0.47

2.1

2.3

133.65

131.33

g/l

2.14

674

4732

Benign neoplasm of male genital organs

188

0.74

0.47

2.1

2.6

124.38

130.07

g/l

—

149

Other nutritional anaemias

1.42

0.47

1.3

2.1

120.71

128.61

g/l

—

Injury of muscle and tendon at ankle and foot level

191

1.26

0.46

2.1

2.4

129.59

132.32

g/l

0.21

152

Family history of other specific disorders

1.39

0.46

2.0

2.2

127.62

132.95

g/l

—

Female infertility

241

1544

0.93

0.46

2.4

2.1

129.41

129.09

g/l

0.08

190

1191

Motor disorders, excluding more controls

1.39

0.46

2.7

3.3

135.00

134.18

g/l

0.05

Pedal cyclist injured in transport accident

246

2307

1.07

0.45

2.2

130.81

131.61

g/l

0.19

193

1799

Laparoscopic left hemicolectomy

165

1.28

0.45

1.9

2.3

122.86

127.93

g/l

0.26

133

Tooth eruption problems

138

1222

1.09

0.45

2.7

2.2

132.57

133.09

g/l

0.12

116

1036

Effects of foreign body entering through natural orifice

276

2600

1.06

0.45

2.0

2.3

133.74

132.44

g/l

0.38

230

2027

Tongue abnormality

591

1.14

0.44

2.1

2.3

130.69

128.04

g/l

0.43

470

Optic neuritis

311

1.19

0.44

3.1

2.1

121.88

130.38

g/l

1.51

250

Medical treatment for female infertility

136

1466

0.92

0.44

2.1

1.9

127.00

132.48

g/l

2.44

114

1171

Abnormalities of forces of labour

683

0.88

0.44

1.5

1.9

136.03

131.84

g/l

0.71

527

Benign neoplasm: Skin of other and unspecified parts of face

119

1087

1.10

0.43

2.4

2.2

127.99

127.53

g/l

0.08

849

Injury of blood vessels at forearm level

1.64

0.43

3.0

2.3

116.80

132.43

g/l

—

Crowding of teeth, including avohilmo

654

1.12

0.43

3.0

2.2

136.65

133.82

g/l

0.61

570

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.63

0.43

3.4

1.6

132.00

130.76

g/l

—

Transient global amnesia

106

963

1.10

0.43

2.1

2.4

133.24

126.56

g/l

2.32

731

Hepatocellular carcinoma, including Hilmo

303

1.19

0.43

2.5

2.1

120.48

133.13

g/l

2.59

241

Malignant melanoma of skin

136

1252

1.09

0.42

2.0

2.2

128.79

131.08

g/l

0.50

107

980

Congenital malformations of uterus and cervix

131

1.30

0.42

2.1

2.0

128.67

132.78

g/l

0.46

110

Other disorders of eye and adnexa

150

1387

1.08

0.42

2.3

130.31

129.53

g/l

0.15

113

1085

Congenital glaucoma

0.00

0.42

0.0

2.1

—

118.70

—

Carcinoma in situ of bronchus and lung

0.00

0.42

0.0

2.9

—

126.70

—

Pityriasis rosea

1.39

0.42

3.3

1.9

144.88

129.10

g/l

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.41

0.0

1.9

—

131.36

—

Drug-induced tremor

1.37

0.41

2.9

1.9

129.00

128.50

g/l

—

Melanocytic naevi of lower limb, including hip

379

1.16

0.41

2.8

2.3

127.72

130.59

g/l

0.28

305

Propionic acid derivatives

400

1917

1.05

0.41

2.4

2.6

131.94

128.49

g/l

2.06

315

1618

Cyclic neutropenia

0.00

0.41

0.0

2.3

—

134.10

—

Unicornuate uterus

0.00

0.41

0.0

2.1

—

123.73

—

Pterygium

296

1.19

0.41

1.8

2.4

131.30

129.11

g/l

0.15

238

Multiple delivery

596

1.13

0.40

1.7

2.2

135.46

129.12

g/l

2.19

435

Other drug-induced secondary parkinsonism

1.38

0.40

7.1

2.0

118.33

131.48

g/l

0.90

Intentional self-harm by drowning and submersion

0.00

0.40

0.0

2.1

—

126.67

—

Congenital malformations of nose, including avohilmo

0.00

0.40

0.0

2.9

—

134.00

—

Laparoscopic right hemicolectomy

625

1.12

0.40

1.6

2.3

123.09

127.13

g/l

0.59

497

Other infective otitis externa

550

0.87

0.40

2.9

2.3

130.16

130.43

g/l

0.02

437

Localized swelling, mass and lump of skin and subcutaneous tissue

353

3703

0.95

0.40

2.3

128.61

129.14

g/l

0.14

236

2844

Anisometropia and aniseikonia

306

1.18

0.40

2.5

2.3

124.89

130.31

g/l

0.54

250

Lesion of plantar nerve

531

1.13

0.39

2.1

2.3

134.00

126.91

g/l

1.76

404

Macular cyst

325

1.17

0.39

1.8

2.4

129.10

125.94

g/l

0.31

258

Other disorders of the genitourinary system

143

1325

1.08

0.39

2.1

2.3

128.05

126.01

g/l

0.42

102

1015

Multiple congenital exostoses, including avohilmo

0.00

0.39

0.0

1.9

—

132.85

—

Melanocytic naevi

354

3376

1.05

0.39

3.0

2.3

129.76

129.94

g/l

0.05

274

2617

Other specified and unspecified disorders of lens

1.36

0.38

2.1

128.86

125.39

g/l

—

Separation of retinal layers (serosa)

354

1.16

0.38

2.8

2.3

139.55

130.26

g/l

1.74

271

Graves ophthalmopathy

197

1.22

0.38

2.0

2.1

133.83

128.86

g/l

0.47

154

Disorders of lacrimal system and orbit in diseases classified elsewhere

197

1.22

0.38

2.0

133.83

129.77

g/l

0.37

158

Maternal care related to the fetus and amniotic cavity and possible delivery problems

397

2224

1.05

0.38

2.2

2.0

129.98

130.27

g/l

0.11

329

1717

Contusion of toe(s) without damage to nail

197

1.22

0.38

1.9

2.0

134.75

131.64

g/l

0.24

163

Effects of heat and light

1.31

0.37

1.6

2.1

135.00

127.35

g/l

—

Delayed milestone in childhood

128

1.27

0.37

3.4

3.3

130.11

136.97

g/l

0.71

115

Contact with other sharp object(s)

572

1.12

0.37

2.4

2.3

132.44

134.39

g/l

0.24

463

Delivery, wide proxy

403

2046

1.05

0.36

2.4

2.1

126.80

126.64

g/l

0.05

325

1597

Inflammatory disease of cervix uteri

516

1.13

0.36

2.2

127.80

126.26

g/l

0.23

406

Antenatal screening

166

994

0.93

0.36

2.0

1.9

130.31

132.56

g/l

0.77

132

810

Benign neoplasm: Skin of eyelid, including canthus

158

1688

0.93

0.35

2.4

2.2

123.81

127.40

g/l

0.96

118

1299

Disorders of other and unspecified cranial nerves

1.41

0.35

2.7

2.4

142.50

123.94

g/l

—

Polypectomy (DHB20)

622

1.11

0.35

2.8

2.2

134.84

130.69

g/l

0.77

490

LeFortI or BSSO operation

273

1.18

0.35

1.8

2.0

132.33

134.54

g/l

0.21

218

Intrahepatic Cholestasis of Pregnancy (ICP)

452

1.13

0.34

1.9

2.2

132.33

131.44

g/l

0.15

371

Progressive vascular leukoencephalopathy

462

1.13

0.34

2.9

2.3

133.90

124.21

g/l

1.96

369

Postpartum haemorrhage due to anatomy

773

0.90

0.34

1.5

2.2

129.53

131.38

g/l

0.36

664

Conductive hearing loss, unspecified

758

1.10

0.33

2.3

2.2

131.03

128.95

g/l

0.29

584

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

0.69

0.33

1.7

1.9

129.83

129.45

g/l

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hemoglobin [Mass/volume] in Capillary blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS